data_6l95_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6l95 _Structure_validation_residue.Date_analyzed 2020-11-13 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 m -65.77 -45.74 81.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.1 -0.375 . . . . 0.0 110.397 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -68.33 -43.89 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.072 -0.392 . . . . 0.0 110.545 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.4 p -65.2 -43.6 91.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.944 -0.472 . . . . 0.0 110.85 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 tp -66.45 -40.58 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.87 -46.94 88.62 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.23 -39.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.5 80.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.32 98.69 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -44.62 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -43.49 98.72 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 m -60.88 -42.21 97.52 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.66 73.05 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -60.11 -49.16 78.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.42 -42.12 96.23 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.277 -0.265 . . . . 0.0 111.217 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 m -68.83 -47.33 66.29 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.844 -0.535 . . . . 0.0 110.589 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.07 -46.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.015 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.09 -39.7 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.706 -0.621 . . . . 0.0 110.109 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.3 m -65.37 -43.97 89.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.831 -0.543 . . . . 0.0 110.231 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 5.8 tp -66.72 -37.89 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.853 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -46.78 87.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.04 -39.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.22 93.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.872 -0.517 . . . . 0.0 109.881 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.5 55.06 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.53 -42.0 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 117.801 0.8 . . . . 0.0 109.002 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.5 tt -61.92 -43.1 99.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.84 -47.01 79.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.31 74.99 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -46.57 86.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.2 -40.94 97.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.395 -0.19 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.6 m -63.96 -47.02 82.07 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 46.9 mt -65.93 -41.15 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -37.28 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.0 -27.05 54.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.1 p -67.8 -43.5 79.55 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.039 -0.413 . . . . 0.0 110.588 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.4 m -68.21 -45.09 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.722 -0.611 . . . . 0.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 t -65.34 -43.16 91.79 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.882 -0.511 . . . . 0.0 111.231 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.39 -38.66 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.67 -0.644 . . . . 0.0 109.873 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -47.28 82.17 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.39 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.67 75.49 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.7 -39.38 93.68 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.38 -45.04 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.16 -43.05 96.36 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.6 p -60.62 -47.0 88.14 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.4 72.74 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.746 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 p -59.19 -46.64 87.88 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.08 -42.79 96.84 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.327 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.1 p -68.37 -47.4 67.51 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.786 -0.571 . . . . 0.0 110.519 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.02 -45.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 9.6 m0 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.261 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.16 -43.91 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 30.5 p -65.39 -43.93 89.12 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.634 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.63 -37.77 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.87 88.81 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.49 -39.92 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.17 87.32 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.15 -41.96 78.16 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.44 -38.44 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.86 -43.24 99.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -47.12 75.77 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.3 71.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.295 -0.253 . . . . 0.0 110.382 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.9 m -66.02 -49.93 66.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.33 -41.93 96.55 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.515 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -70.05 -47.48 61.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.829 -0.544 . . . . 0.0 110.566 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.4 -45.03 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.3 -38.86 77.9 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -62.45 -39.1 92.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.07 -0.394 . . . . 0.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -83.37 -9.48 59.02 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.715 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.8 mtt . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 179.66 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.5 p -64.74 -48.13 75.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.045 -0.41 . . . . 0.0 110.118 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 28.8 m -68.4 -39.35 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.922 -0.486 . . . . 0.0 110.355 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.0 p -65.14 -43.68 91.09 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.923 -0.485 . . . . 0.0 110.574 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.5 tp -66.32 -37.93 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.9 -47.21 85.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 51.3 t -67.23 -39.42 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.72 82.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.029 -0.419 . . . . 0.0 110.051 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.06 97.07 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -68.83 -43.71 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -43.48 90.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.186 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 p -66.87 -47.52 71.6 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.162 -0.337 . . . . 0.0 110.197 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.12 77.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.736 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.3 t -55.89 -41.01 73.84 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -40.92 96.4 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.4 p -73.82 -45.72 49.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.684 -0.635 . . . . 0.0 111.316 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.73 -46.02 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.26 -43.74 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.796 -0.565 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 5.0 t -64.95 -43.05 94.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.811 -0.556 . . . . 0.0 111.397 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tp -66.04 -38.04 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.692 -0.63 . . . . 0.0 109.395 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.0 -43.46 91.52 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -39.66 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.69 -33.95 76.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.842 -0.536 . . . . 0.0 110.694 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.36 -46.32 34.14 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.22 -34.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.83 -42.95 99.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -40.34 96.8 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.32 85.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.27 -0.269 . . . . 0.0 110.647 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 6.3 p -66.88 -46.79 73.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.27 97.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.411 -0.181 . . . . 0.0 111.225 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 12.3 p -72.42 -47.34 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 0.0 110.334 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.18 -43.39 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -57.98 -44.29 87.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.16 -36.67 84.81 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -76.85 -26.97 54.89 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 53.6 mtt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.792 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 24.5 p -66.19 -46.98 75.42 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.146 -0.346 . . . . 0.0 110.216 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.08 -42.84 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.975 -0.453 . . . . 0.0 110.747 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.1 m -62.85 -43.92 97.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.757 -0.59 . . . . 0.0 110.419 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.38 -38.35 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.56 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.15 -46.97 75.58 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.21 -39.81 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.9 88.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.862 -0.524 . . . . 0.0 109.812 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.98 -40.7 88.76 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.8 t -67.12 -40.98 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -43.64 98.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.2 m -60.14 -46.27 90.21 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.88 66.14 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.2 p -61.4 -43.71 98.4 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.11 -45.18 89.73 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.216 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.0 p -68.29 -47.24 68.19 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.848 -0.532 . . . . 0.0 110.93 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.13 -44.32 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 3.5 t90 . . . . . 0 N--CA 1.496 1.838 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.036 -178.71 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.26 -44.34 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 18.7 p -65.15 -43.43 91.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.199 -0.313 . . . . 0.0 111.56 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.35 -40.75 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.709 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.52 -46.51 82.58 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.12 -39.95 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.18 88.97 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.16 -38.44 96.52 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.6 -41.45 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.04 -43.16 96.38 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -44.26 89.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.25 71.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 m -65.44 -49.34 69.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.36 -40.85 96.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 122.311 -0.243 . . . . 0.0 110.878 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -62.8 -47.2 84.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.854 -0.529 . . . . 0.0 110.028 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.06 -46.43 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -58.1 -41.99 84.73 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.69 -39.26 93.35 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -76.75 -27.08 55.24 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.068 -0.395 . . . . 0.0 110.216 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.918 -0.489 . . . . 0.0 110.359 -179.505 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.4 t -67.88 -46.04 72.79 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.082 -0.386 . . . . 0.0 110.432 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 28.5 m -68.29 -45.79 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.893 -0.504 . . . . 0.0 110.912 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.4 t -65.18 -43.32 92.07 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.781 -0.574 . . . . 0.0 110.969 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.2 tp -66.1 -38.7 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.526 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -60.04 -47.0 87.66 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.96 -40.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.71 80.83 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.07 95.54 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.17 -45.04 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.5 -43.23 97.84 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.3 p -63.42 -45.98 88.47 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.89 68.06 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -59.63 -48.83 80.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.36 -41.55 96.67 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.345 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -70.14 -46.94 63.69 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.821 -0.549 . . . . 0.0 111.052 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.8 mt -66.92 -42.37 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 122.236 -0.29 . . . . 0.0 111.01 -178.337 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 6.7 t -68.29 -42.75 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.938 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 18.2 tt -66.51 -38.4 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -47.16 85.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.97 -39.74 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.93 87.59 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.78 -39.62 76.4 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.18 -42.78 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.01 -43.18 99.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 29.9 m -62.18 -43.83 97.95 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -61.59 -49.44 76.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.002 -0.436 . . . . 0.0 109.897 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.21 -40.86 96.93 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.291 -0.256 . . . . 0.0 110.812 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 10.3 p -64.11 -47.23 80.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 55.2 mt -66.39 -36.21 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -44.6 86.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.26 -0.275 . . . . 0.0 110.674 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -72.0 -27.66 62.88 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.67 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -76.89 -26.93 54.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.847 -0.533 . . . . 0.0 110.375 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 24.2 mtt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.485 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.499 2.01 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.5 t -67.13 -39.39 86.6 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.84 -39.38 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -59.43 -41.4 89.5 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 51.1 mm -65.8 -46.88 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.28 -47.49 85.19 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.552 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.4 m -67.6 -46.19 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.996 -0.44 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.16 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.98 99.22 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.99 -43.89 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 117.846 0.823 . . . . 0.0 108.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.01 -43.11 99.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -63.85 -46.88 83.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.56 80.63 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m -55.68 -40.26 72.07 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -40.9 96.49 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.982 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.8 p -73.93 -47.17 39.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.653 -0.654 . . . . 0.0 110.782 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.9 mt -63.32 -49.06 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 19.5 t90 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.792 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 45.4 p . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.4 -40.95 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 11.3 m -65.0 -43.86 91.16 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.221 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 tt -66.5 -42.48 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.185 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.88 -47.08 86.2 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.89 -39.96 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.19 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.77 94.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.58 -44.15 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.94 -43.35 99.03 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 19.3 m -64.62 -38.82 92.33 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.86 -36.3 72.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.347 -0.22 . . . . 0.0 110.905 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.3 p -69.31 -42.89 74.81 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.21 -43.34 95.34 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.423 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p -75.15 -47.38 28.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.713 -0.617 . . . . 0.0 110.795 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.42 -43.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -57.95 -39.82 79.04 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.797 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -78.04 -27.3 48.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.169 -0.332 . . . . 0.0 110.758 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.26 8.75 34.02 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.885 -0.509 . . . . 0.0 111.774 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.2 ptm . . . . . 0 N--CA 1.502 2.173 0 CA-C-N 119.022 0.828 . . . . 0.0 109.824 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 63.2 p -67.93 -48.62 65.43 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.078 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -39.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.751 -0.593 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 47.8 p -65.34 -39.18 92.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.156 -0.34 . . . . 0.0 111.61 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.36 -40.85 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-N 118.705 0.684 . . . . 0.0 109.653 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -63.99 -44.62 92.12 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.18 -39.6 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.12 87.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.36 -42.24 97.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.99 -44.09 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.98 -43.2 99.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.9 m -59.0 -39.47 81.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.029 -0.42 . . . . 0.0 110.016 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.79 -37.44 73.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.019 -0.426 . . . . 0.0 110.763 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.3 t -58.98 -46.3 88.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.54 -42.49 95.7 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.57 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.8 p -68.96 -47.68 65.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.8 mt -67.14 -50.87 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 18.5 t90 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.29 -44.64 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 9.9 m -65.16 -43.39 91.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.387 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.11 -47.36 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.387 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.35 -46.8 72.32 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.1 -39.4 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.57 82.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.843 -0.535 . . . . 0.0 109.69 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.28 -41.2 69.13 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -44.43 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 118.078 0.939 . . . . 0.0 109.077 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.22 -43.2 98.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 59.5 m -63.93 -43.07 96.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.51 82.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.1 m -63.32 -43.12 98.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.37 -41.05 96.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.277 -0.264 . . . . 0.0 111.331 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 36.7 p -68.48 -47.28 67.47 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.64 -0.663 . . . . 0.0 110.464 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mt -65.55 -50.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -62.03 -45.09 95.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.66 -38.99 92.89 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -77.07 -27.22 54.18 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.189 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 42.5 mtt . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.963 -0.461 . . . . 0.0 109.804 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 25.0 m -70.06 -38.33 75.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -68.29 -44.78 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.455 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.52 -42.91 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.037 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -47.18 87.44 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.38 -39.76 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.85 80.41 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.14 88.79 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.53 -42.43 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.22 -43.09 99.61 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.614 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -66.51 -47.54 72.61 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.971 -0.456 . . . . 0.0 110.107 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.33 78.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -58.36 -36.03 72.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.15 -42.24 96.85 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 122.058 -0.401 . . . . 0.0 111.509 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.8 m -74.93 -47.25 30.65 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.846 0.748 . . . . 0.0 110.689 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.7 mt -67.22 -45.84 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 46.4 t90 . . . . . 0 N--CA 1.5 2.039 0 O-C-N 122.004 -0.435 . . . . 0.0 110.389 -178.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.499 2.01 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.56 -38.78 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.1 -41.47 94.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.165 -0.334 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.42 -42.89 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.11 -45.91 75.76 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.72 -39.92 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.69 88.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.85 -0.531 . . . . 0.0 109.667 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.33 -38.12 91.16 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.99 -45.04 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.82 -43.5 79.47 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -69.05 -38.83 79.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.27 73.79 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.6 m -51.49 -45.66 62.89 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 29.4 mt -64.32 -40.53 96.09 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.675 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 33.8 p -70.85 -47.46 59.24 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.849 -0.532 . . . . 0.0 112.424 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 17.3 pt -67.11 -40.51 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.887 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -36.01 71.57 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.665 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.61 -38.96 90.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.048 -0.408 . . . . 0.0 110.277 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -91.56 -16.84 26.54 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 110.977 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 5.2 mmt . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.771 -0.581 . . . . 0.0 109.652 -179.627 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 t -70.12 -38.16 75.5 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.2 -43.97 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 74.8 m -65.25 -43.36 91.63 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 122.384 -0.197 . . . . 0.0 111.465 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.74 -41.0 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.483 -0.761 . . . . 0.0 110.59 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -61.91 -47.19 86.06 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 m -67.3 -38.96 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.07 84.93 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.61 92.42 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.87 -44.06 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 117.614 0.707 . . . . 0.0 109.15 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.73 -43.25 84.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.364 -0.21 . . . . 0.0 110.436 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 p -60.22 -47.63 85.16 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.06 -0.4 . . . . 0.0 110.374 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -69.85 -31.63 69.58 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.037 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 t -58.61 -40.76 84.17 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.44 -42.09 96.19 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.105 -0.372 . . . . 0.0 111.262 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 m -72.84 -47.42 46.4 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 118.812 0.733 . . . . 0.0 110.592 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.15 -49.67 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 122.113 -0.367 . . . . 0.0 110.255 -178.202 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.0 -40.69 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.7 m -64.51 -43.3 94.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.218 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -48.57 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.857 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.4 -47.39 70.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.859 -0.526 . . . . 0.0 110.137 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.19 -39.74 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.87 84.08 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 118.453 0.569 . . . . 0.0 109.94 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.74 -44.54 89.18 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.27 -39.56 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 117.683 0.741 . . . . 0.0 109.171 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -43.24 99.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.74 -47.13 84.91 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.39 -41.1 96.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 122.329 -0.232 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 19.1 m -69.07 -49.44 57.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.879 -0.513 . . . . 0.0 109.727 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.58 97.07 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.574 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 20.8 p -69.56 -47.51 63.4 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 118.606 0.639 . . . . 0.0 110.558 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.66 -45.43 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -57.91 -45.13 86.95 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.344 -0.223 . . . . 0.0 111.292 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -23.07 63.86 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.545 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -84.79 -13.65 50.49 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.873 -0.517 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.624 -0.672 . . . . 0.0 110.166 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.4 m -61.86 -47.2 86.08 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.16 -38.87 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.005 -0.435 . . . . 0.0 110.426 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 20.8 p -64.16 -43.91 93.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.784 -0.573 . . . . 0.0 111.561 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.69 -42.7 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 118.502 0.592 . . . . 0.0 109.902 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -46.64 86.24 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.64 -39.72 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.875 -0.516 . . . . 0.0 110.451 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.84 -43.91 48.91 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.87 -43.75 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 118.015 0.908 . . . . 0.0 108.938 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.01 -42.97 99.95 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.412 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 p -64.34 -47.27 79.98 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.61 78.21 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 m -58.95 -39.4 81.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -41.27 96.7 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 122.12 -0.362 . . . . 0.0 111.382 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -47.16 30.36 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -48.21 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 122.031 -0.418 . . . . 0.0 110.175 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.944 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.799 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.27 -39.45 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.906 -0.496 . . . . 0.0 109.922 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 27.5 m -62.31 -41.98 98.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.227 -0.296 . . . . 0.0 111.063 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.68 -41.77 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.932 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.08 -47.2 71.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.974 -0.454 . . . . 0.0 110.13 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.05 -39.76 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.485 . . . . 0.0 109.799 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.85 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.6 -42.29 88.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.1 -40.92 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 22.5 m -68.55 -43.6 76.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.24 77.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.213 -0.304 . . . . 0.0 110.319 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.6 p -69.39 -41.44 76.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.88 -44.24 93.62 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.46 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -47.29 74.33 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.32 -49.89 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -44.06 88.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -65.02 -37.86 89.02 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -78.84 -22.02 46.76 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.065 -0.397 . . . . 0.0 110.196 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 19.9 mmt . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.867 -0.52 . . . . 0.0 110.131 -179.719 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 m -57.52 -47.77 81.07 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.939 -0.475 . . . . 0.0 110.152 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.04 -38.91 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.339 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.4 p -65.4 -44.17 88.31 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.661 -0.649 . . . . 0.0 110.349 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.69 -42.06 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.71 -46.88 86.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -39.93 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.59 80.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.02 -39.7 93.18 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.38 -44.56 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.023 0.912 . . . . 0.0 108.604 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.46 -43.16 95.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.0 m -68.99 -45.67 70.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.51 80.76 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.8 p -57.97 -39.68 78.75 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -41.01 97.11 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.879 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 p -69.5 -47.35 64.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.656 -0.652 . . . . 0.0 110.88 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.43 -46.29 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.35 -40.36 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 16.7 m -58.99 -43.14 91.4 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.3 mp -65.39 -45.41 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -44.14 89.87 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.02 -39.9 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -40.07 70.14 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.26 99.8 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.32 -38.01 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.78 -43.18 99.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 11.4 m -58.98 -41.26 87.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.04 91.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -49.37 76.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -41.08 97.3 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.369 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.7 p -67.43 -47.54 69.9 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.683 -0.636 . . . . 0.0 111.339 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.23 -42.23 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.38 -44.25 97.48 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.869 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.78 -36.32 72.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -76.83 -27.08 55.0 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.371 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.93 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 59.4 p -70.05 -34.69 73.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.6 t -68.42 -42.42 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.1 m -65.24 -43.98 89.66 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.096 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.64 -44.56 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.092 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -46.89 76.73 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.78 -39.62 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.07 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 118.564 0.62 . . . . 0.0 109.621 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.38 -44.26 85.17 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.8 t -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.66 -43.33 99.07 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -47.36 72.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.785 -0.572 . . . . 0.0 109.676 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.16 70.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.835 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.1 t -59.87 -46.86 87.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.51 -42.52 95.75 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -67.88 -47.37 69.04 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.234 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.46 -48.16 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.3 t-105 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.809 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.503 2.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.53 -42.46 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.803 -0.561 . . . . 0.0 110.437 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -64.97 -43.42 92.7 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 122.089 -0.382 . . . . 0.0 111.404 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.27 -41.79 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.718 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.03 -45.24 89.78 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.09 -39.64 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.55 75.14 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.03 -42.13 94.8 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.99 -44.38 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.05 -43.14 99.48 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 57.1 m -62.42 -45.21 94.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.91 85.49 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.091 -0.381 . . . . 0.0 110.749 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.7 p -69.82 -47.71 61.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.92 -40.61 96.87 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.499 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 4.0 m -75.0 -47.19 30.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.233 0.924 . . . . 0.0 110.23 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.21 -44.46 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -67.46 -43.11 81.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.092 -0.38 . . . . 0.0 110.974 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -66.89 -37.17 83.88 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.878 -0.514 . . . . 0.0 110.234 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -82.77 -27.31 31.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.042 -0.411 . . . . 0.0 110.169 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 32.2 mtt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.91 -0.494 . . . . 0.0 109.716 179.9 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 26.7 p -69.18 -31.82 70.7 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.75 -43.91 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.5 m -65.02 -44.02 90.54 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.9 tt -66.73 -38.87 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.52 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.01 -45.98 89.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.34 -39.29 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.03 85.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.995 -0.441 . . . . 0.0 109.932 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.06 72.61 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.89 -34.19 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 122.003 -0.704 . . . . 0.0 109.25 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -43.2 91.34 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -62.86 -47.22 84.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.568 . . . . 0.0 109.944 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.29 -40.81 67.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -58.67 -42.85 89.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.33 -43.06 95.81 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.186 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.03 -47.36 52.35 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.776 -0.577 . . . . 0.0 110.491 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.23 -49.2 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 62.8 t90 . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.218 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 120.31 0.1 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.2 -40.37 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.517 . . . . 0.0 110.811 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.5 m -65.04 -43.61 91.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.684 -0.635 . . . . 0.0 110.96 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -47.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.657 -0.652 . . . . 0.0 110.15 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.36 -47.45 70.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.006 -0.434 . . . . 0.0 110.105 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.22 -39.96 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.22 86.43 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.14 99.6 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.0 -39.98 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 mt -62.02 -43.64 98.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.22 -0.3 . . . . 0.0 110.368 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -46.95 65.79 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.999 -0.438 . . . . 0.0 109.839 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.31 98.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.251 -0.28 . . . . 0.0 110.604 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 58.5 m -69.13 -50.04 51.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.887 -0.508 . . . . 0.0 110.317 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.47 -41.41 96.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.307 -0.246 . . . . 0.0 111.638 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 28.1 p -68.07 -47.34 68.58 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.408 0.549 . . . . 0.0 111.1 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.31 -44.83 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -62.15 -45.32 93.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.783 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -78.3 -31.09 48.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.771 -0.58 . . . . 0.0 110.985 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -79.1 -25.66 43.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.032 -0.418 . . . . 0.0 110.66 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 51.0 mtt . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.819 -0.551 . . . . 0.0 109.807 -179.808 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.5 m -59.3 -47.02 86.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.138 -0.351 . . . . 0.0 110.171 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.5 m -63.74 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 109.912 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -58.65 -43.43 89.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.099 -0.375 . . . . 0.0 110.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 tp -65.51 -41.75 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.65 -45.75 91.37 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.65 -39.63 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.692 -0.63 . . . . 0.0 109.807 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.52 -42.96 62.62 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.96 -44.36 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 117.977 0.889 . . . . 0.0 108.967 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.85 -43.3 99.16 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.5 m -58.94 -44.74 91.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.25 69.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.11 -0.369 . . . . 0.0 111.52 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -59.57 -44.42 93.31 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.43 -44.7 90.37 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 13.3 p -66.03 -47.76 73.33 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.429 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 59.0 mt -67.7 -50.76 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 . . . . . 0 N--CA 1.496 1.863 0 O-C-N 122.357 -0.214 . . . . 0.0 110.64 -178.373 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 7.5 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 120.513 0.197 . . . . 0.0 110.479 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.57 -39.24 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.765 -0.584 . . . . 0.0 110.264 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 21.2 p -64.16 -43.31 95.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.96 -0.463 . . . . 0.0 111.847 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.08 -42.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 118.798 0.727 . . . . 0.0 109.98 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.08 -45.7 76.53 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.34 -40.3 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.79 79.0 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.847 -0.533 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.23 94.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.79 -43.09 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.45 -43.45 98.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 1.9 p -61.73 -47.19 86.37 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 120.949 0.404 . . . . 0.0 110.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.72 -29.34 70.04 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.089 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -50.72 58.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.84 -0.538 . . . . 0.0 110.461 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -44.15 90.42 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.582 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -47.5 85.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.181 -0.325 . . . . 0.0 111.156 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.12 -46.03 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -64.7 -34.93 79.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.3 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -63.51 -35.42 80.41 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.066 -0.397 . . . . 0.0 110.087 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -91.13 0.69 57.48 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 122.018 -0.426 . . . . 0.0 111.057 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.741 -0.599 . . . . 0.0 109.765 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 m -69.14 -48.07 63.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.206 -0.309 . . . . 0.0 110.34 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.84 -41.6 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.08 -0.388 . . . . 0.0 111.088 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 t -62.86 -41.45 99.38 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.967 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.25 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.29 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.07 -47.45 85.81 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.822 -0.549 . . . . 0.0 109.853 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.14 -39.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.912 -0.493 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.93 93.39 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.9 -42.37 94.94 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.79 -44.99 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.98 -42.95 97.06 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.3 m -63.96 -44.34 93.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.08 -41.31 96.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.066 -0.397 . . . . 0.0 110.453 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -36.37 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.56 -41.79 96.08 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -36.1 65.64 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.871 0.759 . . . . 0.0 110.059 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.33 -47.93 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.76 -43.66 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.4 p -64.76 -43.34 93.6 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.915 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.25 -48.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -47.1 85.8 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.23 -39.84 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.29 73.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.922 -0.486 . . . . 0.0 110.449 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.77 -43.64 58.72 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.06 -43.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 117.735 0.767 . . . . 0.0 108.957 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.18 -43.31 95.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 64.4 m -64.7 -43.0 94.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.045 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 30.3 t -68.96 -45.74 69.91 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.41 -44.04 92.5 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.588 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.8 m -65.26 -47.05 78.1 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 118.637 0.653 . . . . 0.0 109.954 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -66.94 -47.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -60.53 -38.34 84.12 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.02 -39.14 91.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -80.29 -27.23 38.55 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.232 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.7 mtm . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.233 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.2 m -99.44 132.18 23.68 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -66.86 149.62 83.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.842 1.695 . . . . 0.0 111.842 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.8 m -81.29 157.14 25.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -102.07 -8.75 21.16 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.212 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -69.09 -40.3 78.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 110.093 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 m -65.77 -45.74 81.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.1 -0.375 . . . . 0.0 110.397 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 35.4 m -68.33 -43.89 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.072 -0.392 . . . . 0.0 110.545 -179.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.4 p -65.2 -43.6 91.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.944 -0.472 . . . . 0.0 110.85 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 tp -66.45 -40.58 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.87 -46.94 88.62 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.23 -39.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.5 80.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.32 98.69 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -44.62 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -43.49 98.72 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 m -60.88 -42.21 97.52 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.66 73.05 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -60.11 -49.16 78.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.42 -42.12 96.23 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.277 -0.265 . . . . 0.0 111.217 -179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 m -68.83 -47.33 66.29 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.844 -0.535 . . . . 0.0 110.589 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.07 -46.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -58.17 -45.04 88.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -66.42 -36.07 81.89 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -78.88 -20.83 48.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.013 -0.43 . . . . 0.0 110.202 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 39.0 mtt -96.49 27.85 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.908 -0.495 . . . . 0.0 109.69 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.655 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.625 179.903 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 40.7 p -124.03 83.9 55.33 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -72.33 161.14 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.203 1.935 . . . . 0.0 112.253 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -51.63 160.77 0.59 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 122.14 -0.35 . . . . 0.0 110.109 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -65.97 -31.46 72.38 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.3 -39.57 81.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 25.1 m -63.79 -43.0 97.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.26 -0.275 . . . . 0.0 110.554 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.09 -39.7 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.706 -0.621 . . . . 0.0 110.109 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.3 m -65.37 -43.97 89.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.831 -0.543 . . . . 0.0 110.231 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 5.8 tp -66.72 -37.89 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.853 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.37 -46.78 87.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.04 -39.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.22 93.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.872 -0.517 . . . . 0.0 109.881 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.5 55.06 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.53 -42.0 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 117.801 0.8 . . . . 0.0 109.002 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.5 tt -61.92 -43.1 99.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.84 -47.01 79.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.31 74.99 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -46.57 86.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.2 -40.94 97.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.395 -0.19 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.6 m -63.96 -47.02 82.07 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 46.9 mt -65.93 -41.15 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -37.28 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.0 -27.05 54.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 49.5 mtt -99.98 38.24 1.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 CA-C-O 117.939 -1.478 . . . . 0.0 109.596 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.4 m -111.79 89.84 11.93 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.0 159.35 34.11 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.131 1.888 . . . . 0.0 112.239 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 p -61.73 120.23 10.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -96.91 -9.38 28.57 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.263 -0.273 . . . . 0.0 110.535 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -68.7 -34.44 75.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.1 p -67.8 -43.5 79.55 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.039 -0.413 . . . . 0.0 110.588 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.4 m -68.21 -45.09 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.722 -0.611 . . . . 0.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.6 t -65.34 -43.16 91.79 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.882 -0.511 . . . . 0.0 111.231 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tp -66.39 -38.66 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.67 -0.644 . . . . 0.0 109.873 -179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -47.28 82.17 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.39 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.67 75.49 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.7 -39.38 93.68 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.38 -45.04 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.6 tt -64.16 -43.05 96.36 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.6 p -60.62 -47.0 88.14 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.4 72.74 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.746 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.1 p -59.19 -46.64 87.88 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.08 -42.79 96.84 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.327 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.1 p -68.37 -47.4 67.51 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.786 -0.571 . . . . 0.0 110.519 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.02 -45.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -59.43 -38.48 80.79 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -63.0 -39.3 94.35 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.2 -16.78 36.7 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.071 -0.393 . . . . 0.0 110.556 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.7 mmt -98.53 22.38 9.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.802 -0.561 . . . . 0.0 109.962 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.739 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 41.3 p -131.71 85.94 50.21 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.0 159.44 34.06 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.206 1.937 . . . . 0.0 112.281 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -119.2 130.96 55.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -35.61 20.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -60.23 -32.89 71.55 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 20.4 p -64.16 -31.68 72.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.16 -43.91 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 30.5 p -65.39 -43.93 89.12 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.634 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.63 -37.77 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -58.77 -45.87 88.81 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.49 -39.92 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.17 87.32 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.15 -41.96 78.16 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.44 -38.44 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 9.0 tt -61.86 -43.24 99.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -47.12 75.77 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.3 71.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.295 -0.253 . . . . 0.0 110.382 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.9 m -66.02 -49.93 66.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.33 -41.93 96.55 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.515 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -70.05 -47.48 61.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.829 -0.544 . . . . 0.0 110.566 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.4 -45.03 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.3 -38.86 77.9 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -62.45 -39.1 92.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.07 -0.394 . . . . 0.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -83.37 -9.48 59.02 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.715 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.8 mtt -91.04 34.56 0.92 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.521 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 m -125.52 137.65 30.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 158.16 34.01 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.901 1.734 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.1 m -82.94 129.46 35.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 5.6 m-90 -101.31 -2.91 29.91 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.976 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.59 -38.49 81.36 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.553 -0.717 . . . . 0.0 109.66 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.5 p -64.74 -48.13 75.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.045 -0.41 . . . . 0.0 110.118 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 28.8 m -68.4 -39.35 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.922 -0.486 . . . . 0.0 110.355 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.0 p -65.14 -43.68 91.09 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.923 -0.485 . . . . 0.0 110.574 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.5 tp -66.32 -37.93 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.9 -47.21 85.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 51.3 t -67.23 -39.42 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.72 82.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.029 -0.419 . . . . 0.0 110.051 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.06 97.07 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -68.83 -43.71 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -43.48 90.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.186 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 p -66.87 -47.52 71.6 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.162 -0.337 . . . . 0.0 110.197 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.12 77.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.736 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.3 t -55.89 -41.01 73.84 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -40.92 96.4 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.4 p -73.82 -45.72 49.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.684 -0.635 . . . . 0.0 111.316 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.73 -46.02 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -35.2 70.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.52 -39.05 77.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.161 -0.337 . . . . 0.0 110.39 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -91.65 -10.81 38.95 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.118 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 76.0 mmm -110.43 24.95 12.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 109.92 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.69 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.666 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 32.3 p -125.69 87.68 55.47 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.16 149.01 45.31 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.107 1.871 . . . . 0.0 112.39 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m 62.87 151.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -101.7 -22.45 14.42 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 122.221 -0.299 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.26 -33.08 75.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.929 -0.482 . . . . 0.0 110.069 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 6.2 t -66.76 -43.95 82.71 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.0 -0.437 . . . . 0.0 110.607 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 16.6 m -68.26 -43.74 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.796 -0.565 . . . . 0.0 111.019 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 5.0 t -64.95 -43.05 94.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.811 -0.556 . . . . 0.0 111.397 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tp -66.04 -38.04 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.692 -0.63 . . . . 0.0 109.395 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.0 -43.46 91.52 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -39.66 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.69 -33.95 76.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.842 -0.536 . . . . 0.0 110.694 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.36 -46.32 34.14 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.22 -34.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.83 -42.95 99.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -40.34 96.8 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.32 85.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.27 -0.269 . . . . 0.0 110.647 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 6.3 p -66.88 -46.79 73.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.27 97.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.411 -0.181 . . . . 0.0 111.225 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 12.3 p -72.42 -47.34 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 0.0 110.334 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.18 -43.39 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -57.98 -44.29 87.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.16 -36.67 84.81 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -76.85 -26.97 54.89 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 53.6 mtt -82.97 52.75 2.24 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.621 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.0 p -123.68 138.08 29.74 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.5 142.04 35.87 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.876 1.717 . . . . 0.0 112.117 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.1 p -133.03 116.36 16.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -77.42 -16.28 58.9 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.495 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -39.03 82.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.663 -0.648 . . . . 0.0 109.695 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 24.5 p -66.19 -46.98 75.42 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.146 -0.346 . . . . 0.0 110.216 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.08 -42.84 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.975 -0.453 . . . . 0.0 110.747 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.1 m -62.85 -43.92 97.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.757 -0.59 . . . . 0.0 110.419 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.38 -38.35 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.56 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -66.15 -46.97 75.58 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.21 -39.81 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.9 88.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.862 -0.524 . . . . 0.0 109.812 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.98 -40.7 88.76 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.8 t -67.12 -40.98 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.48 -43.64 98.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.2 m -60.14 -46.27 90.21 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.88 66.14 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.2 p -61.4 -43.71 98.4 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -64.11 -45.18 89.73 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.216 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.0 p -68.29 -47.24 68.19 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.848 -0.532 . . . . 0.0 110.93 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.13 -44.32 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -59.98 -44.51 94.44 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.036 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -64.39 -39.09 93.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -76.91 -27.27 54.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.372 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 94.7 mtp -97.35 28.07 3.88 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.856 -0.528 . . . . 0.0 109.721 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 CA-C-O 117.957 -1.469 . . . . 0.0 109.517 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 12.7 m -129.0 92.43 39.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.99 160.48 49.47 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.988 1.792 . . . . 0.0 112.091 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 77.6 p -123.86 161.71 24.76 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 -5.37 44.65 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.834 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -62.74 -37.57 87.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.634 -0.666 . . . . 0.0 109.944 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 15.5 m -70.01 -39.11 76.04 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 4.0 t -68.26 -44.34 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 18.7 p -65.15 -43.43 91.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.199 -0.313 . . . . 0.0 111.56 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.35 -40.75 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.709 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.52 -46.51 82.58 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 75.1 t -67.12 -39.95 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.18 88.97 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.16 -38.44 96.52 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.6 -41.45 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.9 tt -64.04 -43.16 96.38 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -44.26 89.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.78 -36.25 71.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 m -65.44 -49.34 69.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.36 -40.85 96.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 122.311 -0.243 . . . . 0.0 110.878 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -62.8 -47.2 84.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.854 -0.529 . . . . 0.0 110.028 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.06 -46.43 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -58.1 -41.99 84.73 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.69 -39.26 93.35 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -76.75 -27.08 55.24 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.068 -0.395 . . . . 0.0 110.216 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 4.8 mmt -89.21 23.75 2.38 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.918 -0.489 . . . . 0.0 110.359 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.733 0 CA-C-O 118.038 -1.423 . . . . 0.0 109.636 179.657 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.9 p -127.31 85.19 61.52 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.98 152.48 80.25 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.249 1.966 . . . . 0.0 111.838 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 5.0 t -59.26 133.8 56.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 8.4 m-90 -98.49 -8.85 25.96 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.899 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.25 -36.87 82.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.792 -0.567 . . . . 0.0 110.012 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 6.4 t -67.88 -46.04 72.79 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.082 -0.386 . . . . 0.0 110.432 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 28.5 m -68.29 -45.79 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.893 -0.504 . . . . 0.0 110.912 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.4 t -65.18 -43.32 92.07 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.781 -0.574 . . . . 0.0 110.969 -178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.2 tp -66.1 -38.7 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.526 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -60.04 -47.0 87.66 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.96 -40.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.71 80.83 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.07 95.54 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.17 -45.04 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.5 -43.23 97.84 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.3 p -63.42 -45.98 88.47 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.89 68.06 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -59.63 -48.83 80.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.36 -41.55 96.67 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.345 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -70.14 -46.94 63.69 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.821 -0.549 . . . . 0.0 111.052 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.8 mt -66.92 -42.37 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -57.84 -38.89 76.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.236 -0.29 . . . . 0.0 111.01 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -78.07 -23.1 48.16 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.703 -0.623 . . . . 0.0 111.497 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.42 -27.58 29.47 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.666 0.666 . . . . 0.0 110.989 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.16 33.13 2.59 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.763 0 CA-C-O 117.877 -1.513 . . . . 0.0 109.848 179.294 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 14.4 m -123.8 100.63 37.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -66.96 156.04 68.1 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.967 1.778 . . . . 0.0 111.883 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t -55.68 171.6 0.2 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 11.4 t90 -94.42 -13.1 26.6 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.281 -0.262 . . . . 0.0 110.646 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.0 -32.88 70.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.83 -0.544 . . . . 0.0 109.897 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.1 t -67.74 -32.13 72.52 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 6.7 t -68.29 -42.75 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.938 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 18.2 tt -66.51 -38.4 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.43 -47.16 85.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.97 -39.74 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.93 87.59 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.78 -39.62 76.4 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 58.5 t -67.18 -42.78 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 10.0 tt -63.01 -43.18 99.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 29.9 m -62.18 -43.83 97.95 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -61.59 -49.44 76.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.002 -0.436 . . . . 0.0 109.897 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.21 -40.86 96.93 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.291 -0.256 . . . . 0.0 110.812 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 10.3 p -64.11 -47.23 80.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 55.2 mt -66.39 -36.21 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -44.6 86.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.26 -0.275 . . . . 0.0 110.674 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -72.0 -27.66 62.88 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.67 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -76.89 -26.93 54.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.847 -0.533 . . . . 0.0 110.375 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 24.2 mtt -98.95 31.06 3.12 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.698 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.8 p -122.87 115.88 29.16 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.68 142.34 63.61 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.818 1.679 . . . . 0.0 112.167 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.8 m -162.58 41.4 0.12 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -85.54 -2.75 58.47 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.895 -0.503 . . . . 0.0 110.776 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -58.96 -46.26 88.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.596 -0.69 . . . . 0.0 109.782 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.5 t -67.13 -39.39 86.6 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.84 -39.38 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -59.43 -41.4 89.5 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 51.1 mm -65.8 -46.88 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.28 -47.49 85.19 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.552 -178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 34.4 m -67.6 -46.19 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.996 -0.44 . . . . 0.0 109.946 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.56 -40.16 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.98 99.22 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.8 t -69.99 -43.89 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 117.846 0.823 . . . . 0.0 108.863 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.01 -43.11 99.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -63.85 -46.88 83.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.56 80.63 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m -55.68 -40.26 72.07 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -40.9 96.49 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.982 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.8 p -73.93 -47.17 39.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.653 -0.654 . . . . 0.0 110.782 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.9 mt -63.32 -49.06 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -62.35 -45.12 94.63 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -69.36 -35.39 75.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.126 -0.359 . . . . 0.0 110.164 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -80.58 -24.0 39.48 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 68.2 mtt -105.29 27.48 8.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.944 -0.472 . . . . 0.0 110.075 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.718 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.843 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 24.8 p -118.28 92.79 43.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.96 161.03 44.61 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.071 1.848 . . . . 0.0 112.065 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 5.8 t -58.02 135.8 57.03 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -101.89 -9.35 20.79 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.918 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -63.35 -45.89 89.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.672 -0.643 . . . . 0.0 109.546 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 45.4 p -70.11 -33.79 72.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 6.2 t -68.4 -40.95 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 11.3 m -65.0 -43.86 91.16 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.221 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 tt -66.5 -42.48 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.185 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.88 -47.08 86.2 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 57.3 t -65.89 -39.96 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.19 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.77 94.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.58 -44.15 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 10.2 tt -61.94 -43.35 99.03 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 19.3 m -64.62 -38.82 92.33 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.86 -36.3 72.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.347 -0.22 . . . . 0.0 110.905 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.3 p -69.31 -42.89 74.81 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.21 -43.34 95.34 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.423 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p -75.15 -47.38 28.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.713 -0.617 . . . . 0.0 110.795 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.42 -43.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -57.95 -39.82 79.04 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.797 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -78.04 -27.3 48.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.169 -0.332 . . . . 0.0 110.758 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.26 8.75 34.02 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.885 -0.509 . . . . 0.0 111.774 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.2 ptm -101.53 30.61 4.18 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 119.022 0.828 . . . . 0.0 109.824 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.826 0 CA-C-O 118.034 -1.426 . . . . 0.0 109.694 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.7 t -125.25 91.62 48.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 122.132 -0.628 . . . . 0.0 109.506 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.98 148.52 82.03 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.142 1.894 . . . . 0.0 111.665 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.9 t -124.22 134.91 53.14 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -99.14 -2.35 37.13 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -58.44 -33.75 70.05 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.475 -0.766 . . . . 0.0 110.481 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 63.2 p -67.93 -48.62 65.43 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.078 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -39.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.751 -0.593 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 47.8 p -65.34 -39.18 92.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.156 -0.34 . . . . 0.0 111.61 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.9 tp -65.36 -40.85 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-N 118.705 0.684 . . . . 0.0 109.653 -178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -63.99 -44.62 92.12 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.18 -39.6 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.12 87.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.36 -42.24 97.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.99 -44.09 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.98 -43.2 99.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.9 m -59.0 -39.47 81.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.029 -0.42 . . . . 0.0 110.016 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.79 -37.44 73.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.019 -0.426 . . . . 0.0 110.763 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.3 t -58.98 -46.3 88.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.54 -42.49 95.7 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.57 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.8 p -68.96 -47.68 65.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.8 mt -67.14 -50.87 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -60.31 -40.05 89.15 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -78.21 -23.35 47.54 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.08 -0.387 . . . . 0.0 111.363 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -27.3 16.05 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.655 0.661 . . . . 0.0 111.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 7.9 ptm -135.29 33.81 3.06 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.836 -0.54 . . . . 0.0 109.548 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.894 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.261 179.497 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 65.1 p -99.08 138.15 20.55 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.03 146.65 77.9 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.879 1.719 . . . . 0.0 111.983 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 22.9 p -120.62 161.82 20.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -60.28 -35.07 74.7 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.01 -33.32 70.59 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.028 -0.42 . . . . 0.0 110.207 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 10.0 m -69.96 -40.8 75.19 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 4.1 t -68.29 -44.64 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 9.9 m -65.16 -43.39 91.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.387 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.11 -47.36 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.387 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.35 -46.8 72.32 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 91.9 t -65.1 -39.4 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.57 82.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.843 -0.535 . . . . 0.0 109.69 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.28 -41.2 69.13 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -44.43 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 118.078 0.939 . . . . 0.0 109.077 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tt -63.22 -43.2 98.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 59.5 m -63.93 -43.07 96.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.51 82.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.1 m -63.32 -43.12 98.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.37 -41.05 96.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.277 -0.264 . . . . 0.0 111.331 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 36.7 p -68.48 -47.28 67.47 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.64 -0.663 . . . . 0.0 110.464 -177.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mt -65.55 -50.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -62.03 -45.09 95.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.66 -38.99 92.89 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -77.07 -27.22 54.18 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.189 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 42.5 mtt -96.14 31.57 2.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.963 -0.461 . . . . 0.0 109.804 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.512 179.79 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 m -115.23 83.3 10.01 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.06 157.19 34.19 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.208 1.939 . . . . 0.0 112.242 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -90.5 135.72 33.52 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -59.78 -36.58 76.99 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.06 -36.15 74.56 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 25.0 m -70.06 -38.33 75.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 4.9 t -68.29 -44.78 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.455 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.52 -42.91 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.037 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.69 -47.18 87.44 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.4 t -61.38 -39.76 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.85 80.41 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.14 88.79 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 16.1 t -69.53 -42.43 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.22 -43.09 99.61 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.614 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -66.51 -47.54 72.61 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.971 -0.456 . . . . 0.0 110.107 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.33 78.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -58.36 -36.03 72.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.15 -42.24 96.85 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 122.058 -0.401 . . . . 0.0 111.509 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.8 m -74.93 -47.25 30.65 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.846 0.748 . . . . 0.0 110.689 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.7 mt -67.22 -45.84 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 46.4 t90 -60.15 -28.78 68.19 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.004 -0.435 . . . . 0.0 110.389 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.59 -39.13 90.1 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -89.85 0.9 56.76 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 122.099 -0.376 . . . . 0.0 110.745 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 42.0 mtt -108.8 64.82 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.732 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.668 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 19.8 p -127.32 92.75 42.82 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.47 158.21 44.36 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.982 1.788 . . . . 0.0 112.02 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 1.5 m -78.2 155.03 30.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -99.83 -2.83 33.98 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 122.186 -0.321 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -62.99 -33.11 74.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 110.306 -179.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.6 t -64.31 -48.41 75.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.771 -179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.56 -38.78 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.1 -41.47 94.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.165 -0.334 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.42 -42.89 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.11 -45.91 75.76 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 63.4 t -66.72 -39.92 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.69 88.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.85 -0.531 . . . . 0.0 109.667 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.33 -38.12 91.16 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.99 -45.04 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.82 -43.5 79.47 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -69.05 -38.83 79.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.75 -50.27 73.79 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.6 m -51.49 -45.66 62.89 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 29.4 mt -64.32 -40.53 96.09 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.675 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 33.8 p -70.85 -47.46 59.24 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.849 -0.532 . . . . 0.0 112.424 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 17.3 pt -67.11 -40.51 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.887 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -36.01 71.57 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.665 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.61 -38.96 90.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.048 -0.408 . . . . 0.0 110.277 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -91.56 -16.84 26.54 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 110.977 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 5.2 mmt -92.85 31.77 1.35 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.771 -0.581 . . . . 0.0 109.652 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.744 0 CA-C-O 117.926 -1.486 . . . . 0.0 109.596 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.9 m -125.09 93.68 45.14 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.7 151.01 83.46 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.122 1.881 . . . . 0.0 111.963 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.6 p -79.62 164.75 23.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -98.74 -2.94 36.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.139 -0.351 . . . . 0.0 111.063 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -65.33 -47.02 77.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.605 -0.685 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 t -70.12 -38.16 75.5 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.2 -43.97 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 74.8 m -65.25 -43.36 91.63 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 122.384 -0.197 . . . . 0.0 111.465 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.74 -41.0 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.483 -0.761 . . . . 0.0 110.59 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -61.91 -47.19 86.06 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 m -67.3 -38.96 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.07 84.93 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.61 92.42 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.87 -44.06 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 117.614 0.707 . . . . 0.0 109.15 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.73 -43.25 84.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.364 -0.21 . . . . 0.0 110.436 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 p -60.22 -47.63 85.16 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.06 -0.4 . . . . 0.0 110.374 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -69.85 -31.63 69.58 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.037 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 t -58.61 -40.76 84.17 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.3 mt -64.44 -42.09 96.19 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.105 -0.372 . . . . 0.0 111.262 -178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 m -72.84 -47.42 46.4 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 118.812 0.733 . . . . 0.0 110.592 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.15 -49.67 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -57.9 -37.07 73.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.113 -0.367 . . . . 0.0 110.255 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -61.91 -35.16 77.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 122.127 -0.358 . . . . 0.0 110.035 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -87.8 -0.56 57.11 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.921 -0.487 . . . . 0.0 111.303 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 48.5 mtp -89.35 23.12 2.63 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 118.755 0.707 . . . . 0.0 110.016 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.604 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.532 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 2.9 m -108.09 91.42 7.9 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.46 161.01 47.59 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.998 1.799 . . . . 0.0 111.999 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 7.3 t -96.37 151.22 19.74 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -16.69 17.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.133 -0.354 . . . . 0.0 110.413 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -58.95 -46.21 88.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.766 -0.584 . . . . 0.0 110.02 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 69.9 p -70.09 -33.75 72.29 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.0 -40.69 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.7 m -64.51 -43.3 94.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.218 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -48.57 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.857 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.4 -47.39 70.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.859 -0.526 . . . . 0.0 110.137 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.19 -39.74 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.87 84.08 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 118.453 0.569 . . . . 0.0 109.94 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.74 -44.54 89.18 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.27 -39.56 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 117.683 0.741 . . . . 0.0 109.171 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -43.24 99.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.74 -47.13 84.91 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.39 -41.1 96.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 122.329 -0.232 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 19.1 m -69.07 -49.44 57.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.879 -0.513 . . . . 0.0 109.727 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.58 97.07 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.574 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 20.8 p -69.56 -47.51 63.4 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 118.606 0.639 . . . . 0.0 110.558 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.66 -45.43 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -57.91 -45.13 86.95 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.344 -0.223 . . . . 0.0 111.292 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -23.07 63.86 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.545 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -84.79 -13.65 50.49 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.873 -0.517 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.9 mtt -67.94 -27.27 66.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.624 -0.672 . . . . 0.0 110.166 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.653 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 p -97.35 138.02 21.16 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -66.85 161.07 43.79 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.845 1.697 . . . . 0.0 111.672 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.5 p -50.3 115.82 1.61 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 3.6 t90 -87.38 -19.52 28.01 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.261 -0.275 . . . . 0.0 110.363 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -67.03 -41.6 86.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.927 -0.483 . . . . 0.0 110.399 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.4 m -61.86 -47.2 86.08 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 32.0 m -68.16 -38.87 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.005 -0.435 . . . . 0.0 110.426 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 20.8 p -64.16 -43.91 93.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.784 -0.573 . . . . 0.0 111.561 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.69 -42.7 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 118.502 0.592 . . . . 0.0 109.902 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.15 -46.64 86.24 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.64 -39.72 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.875 -0.516 . . . . 0.0 110.451 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.84 -43.91 48.91 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -68.87 -43.75 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 118.015 0.908 . . . . 0.0 108.938 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.01 -42.97 99.95 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.412 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 p -64.34 -47.27 79.98 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.61 78.21 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 m -58.95 -39.4 81.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -41.27 96.7 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 122.12 -0.362 . . . . 0.0 111.382 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -47.16 30.36 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -48.21 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 122.031 -0.418 . . . . 0.0 110.175 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -44.22 84.96 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.799 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -64.21 -39.02 93.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.061 -0.4 . . . . 0.0 110.013 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -80.95 -27.12 36.18 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 59.9 mtt -100.9 51.55 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 CA-C-O 118.142 -1.366 . . . . 0.0 109.875 179.771 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -132.12 137.3 29.79 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.82 158.6 55.53 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 1.7 p -60.08 149.25 33.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -71.42 -23.03 61.78 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.325 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.96 -37.62 77.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.875 -0.516 . . . . 0.0 110.513 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 42.2 p -67.36 -48.36 67.67 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.982 -0.449 . . . . 0.0 110.376 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.4 m -68.27 -39.45 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.906 -0.496 . . . . 0.0 109.922 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 27.5 m -62.31 -41.98 98.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.227 -0.296 . . . . 0.0 111.063 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.68 -41.77 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.932 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.08 -47.2 71.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.974 -0.454 . . . . 0.0 110.13 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 31.6 m -67.05 -39.76 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.485 . . . . 0.0 109.799 -179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.85 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.6 -42.29 88.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.1 -40.92 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.4 tt -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 22.5 m -68.55 -43.6 76.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.24 77.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.213 -0.304 . . . . 0.0 110.319 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.6 p -69.39 -41.44 76.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 6.7 mp -63.88 -44.24 93.62 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.46 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -47.29 74.33 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.32 -49.89 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -44.06 88.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -65.02 -37.86 89.02 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -78.84 -22.02 46.76 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.065 -0.397 . . . . 0.0 110.196 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 19.9 mmt -91.86 27.63 2.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.867 -0.52 . . . . 0.0 110.131 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.757 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.727 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.0 p -128.56 96.02 31.25 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.64 157.78 60.42 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.837 1.691 . . . . 0.0 111.952 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.4 p -99.39 122.25 42.26 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -87.96 -14.64 38.68 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.208 -0.308 . . . . 0.0 110.366 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.64 -32.76 74.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 0.0 109.682 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 m -57.52 -47.77 81.07 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.939 -0.475 . . . . 0.0 110.152 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.04 -38.91 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.339 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.4 p -65.4 -44.17 88.31 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.661 -0.649 . . . . 0.0 110.349 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 1.6 mp -66.69 -42.06 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.71 -46.88 86.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -39.93 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.59 80.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.02 -39.7 93.18 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.38 -44.56 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.023 0.912 . . . . 0.0 108.604 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.8 tt -64.46 -43.16 95.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.0 m -68.99 -45.67 70.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.51 80.76 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.8 p -57.97 -39.68 78.75 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -41.01 97.11 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.879 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 p -69.5 -47.35 64.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.656 -0.652 . . . . 0.0 110.88 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.43 -46.29 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -76.69 -29.28 56.23 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.09 -0.381 . . . . 0.0 110.254 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -89.09 7.39 35.27 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.953 -0.467 . . . . 0.0 111.008 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.7 mtt -65.31 -26.89 68.25 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.562 -0.711 . . . . 0.0 109.968 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.642 0 CA-C-O 117.966 -1.463 . . . . 0.0 109.54 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 27.1 p -131.78 72.85 79.52 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.52 157.87 36.32 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.156 1.904 . . . . 0.0 112.271 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 66.1 p 49.14 91.4 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -80.36 -36.49 33.99 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.37 -35.08 76.47 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 19.3 m -59.36 -33.74 71.54 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 12.4 t -62.35 -40.36 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 16.7 m -58.99 -43.14 91.4 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.3 mp -65.39 -45.41 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -58.62 -44.14 89.87 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 86.7 t -59.02 -39.9 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -40.07 70.14 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.26 99.8 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 96.4 t -64.32 -38.01 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.78 -43.18 99.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 11.4 m -58.98 -41.26 87.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.04 91.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -49.37 76.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -41.08 97.3 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.369 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.7 p -67.43 -47.54 69.9 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.683 -0.636 . . . . 0.0 111.339 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.23 -42.23 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.38 -44.25 97.48 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.869 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.78 -36.32 72.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -76.83 -27.08 55.0 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.371 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 9.6 mtt -122.3 38.49 4.13 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.724 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 46.6 p -102.77 138.04 19.49 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.27 153.07 35.6 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.988 1.792 . . . . 0.0 112.553 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 14.7 m -117.82 131.98 56.5 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -102.21 -18.37 15.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.228 -0.295 . . . . 0.0 110.755 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -63.21 -46.98 84.47 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.81 -0.556 . . . . 0.0 110.093 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 59.4 p -70.05 -34.69 73.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 11.6 t -68.42 -42.42 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.1 m -65.24 -43.98 89.66 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.096 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.64 -44.56 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.092 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.87 -46.89 76.73 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.535 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 89.4 t -66.78 -39.62 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.07 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 118.564 0.62 . . . . 0.0 109.621 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.38 -44.26 85.17 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.8 t -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.66 -43.33 99.07 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -47.36 72.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.785 -0.572 . . . . 0.0 109.676 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.16 70.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.835 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.1 t -59.87 -46.86 87.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.51 -42.52 95.75 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -67.88 -47.37 69.04 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.234 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.46 -48.16 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.3 t-105 -57.94 -38.06 75.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -61.82 -38.77 89.42 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -86.8 -20.84 26.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.11 -0.369 . . . . 0.0 110.577 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.85 0.33 24.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.841 -0.537 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.639 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.01 89.1 39.22 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 159.58 51.55 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.055 1.837 . . . . 0.0 112.052 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.7 p -76.64 154.73 34.06 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -101.92 -2.6 29.47 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.044 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.75 -39.57 85.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 110.207 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.3 t -66.03 -48.0 72.57 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.067 -0.396 . . . . 0.0 110.32 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.6 m -68.53 -42.46 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.803 -0.561 . . . . 0.0 110.437 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -64.97 -43.42 92.7 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 122.089 -0.382 . . . . 0.0 111.404 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.27 -41.79 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.718 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.03 -45.24 89.78 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 73.8 t -67.09 -39.64 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.55 75.14 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.03 -42.13 94.8 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.99 -44.38 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.05 -43.14 99.48 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 57.1 m -62.42 -45.21 94.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.33 -36.91 85.49 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.091 -0.381 . . . . 0.0 110.749 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.7 p -69.82 -47.71 61.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.92 -40.61 96.87 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.499 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 4.0 m -75.0 -47.19 30.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.233 0.924 . . . . 0.0 110.23 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.21 -44.46 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -67.46 -43.11 81.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.092 -0.38 . . . . 0.0 110.974 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -66.89 -37.17 83.88 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.878 -0.514 . . . . 0.0 110.234 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -82.77 -27.31 31.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.042 -0.411 . . . . 0.0 110.169 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 32.2 mtt -103.05 27.84 6.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.91 -0.494 . . . . 0.0 109.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.696 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.711 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 m -103.74 92.37 4.21 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.32 154.78 71.32 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.059 1.839 . . . . 0.0 112.357 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.6 t -103.68 158.6 16.27 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -23.89 17.88 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -58.97 -39.43 81.72 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 26.7 p -69.18 -31.82 70.7 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 10.4 t -67.75 -43.91 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.5 m -65.02 -44.02 90.54 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 13.9 tt -66.73 -38.87 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.52 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.01 -45.98 89.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.1 t -66.34 -39.29 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.03 85.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.995 -0.441 . . . . 0.0 109.932 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.06 72.61 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.4 t -68.89 -34.19 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 122.003 -0.704 . . . . 0.0 109.25 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.41 -43.2 91.34 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -62.86 -47.22 84.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.568 . . . . 0.0 109.944 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.29 -40.81 67.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -58.67 -42.85 89.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -64.33 -43.06 95.81 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.186 -179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.03 -47.36 52.35 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.776 -0.577 . . . . 0.0 110.491 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.23 -49.2 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -60.27 -39.84 88.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -62.29 -24.94 67.58 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.096 -0.378 . . . . 0.0 110.537 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -76.75 -27.14 55.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.855 -0.528 . . . . 0.0 110.16 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -126.38 36.07 4.55 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 CA-C-O 118.05 -1.417 . . . . 0.0 109.829 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 16.7 p -121.87 94.31 48.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.1 159.32 54.39 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.085 1.857 . . . . 0.0 112.051 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 17.7 p -76.01 163.99 26.6 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -94.4 -10.2 33.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.258 -0.276 . . . . 0.0 110.741 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -60.75 -40.54 92.84 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.589 -0.695 . . . . 0.0 110.182 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 6.9 t -67.84 -48.16 66.95 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.835 -178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 35.9 m -68.2 -40.37 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.517 . . . . 0.0 110.811 -178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.5 m -65.04 -43.61 91.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.684 -0.635 . . . . 0.0 110.96 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.41 -47.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.657 -0.652 . . . . 0.0 110.15 -179.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.36 -47.45 70.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.006 -0.434 . . . . 0.0 110.105 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.1 t -67.22 -39.96 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.22 86.43 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.14 99.6 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.0 -39.98 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 mt -62.02 -43.64 98.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.22 -0.3 . . . . 0.0 110.368 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -46.95 65.79 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.999 -0.438 . . . . 0.0 109.839 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.61 -42.31 98.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.251 -0.28 . . . . 0.0 110.604 -179.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 58.5 m -69.13 -50.04 51.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.887 -0.508 . . . . 0.0 110.317 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.47 -41.41 96.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.307 -0.246 . . . . 0.0 111.638 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 28.1 p -68.07 -47.34 68.58 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.408 0.549 . . . . 0.0 111.1 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.31 -44.83 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -62.15 -45.32 93.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.783 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -78.3 -31.09 48.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.771 -0.58 . . . . 0.0 110.985 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -79.1 -25.66 43.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.032 -0.418 . . . . 0.0 110.66 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 51.0 mtt -100.68 35.31 2.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.819 -0.551 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.749 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.798 179.46 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -111.58 85.21 5.74 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.88 161.3 36.36 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.375 2.05 . . . . 0.0 112.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.8 m 63.08 26.34 15.35 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -89.01 -52.62 4.99 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -69.12 -33.06 72.88 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.5 m -59.3 -47.02 86.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.138 -0.351 . . . . 0.0 110.171 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 19.5 m -63.74 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 109.912 -179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -58.65 -43.43 89.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.099 -0.375 . . . . 0.0 110.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 tp -65.51 -41.75 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.65 -45.75 91.37 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.9 t -64.65 -39.63 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.692 -0.63 . . . . 0.0 109.807 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.52 -42.96 62.62 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.96 -44.36 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 117.977 0.889 . . . . 0.0 108.967 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.85 -43.3 99.16 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.5 m -58.94 -44.74 91.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.25 69.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.11 -0.369 . . . . 0.0 111.52 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -59.57 -44.42 93.31 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.43 -44.7 90.37 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 13.3 p -66.03 -47.76 73.33 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.429 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 59.0 mt -67.7 -50.76 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.3 -42.74 96.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.357 -0.214 . . . . 0.0 110.64 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.86 -32.99 73.37 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.918 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -77.76 -14.45 59.59 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.013 -0.43 . . . . 0.0 110.582 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 45.4 mtt -69.06 -26.6 65.04 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.751 -0.593 . . . . 0.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.649 0 CA-C-O 118.204 -1.331 . . . . 0.0 109.945 -179.77 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 2.4 t -130.03 74.43 80.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 122.189 -0.595 . . . . 0.0 109.424 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.37 156.61 50.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.295 1.997 . . . . 0.0 111.949 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 3.4 p -76.54 170.44 16.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 19.8 m0 -95.35 -34.21 12.23 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.096 -179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.34 -40.98 92.62 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.115 -0.366 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 7.5 t -67.86 -48.06 67.17 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.479 -178.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 34.7 m -68.57 -39.24 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.765 -0.584 . . . . 0.0 110.264 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 21.2 p -64.16 -43.31 95.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.96 -0.463 . . . . 0.0 111.847 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.08 -42.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 118.798 0.727 . . . . 0.0 109.98 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.08 -45.7 76.53 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 92.2 t -66.34 -40.3 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.79 79.0 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.847 -0.533 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.23 94.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.79 -43.09 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.45 -43.45 98.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 1.9 p -61.73 -47.19 86.37 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 120.949 0.404 . . . . 0.0 110.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.72 -29.34 70.04 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.089 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -50.72 58.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.84 -0.538 . . . . 0.0 110.461 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -44.15 90.42 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.582 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -47.5 85.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.181 -0.325 . . . . 0.0 111.156 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.12 -46.03 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -64.7 -34.93 79.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.3 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -63.51 -35.42 80.41 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.066 -0.397 . . . . 0.0 110.087 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -91.13 0.69 57.48 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 122.018 -0.426 . . . . 0.0 111.057 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.29 25.07 3.08 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.741 -0.599 . . . . 0.0 109.765 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 CA-C-O 117.953 -1.47 . . . . 0.0 109.625 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 3.5 t -131.74 89.45 39.35 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.93 161.11 45.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.242 1.962 . . . . 0.0 112.179 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 t -53.52 154.11 3.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.52 -6.0 59.34 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 122.092 -0.38 . . . . 0.0 111.057 -178.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.92 -35.08 79.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.631 -0.668 . . . . 0.0 110.128 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 m -69.14 -48.07 63.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.206 -0.309 . . . . 0.0 110.34 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.84 -41.6 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.08 -0.388 . . . . 0.0 111.088 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 t -62.86 -41.45 99.38 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.967 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 3.7 tp -66.25 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.29 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.07 -47.45 85.81 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.822 -0.549 . . . . 0.0 109.853 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.14 -39.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.912 -0.493 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.93 93.39 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.9 -42.37 94.94 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 42.9 t -69.79 -44.99 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.98 -42.95 97.06 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.3 m -63.96 -44.34 93.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.08 -41.31 96.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.066 -0.397 . . . . 0.0 110.453 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -36.37 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.56 -41.79 96.08 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -36.1 65.64 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.871 0.759 . . . . 0.0 110.059 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.33 -47.93 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -62.66 -36.09 81.76 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -61.88 -39.08 90.7 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -83.01 -27.23 30.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.046 -0.408 . . . . 0.0 110.009 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 65.4 mtt -103.48 25.98 8.99 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 CA-C-O 118.076 -1.402 . . . . 0.0 109.616 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 3.5 m -122.16 78.9 43.39 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.24 155.69 69.48 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.464 2.11 . . . . 0.0 111.901 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 6.7 t -120.5 160.71 22.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -64.01 -11.77 32.08 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 122.107 -0.371 . . . . 0.0 111.146 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -67.13 -47.27 71.61 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.587 0.631 . . . . 0.0 110.232 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 9.9 t -70.3 -33.68 71.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 7.9 t -63.76 -43.66 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.4 p -64.76 -43.34 93.6 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.915 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.25 -48.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.28 -47.1 85.8 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 86.4 t -67.23 -39.84 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.29 73.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.922 -0.486 . . . . 0.0 110.449 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.77 -43.64 58.72 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 62.0 t -70.06 -43.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 117.735 0.767 . . . . 0.0 108.957 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 9.2 tt -64.18 -43.31 95.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 64.4 m -64.7 -43.0 94.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.045 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 30.3 t -68.96 -45.74 69.91 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.41 -44.04 92.5 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.588 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.8 m -65.26 -47.05 78.1 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 118.637 0.653 . . . . 0.0 109.954 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -66.94 -47.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -60.53 -38.34 84.12 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.02 -39.14 91.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -80.29 -27.23 38.55 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.232 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.7 mtm -105.51 22.61 15.18 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.664 0 CA-C-O 118.124 -1.376 . . . . 0.0 109.722 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 m -65.77 -45.74 81.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.1 -0.375 . . . . 0.0 110.397 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 174' ' ' THR . 35.4 m -68.33 -43.89 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.072 -0.392 . . . . 0.0 110.545 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 173' ' ' VAL . 15.4 p -65.2 -43.6 91.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.944 -0.472 . . . . 0.0 110.85 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 tp -66.45 -40.58 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.87 -46.94 88.62 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.23 -39.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.5 80.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.32 98.69 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -44.62 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -43.49 98.72 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 m -60.88 -42.21 97.52 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.66 73.05 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -60.11 -49.16 78.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 185' ' ' LEU . 4.3 mm? -64.42 -42.12 96.23 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.277 -0.265 . . . . 0.0 111.217 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 m -68.83 -47.33 66.29 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.844 -0.535 . . . . 0.0 110.589 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.07 -46.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.015 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.09 -39.7 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.706 -0.621 . . . . 0.0 110.109 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.3 m -65.37 -43.97 89.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.831 -0.543 . . . . 0.0 110.231 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 5.8 tp -66.72 -37.89 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.853 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 176' ' ' PHE . . . . . 0.417 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.7 OUTLIER -59.37 -46.78 87.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.299 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.04 -39.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.22 93.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.872 -0.517 . . . . 0.0 109.881 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.5 55.06 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 180' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 176' ' ' PHE . 57.9 t -69.53 -42.0 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 117.801 0.8 . . . . 0.0 109.002 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.406 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.5 tt -61.92 -43.1 99.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.84 -47.01 79.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.31 74.99 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -46.57 86.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.2 -40.94 97.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.395 -0.19 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.6 m -63.96 -47.02 82.07 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 46.9 mt -65.93 -41.15 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -37.28 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.0 -27.05 54.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.1 p -67.8 -43.5 79.55 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.039 -0.413 . . . . 0.0 110.588 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.4 m -68.21 -45.09 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.722 -0.611 . . . . 0.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 175' ' ' ILE . 7.6 t -65.34 -43.16 91.79 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.882 -0.511 . . . . 0.0 111.231 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' B' ' 175' ' ' ILE . 5.7 tp -66.39 -38.66 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.67 -0.644 . . . . 0.0 109.873 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -47.28 82.17 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.39 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.67 75.49 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.7 -39.38 93.68 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.38 -45.04 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.6 tt -64.16 -43.05 96.36 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.6 p -60.62 -47.0 88.14 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.4 72.74 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.746 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' SER . . . . . 0.434 ' OG ' HD22 ' A' ' 185' ' ' LEU . 8.1 p -59.19 -46.64 87.88 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.434 HD22 ' OG ' ' A' ' 184' ' ' SER . 4.5 mm? -64.08 -42.79 96.84 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.1 p -68.37 -47.4 67.51 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.786 -0.571 . . . . 0.0 110.519 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.02 -45.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 9.6 m0 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.261 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.16 -43.91 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 30.5 p -65.39 -43.93 89.12 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.634 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 175' ' ' ILE . 6.1 tp -66.63 -37.77 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 176' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 175' ' ' ILE . 0.3 OUTLIER -58.77 -45.87 88.81 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.49 -39.92 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.17 87.32 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.15 -41.96 78.16 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.44 -38.44 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.43 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.0 tt -61.86 -43.24 99.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -47.12 75.77 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.3 71.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.295 -0.253 . . . . 0.0 110.382 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.9 m -66.02 -49.93 66.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.33 -41.93 96.55 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.515 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -70.05 -47.48 61.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.829 -0.544 . . . . 0.0 110.566 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.4 -45.03 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.3 -38.86 77.9 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -62.45 -39.1 92.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.07 -0.394 . . . . 0.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -83.37 -9.48 59.02 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.715 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.8 mtt . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 179.66 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.5 p -64.74 -48.13 75.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.045 -0.41 . . . . 0.0 110.118 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 177' ' ' VAL . 28.8 m -68.4 -39.35 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.922 -0.486 . . . . 0.0 110.355 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.0 p -65.14 -43.68 91.09 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.923 -0.485 . . . . 0.0 110.574 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.5 tp -66.32 -37.93 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.9 -47.21 85.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 173' ' ' VAL . 51.3 t -67.23 -39.42 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.72 82.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.029 -0.419 . . . . 0.0 110.051 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.06 97.07 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -68.83 -43.71 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -43.48 90.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.186 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 p -66.87 -47.52 71.6 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.162 -0.337 . . . . 0.0 110.197 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.12 77.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.736 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.3 t -55.89 -41.01 73.84 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -40.92 96.4 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.4 p -73.82 -45.72 49.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.684 -0.635 . . . . 0.0 111.316 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.73 -46.02 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 172' ' ' THR . . . . . 0.406 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.2 t . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.406 ' N ' HG23 ' B' ' 172' ' ' THR . 16.6 m -68.26 -43.74 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.796 -0.565 . . . . 0.0 111.019 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 5.0 t -64.95 -43.05 94.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.811 -0.556 . . . . 0.0 111.397 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tp -66.04 -38.04 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.692 -0.63 . . . . 0.0 109.395 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.0 -43.46 91.52 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -39.66 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.69 -33.95 76.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.842 -0.536 . . . . 0.0 110.694 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.36 -46.32 34.14 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.22 -34.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.83 -42.95 99.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -40.34 96.8 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.32 85.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.27 -0.269 . . . . 0.0 110.647 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 6.3 p -66.88 -46.79 73.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.27 97.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.411 -0.181 . . . . 0.0 111.225 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 12.3 p -72.42 -47.34 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 0.0 110.334 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.18 -43.39 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -57.98 -44.29 87.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.16 -36.67 84.81 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -76.85 -26.97 54.89 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 53.6 mtt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.792 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 24.5 p -66.19 -46.98 75.42 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.146 -0.346 . . . . 0.0 110.216 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.08 -42.84 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.975 -0.453 . . . . 0.0 110.747 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.1 m -62.85 -43.92 97.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.757 -0.59 . . . . 0.0 110.419 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.38 -38.35 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.56 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.1 t80 -66.15 -46.97 75.58 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.21 -39.81 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.9 88.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.862 -0.524 . . . . 0.0 109.812 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.98 -40.7 88.76 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' B' ' 183' ' ' ALA . 61.8 t -67.12 -40.98 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -62.48 -43.64 98.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.2 m -60.14 -46.27 90.21 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.88 66.14 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.2 p -61.4 -43.71 98.4 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 181' ' ' LEU . 4.6 mm? -64.11 -45.18 89.73 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.216 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.0 p -68.29 -47.24 68.19 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.848 -0.532 . . . . 0.0 110.93 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.13 -44.32 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 3.5 t90 . . . . . 0 N--CA 1.496 1.838 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.036 -178.71 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.0 t -68.26 -44.34 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 18.7 p -65.15 -43.43 91.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.199 -0.313 . . . . 0.0 111.56 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.35 -40.75 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.709 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.52 -46.51 82.58 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 173' ' ' VAL . 75.1 t -67.12 -39.95 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.18 88.97 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.16 -38.44 96.52 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.6 -41.45 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.409 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.9 tt -64.04 -43.16 96.38 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -44.26 89.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -57.78 -36.25 71.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 m -65.44 -49.34 69.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.36 -40.85 96.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 122.311 -0.243 . . . . 0.0 110.878 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -62.8 -47.2 84.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.854 -0.529 . . . . 0.0 110.028 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.06 -46.43 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -58.1 -41.99 84.73 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.69 -39.26 93.35 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -76.75 -27.08 55.24 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.068 -0.395 . . . . 0.0 110.216 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.918 -0.489 . . . . 0.0 110.359 -179.505 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 173' ' ' VAL . 6.4 t -67.88 -46.04 72.79 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.082 -0.386 . . . . 0.0 110.432 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 172' ' ' THR . 28.5 m -68.29 -45.79 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.893 -0.504 . . . . 0.0 110.912 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' THR . . . . . 0.408 ' N ' HG23 ' A' ' 173' ' ' VAL . 7.4 t -65.18 -43.32 92.07 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.781 -0.574 . . . . 0.0 110.969 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.2 tp -66.1 -38.7 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.526 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -60.04 -47.0 87.66 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.96 -40.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.71 80.83 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.07 95.54 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.17 -45.04 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.5 -43.23 97.84 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.3 p -63.42 -45.98 88.47 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.89 68.06 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -59.63 -48.83 80.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.36 -41.55 96.67 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.345 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -70.14 -46.94 63.69 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.821 -0.549 . . . . 0.0 111.052 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.8 mt -66.92 -42.37 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 122.236 -0.29 . . . . 0.0 111.01 -178.337 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 6.7 t -68.29 -42.75 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.938 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 18.2 tt -66.51 -38.4 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 176' ' ' PHE . . . . . 0.452 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.43 -47.16 85.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.97 -39.74 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.93 87.59 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.78 -39.62 76.4 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 176' ' ' PHE . 58.5 t -67.18 -42.78 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.488 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.0 tt -63.01 -43.18 99.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 29.9 m -62.18 -43.83 97.95 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -61.59 -49.44 76.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.002 -0.436 . . . . 0.0 109.897 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.21 -40.86 96.93 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.291 -0.256 . . . . 0.0 110.812 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 10.3 p -64.11 -47.23 80.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 55.2 mt -66.39 -36.21 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -44.6 86.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.26 -0.275 . . . . 0.0 110.674 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -72.0 -27.66 62.88 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.67 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -76.89 -26.93 54.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.847 -0.533 . . . . 0.0 110.375 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 24.2 mtt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.485 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.499 2.01 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.5 t -67.13 -39.39 86.6 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.84 -39.38 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -59.43 -41.4 89.5 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 51.1 mm -65.8 -46.88 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -59.28 -47.49 85.19 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.552 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 178' ' ' ALA . 34.4 m -67.6 -46.19 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.996 -0.44 . . . . 0.0 109.946 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . 0.442 ' N ' HG23 ' A' ' 177' ' ' VAL . . . -61.56 -40.16 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.98 99.22 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 176' ' ' PHE . 59.8 t -69.99 -43.89 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 117.846 0.823 . . . . 0.0 108.863 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.01 -43.11 99.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -63.85 -46.88 83.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.56 80.63 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m -55.68 -40.26 72.07 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -40.9 96.49 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.982 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.8 p -73.93 -47.17 39.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.653 -0.654 . . . . 0.0 110.782 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.9 mt -63.32 -49.06 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 19.5 t90 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.792 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 45.4 p . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' B' ' 177' ' ' VAL . 6.2 t -68.4 -40.95 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 11.3 m -65.0 -43.86 91.16 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.221 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 tt -66.5 -42.48 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.185 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.88 -47.08 86.2 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 173' ' ' VAL . 57.3 t -65.89 -39.96 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.19 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.77 94.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.58 -44.15 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.2 tt -61.94 -43.35 99.03 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 19.3 m -64.62 -38.82 92.33 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.86 -36.3 72.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.347 -0.22 . . . . 0.0 110.905 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.3 p -69.31 -42.89 74.81 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.21 -43.34 95.34 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.423 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p -75.15 -47.38 28.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.713 -0.617 . . . . 0.0 110.795 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.42 -43.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -57.95 -39.82 79.04 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.797 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -78.04 -27.3 48.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.169 -0.332 . . . . 0.0 110.758 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.26 8.75 34.02 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.885 -0.509 . . . . 0.0 111.774 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.2 ptm . . . . . 0 N--CA 1.502 2.173 0 CA-C-N 119.022 0.828 . . . . 0.0 109.824 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 175' ' ' ILE . 63.2 p -67.93 -48.62 65.43 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.078 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -39.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.751 -0.593 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 47.8 p -65.34 -39.18 92.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.156 -0.34 . . . . 0.0 111.61 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 172' ' ' THR . 5.9 tp -65.36 -40.85 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-N 118.705 0.684 . . . . 0.0 109.653 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -63.99 -44.62 92.12 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.18 -39.6 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.12 87.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.36 -42.24 97.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.99 -44.09 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.98 -43.2 99.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.9 m -59.0 -39.47 81.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.029 -0.42 . . . . 0.0 110.016 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.79 -37.44 73.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.019 -0.426 . . . . 0.0 110.763 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.3 t -58.98 -46.3 88.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.54 -42.49 95.7 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.57 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.8 p -68.96 -47.68 65.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.8 mt -67.14 -50.87 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 18.5 t90 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.85 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.427 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.1 t -68.29 -44.64 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 9.9 m -65.16 -43.39 91.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.387 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.11 -47.36 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.387 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.35 -46.8 72.32 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 173' ' ' VAL . 91.9 t -65.1 -39.4 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.57 82.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.843 -0.535 . . . . 0.0 109.69 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.28 -41.2 69.13 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -44.43 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 118.078 0.939 . . . . 0.0 109.077 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.8 tt -63.22 -43.2 98.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 182' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 186' ' ' THR . 59.5 m -63.93 -43.07 96.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.51 82.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.1 m -63.32 -43.12 98.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.37 -41.05 96.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.277 -0.264 . . . . 0.0 111.331 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 186' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 182' ' ' THR . 36.7 p -68.48 -47.28 67.47 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.64 -0.663 . . . . 0.0 110.464 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mt -65.55 -50.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -62.03 -45.09 95.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.66 -38.99 92.89 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -77.07 -27.22 54.18 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.189 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 42.5 mtt . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.963 -0.461 . . . . 0.0 109.804 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 25.0 m -70.06 -38.33 75.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 177' ' ' VAL . 4.9 t -68.29 -44.78 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.455 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.52 -42.91 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.037 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.432 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -60.69 -47.18 87.44 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 173' ' ' VAL . 87.4 t -61.38 -39.76 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.85 80.41 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.14 88.79 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 176' ' ' PHE . 16.1 t -69.53 -42.43 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.22 -43.09 99.61 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.614 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -66.51 -47.54 72.61 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.971 -0.456 . . . . 0.0 110.107 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.33 78.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -58.36 -36.03 72.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.15 -42.24 96.85 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 122.058 -0.401 . . . . 0.0 111.509 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.8 m -74.93 -47.25 30.65 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.846 0.748 . . . . 0.0 110.689 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 187' ' ' ILE . 44.7 mt -67.22 -45.84 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 46.4 t90 . . . . . 0 N--CA 1.5 2.039 0 O-C-N 122.004 -0.435 . . . . 0.0 110.389 -178.929 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.6 t . . . . . 0 N--CA 1.499 2.01 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 31.3 m -68.56 -38.78 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.1 -41.47 94.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.165 -0.334 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.42 -42.89 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.11 -45.91 75.76 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 173' ' ' VAL . 63.4 t -66.72 -39.92 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.69 88.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.85 -0.531 . . . . 0.0 109.667 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.33 -38.12 91.16 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.99 -45.04 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.82 -43.5 79.47 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -69.05 -38.83 79.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.403 ' O ' HG12 ' B' ' 187' ' ' ILE . . . -57.75 -50.27 73.79 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.6 m -51.49 -45.66 62.89 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 29.4 mt -64.32 -40.53 96.09 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.675 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 33.8 p -70.85 -47.46 59.24 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.849 -0.532 . . . . 0.0 112.424 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 187' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 187' ' ' ILE . 17.3 pt -67.11 -40.51 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.887 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -36.01 71.57 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.665 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.61 -38.96 90.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.048 -0.408 . . . . 0.0 110.277 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -91.56 -16.84 26.54 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 110.977 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 5.2 mmt . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.771 -0.581 . . . . 0.0 109.652 -179.627 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 t -70.12 -38.16 75.5 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.2 -43.97 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 74.8 m -65.25 -43.36 91.63 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 122.384 -0.197 . . . . 0.0 111.465 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.74 -41.0 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.483 -0.761 . . . . 0.0 110.59 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -61.91 -47.19 86.06 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 m -67.3 -38.96 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.07 84.93 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.61 92.42 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.87 -44.06 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 117.614 0.707 . . . . 0.0 109.15 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.73 -43.25 84.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.364 -0.21 . . . . 0.0 110.436 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 p -60.22 -47.63 85.16 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.06 -0.4 . . . . 0.0 110.374 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -69.85 -31.63 69.58 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.037 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 t -58.61 -40.76 84.17 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 185' ' ' LEU . 1.3 mt -64.44 -42.09 96.19 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.105 -0.372 . . . . 0.0 111.262 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 m -72.84 -47.42 46.4 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 118.812 0.733 . . . . 0.0 110.592 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.15 -49.67 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 122.113 -0.367 . . . . 0.0 110.255 -178.202 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.0 -40.69 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.7 m -64.51 -43.3 94.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.218 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -48.57 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.857 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.4 -47.39 70.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.859 -0.526 . . . . 0.0 110.137 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.19 -39.74 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.87 84.08 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 118.453 0.569 . . . . 0.0 109.94 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.74 -44.54 89.18 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.27 -39.56 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 117.683 0.741 . . . . 0.0 109.171 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -43.24 99.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.74 -47.13 84.91 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.39 -41.1 96.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 122.329 -0.232 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 19.1 m -69.07 -49.44 57.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.879 -0.513 . . . . 0.0 109.727 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.58 97.07 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.574 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 20.8 p -69.56 -47.51 63.4 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 118.606 0.639 . . . . 0.0 110.558 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.66 -45.43 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -57.91 -45.13 86.95 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.344 -0.223 . . . . 0.0 111.292 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -23.07 63.86 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.545 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -84.79 -13.65 50.49 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.873 -0.517 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.624 -0.672 . . . . 0.0 110.166 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.4 m -61.86 -47.2 86.08 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 177' ' ' VAL . 32.0 m -68.16 -38.87 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.005 -0.435 . . . . 0.0 110.426 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 20.8 p -64.16 -43.91 93.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.784 -0.573 . . . . 0.0 111.561 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.69 -42.7 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 118.502 0.592 . . . . 0.0 109.902 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -63.15 -46.64 86.24 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 173' ' ' VAL . 62.6 t -64.64 -39.72 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.875 -0.516 . . . . 0.0 110.451 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.84 -43.91 48.91 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 176' ' ' PHE . 48.1 t -68.87 -43.75 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 118.015 0.908 . . . . 0.0 108.938 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.42 HD23 HD21 ' A' ' 185' ' ' LEU . 6.4 tt -63.01 -42.97 99.95 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.412 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 p -64.34 -47.27 79.98 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.61 78.21 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 m -58.95 -39.4 81.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.42 HD21 HD23 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -64.42 -41.27 96.7 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 122.12 -0.362 . . . . 0.0 111.382 -178.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -47.16 30.36 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -48.21 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 122.031 -0.418 . . . . 0.0 110.175 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.944 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.799 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.422 ' O ' HG22 ' B' ' 177' ' ' VAL . 27.4 m -68.27 -39.45 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.906 -0.496 . . . . 0.0 109.922 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 27.5 m -62.31 -41.98 98.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.227 -0.296 . . . . 0.0 111.063 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.68 -41.77 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.932 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.08 -47.2 71.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.974 -0.454 . . . . 0.0 110.13 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 173' ' ' VAL . 31.6 m -67.05 -39.76 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.485 . . . . 0.0 109.799 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.85 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.6 -42.29 88.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.1 -40.92 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.415 ' O ' HD13 ' B' ' 185' ' ' LEU . 6.4 tt -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 22.5 m -68.55 -43.6 76.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.24 77.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.213 -0.304 . . . . 0.0 110.319 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.6 p -69.39 -41.44 76.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 185' ' ' LEU . . . . . 0.415 HD13 ' O ' ' B' ' 181' ' ' LEU . 6.7 mp -63.88 -44.24 93.62 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.46 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -47.29 74.33 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.32 -49.89 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -44.06 88.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -65.02 -37.86 89.02 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -78.84 -22.02 46.76 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.065 -0.397 . . . . 0.0 110.196 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 19.9 mmt . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.867 -0.52 . . . . 0.0 110.131 -179.719 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 m -57.52 -47.77 81.07 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.939 -0.475 . . . . 0.0 110.152 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.04 -38.91 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.339 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.4 p -65.4 -44.17 88.31 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.661 -0.649 . . . . 0.0 110.349 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.497 HG22 HG22 ' B' ' 175' ' ' ILE . 1.6 mp -66.69 -42.06 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.71 -46.88 86.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -39.93 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.59 80.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.02 -39.7 93.18 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.38 -44.56 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.023 0.912 . . . . 0.0 108.604 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.8 tt -64.46 -43.16 95.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.0 m -68.99 -45.67 70.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.51 80.76 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.8 p -57.97 -39.68 78.75 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -41.01 97.11 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.879 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 p -69.5 -47.35 64.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.656 -0.652 . . . . 0.0 110.88 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.43 -46.29 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 177' ' ' VAL . 12.4 t -62.35 -40.36 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 16.7 m -58.99 -43.14 91.4 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 175' ' ' ILE . 3.3 mp -65.39 -45.41 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 176' ' ' PHE . . . . . 0.473 ' O ' HG23 ' B' ' 180' ' ' VAL . 1.0 OUTLIER -58.62 -44.14 89.87 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.7 t -59.02 -39.9 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -40.07 70.14 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.26 99.8 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 180' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 176' ' ' PHE . 96.4 t -64.32 -38.01 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.78 -43.18 99.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 11.4 m -58.98 -41.26 87.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.04 91.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -49.37 76.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -41.08 97.3 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.369 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.7 p -67.43 -47.54 69.9 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.683 -0.636 . . . . 0.0 111.339 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.23 -42.23 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.38 -44.25 97.48 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.869 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.78 -36.32 72.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -76.83 -27.08 55.0 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.371 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.93 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 59.4 p -70.05 -34.69 73.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 177' ' ' VAL . 11.6 t -68.42 -42.42 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.1 m -65.24 -43.98 89.66 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.096 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.64 -44.56 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.092 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -65.87 -46.89 76.73 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 89.4 t -66.78 -39.62 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.07 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 118.564 0.62 . . . . 0.0 109.621 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.38 -44.26 85.17 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.8 t -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.66 -43.33 99.07 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -47.36 72.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.785 -0.572 . . . . 0.0 109.676 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.16 70.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.835 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.1 t -59.87 -46.86 87.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.51 -42.52 95.75 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -67.88 -47.37 69.04 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.234 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.46 -48.16 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.3 t-105 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.809 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 172' ' ' THR . . . . . 0.456 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.503 2.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.456 ' N ' HG23 ' B' ' 172' ' ' THR . 27.6 m -68.53 -42.46 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.803 -0.561 . . . . 0.0 110.437 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -64.97 -43.42 92.7 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 122.089 -0.382 . . . . 0.0 111.404 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.27 -41.79 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.718 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.03 -45.24 89.78 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 173' ' ' VAL . 73.8 t -67.09 -39.64 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.55 75.14 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.03 -42.13 94.8 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.99 -44.38 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.05 -43.14 99.48 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 57.1 m -62.42 -45.21 94.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -65.33 -36.91 85.49 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.091 -0.381 . . . . 0.0 110.749 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.7 p -69.82 -47.71 61.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.92 -40.61 96.87 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.499 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 4.0 m -75.0 -47.19 30.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.233 0.924 . . . . 0.0 110.23 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.21 -44.46 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -67.46 -43.11 81.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.092 -0.38 . . . . 0.0 110.974 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -66.89 -37.17 83.88 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.878 -0.514 . . . . 0.0 110.234 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -82.77 -27.31 31.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.042 -0.411 . . . . 0.0 110.169 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 32.2 mtt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.91 -0.494 . . . . 0.0 109.716 179.9 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 26.7 p -69.18 -31.82 70.7 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 177' ' ' VAL . 10.4 t -67.75 -43.91 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.5 m -65.02 -44.02 90.54 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.495 HG23 HD12 ' B' ' 175' ' ' ILE . 13.9 tt -66.73 -38.87 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' B' ' 175' ' ' ILE . 1.5 t80 -59.01 -45.98 89.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 173' ' ' VAL . 93.1 t -66.34 -39.29 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.03 85.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.995 -0.441 . . . . 0.0 109.932 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.06 72.61 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.4 t -68.89 -34.19 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 122.003 -0.704 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.7 OUTLIER -65.41 -43.2 91.34 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.209 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -62.86 -47.22 84.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.568 . . . . 0.0 109.944 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.29 -40.81 67.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -58.67 -42.85 89.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 181' ' ' LEU . 3.9 mm? -64.33 -43.06 95.81 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.186 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.03 -47.36 52.35 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.776 -0.577 . . . . 0.0 110.491 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.23 -49.2 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 62.8 t90 . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.218 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.9 t . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 120.31 0.1 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 35.9 m -68.2 -40.37 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.517 . . . . 0.0 110.811 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.5 m -65.04 -43.61 91.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.684 -0.635 . . . . 0.0 110.96 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 175' ' ' ILE . 0.2 OUTLIER -66.41 -47.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.657 -0.652 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.36 -47.45 70.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.006 -0.434 . . . . 0.0 110.105 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 173' ' ' VAL . 85.1 t -67.22 -39.96 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.22 86.43 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.14 99.6 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.0 -39.98 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 mt -62.02 -43.64 98.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.22 -0.3 . . . . 0.0 110.368 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -46.95 65.79 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.999 -0.438 . . . . 0.0 109.839 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.43 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -61.61 -42.31 98.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.251 -0.28 . . . . 0.0 110.604 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 58.5 m -69.13 -50.04 51.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.887 -0.508 . . . . 0.0 110.317 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.47 -41.41 96.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.307 -0.246 . . . . 0.0 111.638 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 28.1 p -68.07 -47.34 68.58 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.408 0.549 . . . . 0.0 111.1 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.31 -44.83 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -62.15 -45.32 93.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.783 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -78.3 -31.09 48.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.771 -0.58 . . . . 0.0 110.985 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -79.1 -25.66 43.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.032 -0.418 . . . . 0.0 110.66 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 51.0 mtt . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.819 -0.551 . . . . 0.0 109.807 -179.808 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.5 m -59.3 -47.02 86.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.138 -0.351 . . . . 0.0 110.171 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.5 m -63.74 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 109.912 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -58.65 -43.43 89.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.099 -0.375 . . . . 0.0 110.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 tp -65.51 -41.75 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.65 -45.75 91.37 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' VAL . 90.9 t -64.65 -39.63 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.692 -0.63 . . . . 0.0 109.807 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.52 -42.96 62.62 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.96 -44.36 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 117.977 0.889 . . . . 0.0 108.967 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.85 -43.3 99.16 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.5 m -58.94 -44.74 91.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.25 69.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.11 -0.369 . . . . 0.0 111.52 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -59.57 -44.42 93.31 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.43 -44.7 90.37 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 13.3 p -66.03 -47.76 73.33 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.429 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 59.0 mt -67.7 -50.76 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 . . . . . 0 N--CA 1.496 1.863 0 O-C-N 122.357 -0.214 . . . . 0.0 110.64 -178.373 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 172' ' ' THR . . . . . 0.45 HG23 ' N ' ' B' ' 173' ' ' VAL . 7.5 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 120.513 0.197 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.547 ' O ' HG23 ' B' ' 177' ' ' VAL . 34.7 m -68.57 -39.24 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.765 -0.584 . . . . 0.0 110.264 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 21.2 p -64.16 -43.31 95.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.96 -0.463 . . . . 0.0 111.847 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.08 -42.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 118.798 0.727 . . . . 0.0 109.98 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.08 -45.7 76.53 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 173' ' ' VAL . 92.2 t -66.34 -40.3 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.79 79.0 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.847 -0.533 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.23 94.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.79 -43.09 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.45 -43.45 98.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 1.9 p -61.73 -47.19 86.37 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 120.949 0.404 . . . . 0.0 110.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.72 -29.34 70.04 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.089 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -50.72 58.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.84 -0.538 . . . . 0.0 110.461 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -44.15 90.42 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.582 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -47.5 85.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.181 -0.325 . . . . 0.0 111.156 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.12 -46.03 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -64.7 -34.93 79.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.3 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -63.51 -35.42 80.41 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.066 -0.397 . . . . 0.0 110.087 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -91.13 0.69 57.48 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 122.018 -0.426 . . . . 0.0 111.057 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.741 -0.599 . . . . 0.0 109.765 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 m -69.14 -48.07 63.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.206 -0.309 . . . . 0.0 110.34 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.84 -41.6 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.08 -0.388 . . . . 0.0 111.088 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 t -62.86 -41.45 99.38 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.967 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ILE . . . . . 0.461 ' CG2' HG21 ' B' ' 175' ' ' ILE . 3.7 tp -66.25 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.29 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.07 -47.45 85.81 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.822 -0.549 . . . . 0.0 109.853 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.14 -39.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.912 -0.493 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.93 93.39 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.9 -42.37 94.94 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 183' ' ' ALA . 42.9 t -69.79 -44.99 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.98 -42.95 97.06 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.3 m -63.96 -44.34 93.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.08 -41.31 96.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.066 -0.397 . . . . 0.0 110.453 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -36.37 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.56 -41.79 96.08 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -36.1 65.64 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.871 0.759 . . . . 0.0 110.059 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.33 -47.93 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 173' ' ' VAL . . . . . 0.438 ' O ' HG23 ' B' ' 177' ' ' VAL . 7.9 t -63.76 -43.66 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.4 p -64.76 -43.34 93.6 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.915 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 175' ' ' ILE . . . . . 0.461 HG21 ' CG2' ' A' ' 175' ' ' ILE . 50.0 mt -66.25 -48.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 176' ' ' PHE . . . . . 0.451 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.28 -47.1 85.8 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 177' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.4 t -67.23 -39.84 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.29 73.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.922 -0.486 . . . . 0.0 110.449 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.77 -43.64 58.72 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 180' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 176' ' ' PHE . 62.0 t -70.06 -43.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 117.735 0.767 . . . . 0.0 108.957 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 181' ' ' LEU . . . . . 0.436 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.2 tt -64.18 -43.31 95.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 64.4 m -64.7 -43.0 94.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 183' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.045 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 30.3 t -68.96 -45.74 69.91 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.41 -44.04 92.5 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.588 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.8 m -65.26 -47.05 78.1 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 118.637 0.653 . . . . 0.0 109.954 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -66.94 -47.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -60.53 -38.34 84.12 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.02 -39.14 91.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -80.29 -27.23 38.55 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.232 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.7 mtm . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.233 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.2 m -99.44 132.18 23.68 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -66.86 149.62 83.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.842 1.695 . . . . 0.0 111.842 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.8 m -81.29 157.14 25.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -102.07 -8.75 21.16 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.212 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -69.09 -40.3 78.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 110.093 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 m -65.77 -45.74 81.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.1 -0.375 . . . . 0.0 110.397 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 174' ' ' THR . 35.4 m -68.33 -43.89 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.072 -0.392 . . . . 0.0 110.545 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 173' ' ' VAL . 15.4 p -65.2 -43.6 91.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.944 -0.472 . . . . 0.0 110.85 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 tp -66.45 -40.58 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.87 -46.94 88.62 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.23 -39.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.5 80.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.32 98.69 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -44.62 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -43.49 98.72 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 m -60.88 -42.21 97.52 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.66 73.05 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -60.11 -49.16 78.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 185' ' ' LEU . 4.3 mm? -64.42 -42.12 96.23 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.277 -0.265 . . . . 0.0 111.217 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 m -68.83 -47.33 66.29 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.844 -0.535 . . . . 0.0 110.589 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.07 -46.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -58.17 -45.04 88.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -66.42 -36.07 81.89 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -78.88 -20.83 48.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.013 -0.43 . . . . 0.0 110.202 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 39.0 mtt -96.49 27.85 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.908 -0.495 . . . . 0.0 109.69 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.655 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.625 179.903 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 40.7 p -124.03 83.9 55.33 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -72.33 161.14 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.203 1.935 . . . . 0.0 112.253 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -51.63 160.77 0.59 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 122.14 -0.35 . . . . 0.0 110.109 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -65.97 -31.46 72.38 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.3 -39.57 81.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 25.1 m -63.79 -43.0 97.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.26 -0.275 . . . . 0.0 110.554 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.09 -39.7 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.706 -0.621 . . . . 0.0 110.109 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.3 m -65.37 -43.97 89.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.831 -0.543 . . . . 0.0 110.231 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 5.8 tp -66.72 -37.89 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.853 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 176' ' ' PHE . . . . . 0.417 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.7 OUTLIER -59.37 -46.78 87.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.299 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.04 -39.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.22 93.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.872 -0.517 . . . . 0.0 109.881 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.5 55.06 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 176' ' ' PHE . 57.9 t -69.53 -42.0 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 117.801 0.8 . . . . 0.0 109.002 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.406 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.5 tt -61.92 -43.1 99.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.84 -47.01 79.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.31 74.99 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -46.57 86.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.2 -40.94 97.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.395 -0.19 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.6 m -63.96 -47.02 82.07 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 46.9 mt -65.93 -41.15 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -37.28 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.0 -27.05 54.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 49.5 mtt -99.98 38.24 1.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 CA-C-O 117.939 -1.478 . . . . 0.0 109.596 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.4 m -111.79 89.84 11.93 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.0 159.35 34.11 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.131 1.888 . . . . 0.0 112.239 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 p -61.73 120.23 10.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.413 ' O ' HG22 ' A' ' 174' ' ' THR . 1.0 OUTLIER -96.91 -9.38 28.57 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.263 -0.273 . . . . 0.0 110.535 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -68.7 -34.44 75.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.1 p -67.8 -43.5 79.55 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.039 -0.413 . . . . 0.0 110.588 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.4 m -68.21 -45.09 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.722 -0.611 . . . . 0.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 170' ' ' TRP . 7.6 t -65.34 -43.16 91.79 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.882 -0.511 . . . . 0.0 111.231 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' B' ' 175' ' ' ILE . 5.7 tp -66.39 -38.66 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.67 -0.644 . . . . 0.0 109.873 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -47.28 82.17 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.39 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.67 75.49 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.7 -39.38 93.68 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.38 -45.04 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.6 tt -64.16 -43.05 96.36 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.6 p -60.62 -47.0 88.14 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.4 72.74 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.746 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.434 ' OG ' HD22 ' A' ' 185' ' ' LEU . 8.1 p -59.19 -46.64 87.88 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.434 HD22 ' OG ' ' A' ' 184' ' ' SER . 4.5 mm? -64.08 -42.79 96.84 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.1 p -68.37 -47.4 67.51 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.786 -0.571 . . . . 0.0 110.519 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.02 -45.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -59.43 -38.48 80.79 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -63.0 -39.3 94.35 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.2 -16.78 36.7 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.071 -0.393 . . . . 0.0 110.556 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.7 mmt -98.53 22.38 9.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.802 -0.561 . . . . 0.0 109.962 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.739 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 41.3 p -131.71 85.94 50.21 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.0 159.44 34.06 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.206 1.937 . . . . 0.0 112.281 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -119.2 130.96 55.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -35.61 20.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -60.23 -32.89 71.55 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 20.4 p -64.16 -31.68 72.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.16 -43.91 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 30.5 p -65.39 -43.93 89.12 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.634 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 175' ' ' ILE . 6.1 tp -66.63 -37.77 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 176' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 175' ' ' ILE . 0.3 OUTLIER -58.77 -45.87 88.81 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.49 -39.92 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.17 87.32 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.15 -41.96 78.16 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.44 -38.44 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.43 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.0 tt -61.86 -43.24 99.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -47.12 75.77 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.3 71.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.295 -0.253 . . . . 0.0 110.382 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.9 m -66.02 -49.93 66.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.33 -41.93 96.55 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.515 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -70.05 -47.48 61.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.829 -0.544 . . . . 0.0 110.566 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.4 -45.03 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.3 -38.86 77.9 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -62.45 -39.1 92.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.07 -0.394 . . . . 0.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -83.37 -9.48 59.02 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.715 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.8 mtt -91.04 34.56 0.92 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.521 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 m -125.52 137.65 30.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 158.16 34.01 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.901 1.734 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.1 m -82.94 129.46 35.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.415 ' O ' HG23 ' A' ' 174' ' ' THR . 5.6 m-90 -101.31 -2.91 29.91 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.976 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.59 -38.49 81.36 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.553 -0.717 . . . . 0.0 109.66 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.5 p -64.74 -48.13 75.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.045 -0.41 . . . . 0.0 110.118 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 177' ' ' VAL . 28.8 m -68.4 -39.35 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.922 -0.486 . . . . 0.0 110.355 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 170' ' ' TRP . 38.0 p -65.14 -43.68 91.09 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.923 -0.485 . . . . 0.0 110.574 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.5 tp -66.32 -37.93 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.9 -47.21 85.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 173' ' ' VAL . 51.3 t -67.23 -39.42 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.72 82.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.029 -0.419 . . . . 0.0 110.051 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.06 97.07 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -68.83 -43.71 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -43.48 90.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.186 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 p -66.87 -47.52 71.6 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.162 -0.337 . . . . 0.0 110.197 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.12 77.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.736 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.3 t -55.89 -41.01 73.84 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -40.92 96.4 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.4 p -73.82 -45.72 49.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.684 -0.635 . . . . 0.0 111.316 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.73 -46.02 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -35.2 70.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.52 -39.05 77.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.161 -0.337 . . . . 0.0 110.39 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -91.65 -10.81 38.95 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.118 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 76.0 mmm -110.43 24.95 12.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 109.92 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.69 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.666 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 32.3 p -125.69 87.68 55.47 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.16 149.01 45.31 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.107 1.871 . . . . 0.0 112.39 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m 62.87 151.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -101.7 -22.45 14.42 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 122.221 -0.299 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.26 -33.08 75.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.929 -0.482 . . . . 0.0 110.069 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 172' ' ' THR . . . . . 0.406 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.2 t -66.76 -43.95 82.71 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.0 -0.437 . . . . 0.0 110.607 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.406 ' N ' HG23 ' B' ' 172' ' ' THR . 16.6 m -68.26 -43.74 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.796 -0.565 . . . . 0.0 111.019 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 5.0 t -64.95 -43.05 94.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.811 -0.556 . . . . 0.0 111.397 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tp -66.04 -38.04 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.692 -0.63 . . . . 0.0 109.395 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.0 -43.46 91.52 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -39.66 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.69 -33.95 76.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.842 -0.536 . . . . 0.0 110.694 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.36 -46.32 34.14 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.22 -34.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.83 -42.95 99.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -40.34 96.8 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.32 85.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.27 -0.269 . . . . 0.0 110.647 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 6.3 p -66.88 -46.79 73.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.27 97.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.411 -0.181 . . . . 0.0 111.225 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 12.3 p -72.42 -47.34 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 0.0 110.334 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.18 -43.39 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -57.98 -44.29 87.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.16 -36.67 84.81 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -76.85 -26.97 54.89 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 53.6 mtt -82.97 52.75 2.24 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.621 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.0 p -123.68 138.08 29.74 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.5 142.04 35.87 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.876 1.717 . . . . 0.0 112.117 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.1 p -133.03 116.36 16.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -77.42 -16.28 58.9 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.495 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -39.03 82.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.663 -0.648 . . . . 0.0 109.695 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 24.5 p -66.19 -46.98 75.42 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.146 -0.346 . . . . 0.0 110.216 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.08 -42.84 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.975 -0.453 . . . . 0.0 110.747 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.1 m -62.85 -43.92 97.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.757 -0.59 . . . . 0.0 110.419 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.38 -38.35 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.56 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.1 t80 -66.15 -46.97 75.58 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.21 -39.81 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.9 88.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.862 -0.524 . . . . 0.0 109.812 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.98 -40.7 88.76 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' B' ' 183' ' ' ALA . 61.8 t -67.12 -40.98 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -62.48 -43.64 98.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.2 m -60.14 -46.27 90.21 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.88 66.14 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.2 p -61.4 -43.71 98.4 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 181' ' ' LEU . 4.6 mm? -64.11 -45.18 89.73 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.216 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.0 p -68.29 -47.24 68.19 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.848 -0.532 . . . . 0.0 110.93 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.13 -44.32 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -59.98 -44.51 94.44 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.036 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -64.39 -39.09 93.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -76.91 -27.27 54.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.372 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 94.7 mtp -97.35 28.07 3.88 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.856 -0.528 . . . . 0.0 109.721 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 CA-C-O 117.957 -1.469 . . . . 0.0 109.517 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 12.7 m -129.0 92.43 39.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.99 160.48 49.47 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.988 1.792 . . . . 0.0 112.091 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 77.6 p -123.86 161.71 24.76 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 -5.37 44.65 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.834 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -62.74 -37.57 87.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.634 -0.666 . . . . 0.0 109.944 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 15.5 m -70.01 -39.11 76.04 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.0 t -68.26 -44.34 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 18.7 p -65.15 -43.43 91.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.199 -0.313 . . . . 0.0 111.56 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.35 -40.75 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.709 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.52 -46.51 82.58 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 173' ' ' VAL . 75.1 t -67.12 -39.95 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.18 88.97 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.16 -38.44 96.52 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.6 -41.45 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.409 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.9 tt -64.04 -43.16 96.38 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -44.26 89.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -57.78 -36.25 71.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 m -65.44 -49.34 69.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.36 -40.85 96.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 122.311 -0.243 . . . . 0.0 110.878 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -62.8 -47.2 84.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.854 -0.529 . . . . 0.0 110.028 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.06 -46.43 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -58.1 -41.99 84.73 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.69 -39.26 93.35 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -76.75 -27.08 55.24 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.068 -0.395 . . . . 0.0 110.216 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 4.8 mmt -89.21 23.75 2.38 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.918 -0.489 . . . . 0.0 110.359 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.733 0 CA-C-O 118.038 -1.423 . . . . 0.0 109.636 179.657 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.9 p -127.31 85.19 61.52 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.98 152.48 80.25 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.249 1.966 . . . . 0.0 111.838 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 172' ' ' THR . 5.0 t -59.26 133.8 56.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.667 ' O ' HG22 ' A' ' 174' ' ' THR . 8.4 m-90 -98.49 -8.85 25.96 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.899 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.25 -36.87 82.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.792 -0.567 . . . . 0.0 110.012 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 169' ' ' THR . 6.4 t -67.88 -46.04 72.79 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.082 -0.386 . . . . 0.0 110.432 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 172' ' ' THR . 28.5 m -68.29 -45.79 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.893 -0.504 . . . . 0.0 110.912 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 170' ' ' TRP . 7.4 t -65.18 -43.32 92.07 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.781 -0.574 . . . . 0.0 110.969 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.2 tp -66.1 -38.7 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.526 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -60.04 -47.0 87.66 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.96 -40.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.71 80.83 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.07 95.54 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.17 -45.04 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.5 -43.23 97.84 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.3 p -63.42 -45.98 88.47 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.89 68.06 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -59.63 -48.83 80.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.36 -41.55 96.67 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.345 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -70.14 -46.94 63.69 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.821 -0.549 . . . . 0.0 111.052 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.8 mt -66.92 -42.37 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -57.84 -38.89 76.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.236 -0.29 . . . . 0.0 111.01 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -78.07 -23.1 48.16 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.703 -0.623 . . . . 0.0 111.497 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.42 -27.58 29.47 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.666 0.666 . . . . 0.0 110.989 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.16 33.13 2.59 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.763 0 CA-C-O 117.877 -1.513 . . . . 0.0 109.848 179.294 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 14.4 m -123.8 100.63 37.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -66.96 156.04 68.1 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.967 1.778 . . . . 0.0 111.883 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t -55.68 171.6 0.2 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.402 ' CD1' HG21 ' B' ' 173' ' ' VAL . 11.4 t90 -94.42 -13.1 26.6 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.281 -0.262 . . . . 0.0 110.646 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.0 -32.88 70.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.83 -0.544 . . . . 0.0 109.897 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.1 t -67.74 -32.13 72.52 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' B' ' 170' ' ' TRP . 6.7 t -68.29 -42.75 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.938 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 18.2 tt -66.51 -38.4 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 176' ' ' PHE . . . . . 0.452 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.43 -47.16 85.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.97 -39.74 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.93 87.59 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.78 -39.62 76.4 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 176' ' ' PHE . 58.5 t -67.18 -42.78 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.488 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.0 tt -63.01 -43.18 99.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 29.9 m -62.18 -43.83 97.95 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -61.59 -49.44 76.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.002 -0.436 . . . . 0.0 109.897 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.21 -40.86 96.93 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.291 -0.256 . . . . 0.0 110.812 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 10.3 p -64.11 -47.23 80.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 55.2 mt -66.39 -36.21 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -44.6 86.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.26 -0.275 . . . . 0.0 110.674 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -72.0 -27.66 62.88 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.67 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -76.89 -26.93 54.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.847 -0.533 . . . . 0.0 110.375 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 24.2 mtt -98.95 31.06 3.12 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.698 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.8 p -122.87 115.88 29.16 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.68 142.34 63.61 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.818 1.679 . . . . 0.0 112.167 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.8 m -162.58 41.4 0.12 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -85.54 -2.75 58.47 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.895 -0.503 . . . . 0.0 110.776 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -58.96 -46.26 88.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.596 -0.69 . . . . 0.0 109.782 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.5 t -67.13 -39.39 86.6 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.84 -39.38 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -59.43 -41.4 89.5 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 51.1 mm -65.8 -46.88 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -59.28 -47.49 85.19 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.552 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 178' ' ' ALA . 34.4 m -67.6 -46.19 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.996 -0.44 . . . . 0.0 109.946 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . 0.442 ' N ' HG23 ' A' ' 177' ' ' VAL . . . -61.56 -40.16 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.98 99.22 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 176' ' ' PHE . 59.8 t -69.99 -43.89 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 117.846 0.823 . . . . 0.0 108.863 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.01 -43.11 99.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -63.85 -46.88 83.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.56 80.63 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m -55.68 -40.26 72.07 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -40.9 96.49 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.982 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.8 p -73.93 -47.17 39.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.653 -0.654 . . . . 0.0 110.782 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.9 mt -63.32 -49.06 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -62.35 -45.12 94.63 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -69.36 -35.39 75.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.126 -0.359 . . . . 0.0 110.164 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -80.58 -24.0 39.48 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 68.2 mtt -105.29 27.48 8.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.944 -0.472 . . . . 0.0 110.075 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.718 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.843 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 24.8 p -118.28 92.79 43.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.96 161.03 44.61 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.071 1.848 . . . . 0.0 112.065 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 5.8 t -58.02 135.8 57.03 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -101.89 -9.35 20.79 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.918 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -63.35 -45.89 89.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.672 -0.643 . . . . 0.0 109.546 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 45.4 p -70.11 -33.79 72.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' B' ' 177' ' ' VAL . 6.2 t -68.4 -40.95 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 11.3 m -65.0 -43.86 91.16 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.221 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 tt -66.5 -42.48 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.185 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.88 -47.08 86.2 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 173' ' ' VAL . 57.3 t -65.89 -39.96 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.19 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.77 94.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.58 -44.15 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.2 tt -61.94 -43.35 99.03 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 19.3 m -64.62 -38.82 92.33 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.86 -36.3 72.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.347 -0.22 . . . . 0.0 110.905 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.3 p -69.31 -42.89 74.81 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.21 -43.34 95.34 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.423 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p -75.15 -47.38 28.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.713 -0.617 . . . . 0.0 110.795 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.42 -43.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -57.95 -39.82 79.04 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.797 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -78.04 -27.3 48.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.169 -0.332 . . . . 0.0 110.758 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.26 8.75 34.02 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.885 -0.509 . . . . 0.0 111.774 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.2 ptm -101.53 30.61 4.18 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 119.022 0.828 . . . . 0.0 109.824 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.826 0 CA-C-O 118.034 -1.426 . . . . 0.0 109.694 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 167' ' ' THR . 3.7 t -125.25 91.62 48.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 122.132 -0.628 . . . . 0.0 109.506 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.98 148.52 82.03 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.142 1.894 . . . . 0.0 111.665 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.9 t -124.22 134.91 53.14 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 174' ' ' THR . 1.7 m-90 -99.14 -2.35 37.13 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -58.44 -33.75 70.05 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.475 -0.766 . . . . 0.0 110.481 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 175' ' ' ILE . 63.2 p -67.93 -48.62 65.43 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.078 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -39.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.751 -0.593 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 170' ' ' TRP . 47.8 p -65.34 -39.18 92.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.156 -0.34 . . . . 0.0 111.61 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 172' ' ' THR . 5.9 tp -65.36 -40.85 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-N 118.705 0.684 . . . . 0.0 109.653 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -63.99 -44.62 92.12 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.18 -39.6 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.12 87.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.36 -42.24 97.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.99 -44.09 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.98 -43.2 99.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.9 m -59.0 -39.47 81.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.029 -0.42 . . . . 0.0 110.016 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.79 -37.44 73.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.019 -0.426 . . . . 0.0 110.763 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.3 t -58.98 -46.3 88.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.54 -42.49 95.7 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.57 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.8 p -68.96 -47.68 65.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.8 mt -67.14 -50.87 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -60.31 -40.05 89.15 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -78.21 -23.35 47.54 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.08 -0.387 . . . . 0.0 111.363 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -27.3 16.05 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.655 0.661 . . . . 0.0 111.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 7.9 ptm -135.29 33.81 3.06 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.836 -0.54 . . . . 0.0 109.548 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.894 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.261 179.497 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 65.1 p -99.08 138.15 20.55 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.03 146.65 77.9 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.879 1.719 . . . . 0.0 111.983 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 22.9 p -120.62 161.82 20.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -60.28 -35.07 74.7 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.01 -33.32 70.59 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.028 -0.42 . . . . 0.0 110.207 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 10.0 m -69.96 -40.8 75.19 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.427 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.1 t -68.29 -44.64 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 9.9 m -65.16 -43.39 91.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.387 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.11 -47.36 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.387 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.35 -46.8 72.32 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 173' ' ' VAL . 91.9 t -65.1 -39.4 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.57 82.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.843 -0.535 . . . . 0.0 109.69 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.28 -41.2 69.13 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -44.43 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 118.078 0.939 . . . . 0.0 109.077 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.8 tt -63.22 -43.2 98.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 182' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 186' ' ' THR . 59.5 m -63.93 -43.07 96.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.51 82.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.1 m -63.32 -43.12 98.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.37 -41.05 96.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.277 -0.264 . . . . 0.0 111.331 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 186' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 182' ' ' THR . 36.7 p -68.48 -47.28 67.47 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.64 -0.663 . . . . 0.0 110.464 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mt -65.55 -50.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -62.03 -45.09 95.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.66 -38.99 92.89 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -77.07 -27.22 54.18 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.189 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 42.5 mtt -96.14 31.57 2.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.963 -0.461 . . . . 0.0 109.804 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.512 179.79 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 m -115.23 83.3 10.01 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.06 157.19 34.19 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.208 1.939 . . . . 0.0 112.242 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -90.5 135.72 33.52 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -59.78 -36.58 76.99 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.06 -36.15 74.56 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 25.0 m -70.06 -38.33 75.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 177' ' ' VAL . 4.9 t -68.29 -44.78 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.455 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.52 -42.91 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.037 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.432 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -60.69 -47.18 87.44 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 173' ' ' VAL . 87.4 t -61.38 -39.76 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.85 80.41 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.14 88.79 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 176' ' ' PHE . 16.1 t -69.53 -42.43 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.22 -43.09 99.61 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.614 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -66.51 -47.54 72.61 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.971 -0.456 . . . . 0.0 110.107 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.33 78.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -58.36 -36.03 72.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.15 -42.24 96.85 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 122.058 -0.401 . . . . 0.0 111.509 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.8 m -74.93 -47.25 30.65 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.846 0.748 . . . . 0.0 110.689 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 187' ' ' ILE . 44.7 mt -67.22 -45.84 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 46.4 t90 -60.15 -28.78 68.19 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.004 -0.435 . . . . 0.0 110.389 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.59 -39.13 90.1 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -89.85 0.9 56.76 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 122.099 -0.376 . . . . 0.0 110.745 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 42.0 mtt -108.8 64.82 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.732 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.668 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 19.8 p -127.32 92.75 42.82 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.47 158.21 44.36 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.982 1.788 . . . . 0.0 112.02 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 169' ' ' THR . . . . . 0.421 HG21 ' OE1' ' B' ' 171' ' ' GLN . 1.5 m -78.2 155.03 30.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -99.83 -2.83 33.98 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 122.186 -0.321 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 171' ' ' GLN . . . . . 0.421 ' OE1' HG21 ' B' ' 169' ' ' THR . 8.5 pt20 -62.99 -33.11 74.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 110.306 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.6 t -64.31 -48.41 75.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.771 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 31.3 m -68.56 -38.78 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.1 -41.47 94.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.165 -0.334 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.42 -42.89 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.11 -45.91 75.76 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 173' ' ' VAL . 63.4 t -66.72 -39.92 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.69 88.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.85 -0.531 . . . . 0.0 109.667 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.33 -38.12 91.16 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.99 -45.04 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.82 -43.5 79.47 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -69.05 -38.83 79.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.403 ' O ' HG12 ' B' ' 187' ' ' ILE . . . -57.75 -50.27 73.79 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.6 m -51.49 -45.66 62.89 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 29.4 mt -64.32 -40.53 96.09 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.675 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 33.8 p -70.85 -47.46 59.24 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.849 -0.532 . . . . 0.0 112.424 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 187' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 187' ' ' ILE . 17.3 pt -67.11 -40.51 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.887 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -36.01 71.57 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.665 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.61 -38.96 90.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.048 -0.408 . . . . 0.0 110.277 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -91.56 -16.84 26.54 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 110.977 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 5.2 mmt -92.85 31.77 1.35 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.771 -0.581 . . . . 0.0 109.652 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.744 0 CA-C-O 117.926 -1.486 . . . . 0.0 109.596 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.9 m -125.09 93.68 45.14 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.7 151.01 83.46 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.122 1.881 . . . . 0.0 111.963 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.6 p -79.62 164.75 23.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -98.74 -2.94 36.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.139 -0.351 . . . . 0.0 111.063 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -65.33 -47.02 77.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.605 -0.685 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 t -70.12 -38.16 75.5 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.2 -43.97 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 74.8 m -65.25 -43.36 91.63 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 122.384 -0.197 . . . . 0.0 111.465 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.74 -41.0 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.483 -0.761 . . . . 0.0 110.59 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -61.91 -47.19 86.06 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 m -67.3 -38.96 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.07 84.93 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.61 92.42 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.87 -44.06 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 117.614 0.707 . . . . 0.0 109.15 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.73 -43.25 84.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.364 -0.21 . . . . 0.0 110.436 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 p -60.22 -47.63 85.16 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.06 -0.4 . . . . 0.0 110.374 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -69.85 -31.63 69.58 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.037 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 t -58.61 -40.76 84.17 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 185' ' ' LEU . 1.3 mt -64.44 -42.09 96.19 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.105 -0.372 . . . . 0.0 111.262 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 m -72.84 -47.42 46.4 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 118.812 0.733 . . . . 0.0 110.592 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.15 -49.67 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -57.9 -37.07 73.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.113 -0.367 . . . . 0.0 110.255 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -61.91 -35.16 77.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 122.127 -0.358 . . . . 0.0 110.035 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -87.8 -0.56 57.11 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.921 -0.487 . . . . 0.0 111.303 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 48.5 mtp -89.35 23.12 2.63 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 118.755 0.707 . . . . 0.0 110.016 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.604 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.532 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 2.9 m -108.09 91.42 7.9 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.46 161.01 47.59 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.998 1.799 . . . . 0.0 111.999 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 7.3 t -96.37 151.22 19.74 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -16.69 17.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.133 -0.354 . . . . 0.0 110.413 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -58.95 -46.21 88.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.766 -0.584 . . . . 0.0 110.02 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 69.9 p -70.09 -33.75 72.29 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.0 -40.69 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.7 m -64.51 -43.3 94.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.218 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -48.57 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.857 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.4 -47.39 70.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.859 -0.526 . . . . 0.0 110.137 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.19 -39.74 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.87 84.08 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 118.453 0.569 . . . . 0.0 109.94 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.74 -44.54 89.18 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.27 -39.56 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 117.683 0.741 . . . . 0.0 109.171 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -43.24 99.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.74 -47.13 84.91 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.39 -41.1 96.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 122.329 -0.232 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 19.1 m -69.07 -49.44 57.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.879 -0.513 . . . . 0.0 109.727 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.58 97.07 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.574 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 20.8 p -69.56 -47.51 63.4 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 118.606 0.639 . . . . 0.0 110.558 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.66 -45.43 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -57.91 -45.13 86.95 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.344 -0.223 . . . . 0.0 111.292 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -23.07 63.86 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.545 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -84.79 -13.65 50.49 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.873 -0.517 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.9 mtt -67.94 -27.27 66.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.624 -0.672 . . . . 0.0 110.166 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.653 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 p -97.35 138.02 21.16 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -66.85 161.07 43.79 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.845 1.697 . . . . 0.0 111.672 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.5 p -50.3 115.82 1.61 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 174' ' ' THR . 3.6 t90 -87.38 -19.52 28.01 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.261 -0.275 . . . . 0.0 110.363 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -67.03 -41.6 86.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.927 -0.483 . . . . 0.0 110.399 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.4 m -61.86 -47.2 86.08 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 177' ' ' VAL . 32.0 m -68.16 -38.87 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.005 -0.435 . . . . 0.0 110.426 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 170' ' ' TRP . 20.8 p -64.16 -43.91 93.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.784 -0.573 . . . . 0.0 111.561 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.69 -42.7 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 118.502 0.592 . . . . 0.0 109.902 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -63.15 -46.64 86.24 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 173' ' ' VAL . 62.6 t -64.64 -39.72 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.875 -0.516 . . . . 0.0 110.451 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.84 -43.91 48.91 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 176' ' ' PHE . 48.1 t -68.87 -43.75 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 118.015 0.908 . . . . 0.0 108.938 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.42 HD23 HD21 ' A' ' 185' ' ' LEU . 6.4 tt -63.01 -42.97 99.95 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.412 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 p -64.34 -47.27 79.98 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.61 78.21 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 m -58.95 -39.4 81.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.42 HD21 HD23 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -64.42 -41.27 96.7 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 122.12 -0.362 . . . . 0.0 111.382 -178.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -47.16 30.36 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -48.21 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 122.031 -0.418 . . . . 0.0 110.175 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -44.22 84.96 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.799 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -64.21 -39.02 93.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.061 -0.4 . . . . 0.0 110.013 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -80.95 -27.12 36.18 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 59.9 mtt -100.9 51.55 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 CA-C-O 118.142 -1.366 . . . . 0.0 109.875 179.771 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -132.12 137.3 29.79 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.82 158.6 55.53 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 1.7 p -60.08 149.25 33.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -71.42 -23.03 61.78 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.325 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.96 -37.62 77.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.875 -0.516 . . . . 0.0 110.513 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 42.2 p -67.36 -48.36 67.67 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.982 -0.449 . . . . 0.0 110.376 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.422 ' O ' HG22 ' B' ' 177' ' ' VAL . 27.4 m -68.27 -39.45 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.906 -0.496 . . . . 0.0 109.922 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 27.5 m -62.31 -41.98 98.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.227 -0.296 . . . . 0.0 111.063 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.68 -41.77 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.932 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.08 -47.2 71.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.974 -0.454 . . . . 0.0 110.13 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 173' ' ' VAL . 31.6 m -67.05 -39.76 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.485 . . . . 0.0 109.799 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.85 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.6 -42.29 88.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.1 -40.92 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.415 ' O ' HD13 ' B' ' 185' ' ' LEU . 6.4 tt -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 22.5 m -68.55 -43.6 76.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.24 77.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.213 -0.304 . . . . 0.0 110.319 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.6 p -69.39 -41.44 76.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 185' ' ' LEU . . . . . 0.415 HD13 ' O ' ' B' ' 181' ' ' LEU . 6.7 mp -63.88 -44.24 93.62 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.46 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -47.29 74.33 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.32 -49.89 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -44.06 88.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -65.02 -37.86 89.02 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -78.84 -22.02 46.76 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.065 -0.397 . . . . 0.0 110.196 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 19.9 mmt -91.86 27.63 2.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.867 -0.52 . . . . 0.0 110.131 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.757 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.727 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.0 p -128.56 96.02 31.25 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.64 157.78 60.42 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.837 1.691 . . . . 0.0 111.952 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.4 p -99.39 122.25 42.26 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -87.96 -14.64 38.68 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.208 -0.308 . . . . 0.0 110.366 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.64 -32.76 74.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 0.0 109.682 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 m -57.52 -47.77 81.07 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.939 -0.475 . . . . 0.0 110.152 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.04 -38.91 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.339 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.4 p -65.4 -44.17 88.31 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.661 -0.649 . . . . 0.0 110.349 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.497 HG22 HG22 ' B' ' 175' ' ' ILE . 1.6 mp -66.69 -42.06 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.71 -46.88 86.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -39.93 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.59 80.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.02 -39.7 93.18 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.38 -44.56 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.023 0.912 . . . . 0.0 108.604 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.8 tt -64.46 -43.16 95.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.0 m -68.99 -45.67 70.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.51 80.76 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.8 p -57.97 -39.68 78.75 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -41.01 97.11 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.879 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 p -69.5 -47.35 64.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.656 -0.652 . . . . 0.0 110.88 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.43 -46.29 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -76.69 -29.28 56.23 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.09 -0.381 . . . . 0.0 110.254 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -89.09 7.39 35.27 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.953 -0.467 . . . . 0.0 111.008 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.7 mtt -65.31 -26.89 68.25 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.562 -0.711 . . . . 0.0 109.968 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.642 0 CA-C-O 117.966 -1.463 . . . . 0.0 109.54 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 27.1 p -131.78 72.85 79.52 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.52 157.87 36.32 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.156 1.904 . . . . 0.0 112.271 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 66.1 p 49.14 91.4 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -80.36 -36.49 33.99 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -35.08 76.47 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 19.3 m -59.36 -33.74 71.54 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 177' ' ' VAL . 12.4 t -62.35 -40.36 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 16.7 m -58.99 -43.14 91.4 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 175' ' ' ILE . 3.3 mp -65.39 -45.41 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 176' ' ' PHE . . . . . 0.473 ' O ' HG23 ' B' ' 180' ' ' VAL . 1.0 OUTLIER -58.62 -44.14 89.87 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.059 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.7 t -59.02 -39.9 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -40.07 70.14 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.26 99.8 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 180' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 176' ' ' PHE . 96.4 t -64.32 -38.01 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.78 -43.18 99.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 11.4 m -58.98 -41.26 87.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.04 91.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -49.37 76.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -41.08 97.3 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.369 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.7 p -67.43 -47.54 69.9 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.683 -0.636 . . . . 0.0 111.339 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.23 -42.23 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.38 -44.25 97.48 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.869 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.78 -36.32 72.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -76.83 -27.08 55.0 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.371 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 9.6 mtt -122.3 38.49 4.13 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.724 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 46.6 p -102.77 138.04 19.49 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.27 153.07 35.6 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.988 1.792 . . . . 0.0 112.553 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 173' ' ' VAL . 14.7 m -117.82 131.98 56.5 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -102.21 -18.37 15.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.228 -0.295 . . . . 0.0 110.755 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -63.21 -46.98 84.47 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.81 -0.556 . . . . 0.0 110.093 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 59.4 p -70.05 -34.69 73.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 177' ' ' VAL . 11.6 t -68.42 -42.42 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.1 m -65.24 -43.98 89.66 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.096 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.64 -44.56 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.092 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -65.87 -46.89 76.73 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 89.4 t -66.78 -39.62 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.07 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 118.564 0.62 . . . . 0.0 109.621 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.38 -44.26 85.17 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.8 t -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.66 -43.33 99.07 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -47.36 72.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.785 -0.572 . . . . 0.0 109.676 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.16 70.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.835 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.1 t -59.87 -46.86 87.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.51 -42.52 95.75 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -67.88 -47.37 69.04 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.234 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.46 -48.16 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.3 t-105 -57.94 -38.06 75.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -61.82 -38.77 89.42 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -86.8 -20.84 26.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.11 -0.369 . . . . 0.0 110.577 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.85 0.33 24.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.841 -0.537 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.639 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.01 89.1 39.22 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 159.58 51.55 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.055 1.837 . . . . 0.0 112.052 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.7 p -76.64 154.73 34.06 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -101.92 -2.6 29.47 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.044 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.75 -39.57 85.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 110.207 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 172' ' ' THR . . . . . 0.456 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.3 t -66.03 -48.0 72.57 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.067 -0.396 . . . . 0.0 110.32 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.456 ' N ' HG23 ' B' ' 172' ' ' THR . 27.6 m -68.53 -42.46 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.803 -0.561 . . . . 0.0 110.437 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -64.97 -43.42 92.7 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 122.089 -0.382 . . . . 0.0 111.404 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.27 -41.79 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.718 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.03 -45.24 89.78 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 173' ' ' VAL . 73.8 t -67.09 -39.64 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.55 75.14 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.03 -42.13 94.8 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.99 -44.38 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.05 -43.14 99.48 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 57.1 m -62.42 -45.21 94.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -65.33 -36.91 85.49 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.091 -0.381 . . . . 0.0 110.749 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.7 p -69.82 -47.71 61.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.92 -40.61 96.87 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.499 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 4.0 m -75.0 -47.19 30.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.233 0.924 . . . . 0.0 110.23 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.21 -44.46 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -67.46 -43.11 81.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.092 -0.38 . . . . 0.0 110.974 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -66.89 -37.17 83.88 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.878 -0.514 . . . . 0.0 110.234 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -82.77 -27.31 31.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.042 -0.411 . . . . 0.0 110.169 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 32.2 mtt -103.05 27.84 6.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.91 -0.494 . . . . 0.0 109.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.696 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.711 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 m -103.74 92.37 4.21 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.32 154.78 71.32 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.059 1.839 . . . . 0.0 112.357 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.6 t -103.68 158.6 16.27 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -23.89 17.88 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -58.97 -39.43 81.72 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 26.7 p -69.18 -31.82 70.7 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 177' ' ' VAL . 10.4 t -67.75 -43.91 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.5 m -65.02 -44.02 90.54 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.495 HG23 HD12 ' B' ' 175' ' ' ILE . 13.9 tt -66.73 -38.87 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' B' ' 175' ' ' ILE . 1.5 t80 -59.01 -45.98 89.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 173' ' ' VAL . 93.1 t -66.34 -39.29 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.03 85.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.995 -0.441 . . . . 0.0 109.932 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.06 72.61 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.4 t -68.89 -34.19 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 122.003 -0.704 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.7 OUTLIER -65.41 -43.2 91.34 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.209 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -62.86 -47.22 84.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.568 . . . . 0.0 109.944 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.29 -40.81 67.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -58.67 -42.85 89.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 181' ' ' LEU . 3.9 mm? -64.33 -43.06 95.81 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.186 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.03 -47.36 52.35 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.776 -0.577 . . . . 0.0 110.491 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.23 -49.2 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -60.27 -39.84 88.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -62.29 -24.94 67.58 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.096 -0.378 . . . . 0.0 110.537 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -76.75 -27.14 55.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.855 -0.528 . . . . 0.0 110.16 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -126.38 36.07 4.55 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 CA-C-O 118.05 -1.417 . . . . 0.0 109.829 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 16.7 p -121.87 94.31 48.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.1 159.32 54.39 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.085 1.857 . . . . 0.0 112.051 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 17.7 p -76.01 163.99 26.6 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -94.4 -10.2 33.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.258 -0.276 . . . . 0.0 110.741 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -60.75 -40.54 92.84 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.589 -0.695 . . . . 0.0 110.182 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.9 t -67.84 -48.16 66.95 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.835 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 35.9 m -68.2 -40.37 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.517 . . . . 0.0 110.811 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.5 m -65.04 -43.61 91.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.684 -0.635 . . . . 0.0 110.96 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 175' ' ' ILE . 0.2 OUTLIER -66.41 -47.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.657 -0.652 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.36 -47.45 70.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.006 -0.434 . . . . 0.0 110.105 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 173' ' ' VAL . 85.1 t -67.22 -39.96 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.22 86.43 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.14 99.6 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.0 -39.98 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 mt -62.02 -43.64 98.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.22 -0.3 . . . . 0.0 110.368 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -46.95 65.79 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.999 -0.438 . . . . 0.0 109.839 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.43 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -61.61 -42.31 98.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.251 -0.28 . . . . 0.0 110.604 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 58.5 m -69.13 -50.04 51.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.887 -0.508 . . . . 0.0 110.317 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.47 -41.41 96.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.307 -0.246 . . . . 0.0 111.638 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 28.1 p -68.07 -47.34 68.58 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.408 0.549 . . . . 0.0 111.1 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.31 -44.83 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -62.15 -45.32 93.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.783 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -78.3 -31.09 48.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.771 -0.58 . . . . 0.0 110.985 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -79.1 -25.66 43.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.032 -0.418 . . . . 0.0 110.66 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 51.0 mtt -100.68 35.31 2.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.819 -0.551 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.749 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.798 179.46 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -111.58 85.21 5.74 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.88 161.3 36.36 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.375 2.05 . . . . 0.0 112.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.8 m 63.08 26.34 15.35 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.43 ' O ' HG22 ' A' ' 173' ' ' VAL . 3.3 t90 -89.01 -52.62 4.99 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -69.12 -33.06 72.88 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.5 m -59.3 -47.02 86.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.138 -0.351 . . . . 0.0 110.171 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.5 m -63.74 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 109.912 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -58.65 -43.43 89.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.099 -0.375 . . . . 0.0 110.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 tp -65.51 -41.75 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.65 -45.75 91.37 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' VAL . 90.9 t -64.65 -39.63 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.692 -0.63 . . . . 0.0 109.807 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.52 -42.96 62.62 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.96 -44.36 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 117.977 0.889 . . . . 0.0 108.967 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.85 -43.3 99.16 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.5 m -58.94 -44.74 91.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.25 69.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.11 -0.369 . . . . 0.0 111.52 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -59.57 -44.42 93.31 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.43 -44.7 90.37 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 13.3 p -66.03 -47.76 73.33 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.429 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 59.0 mt -67.7 -50.76 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.3 -42.74 96.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.357 -0.214 . . . . 0.0 110.64 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.86 -32.99 73.37 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.918 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -77.76 -14.45 59.59 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.013 -0.43 . . . . 0.0 110.582 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 45.4 mtt -69.06 -26.6 65.04 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.751 -0.593 . . . . 0.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.649 0 CA-C-O 118.204 -1.331 . . . . 0.0 109.945 -179.77 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 2.4 t -130.03 74.43 80.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 122.189 -0.595 . . . . 0.0 109.424 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.37 156.61 50.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.295 1.997 . . . . 0.0 111.949 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 3.4 p -76.54 170.44 16.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 170' ' ' TRP . . . . . 0.444 ' O ' HG23 ' B' ' 174' ' ' THR . 19.8 m0 -95.35 -34.21 12.23 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.096 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.34 -40.98 92.62 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.115 -0.366 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 172' ' ' THR . . . . . 0.45 HG23 ' N ' ' B' ' 173' ' ' VAL . 7.5 t -67.86 -48.06 67.17 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.479 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.547 ' O ' HG23 ' B' ' 177' ' ' VAL . 34.7 m -68.57 -39.24 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.765 -0.584 . . . . 0.0 110.264 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 174' ' ' THR . . . . . 0.444 HG23 ' O ' ' B' ' 170' ' ' TRP . 21.2 p -64.16 -43.31 95.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.96 -0.463 . . . . 0.0 111.847 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.08 -42.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 118.798 0.727 . . . . 0.0 109.98 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.08 -45.7 76.53 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 173' ' ' VAL . 92.2 t -66.34 -40.3 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.79 79.0 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.847 -0.533 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.23 94.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.79 -43.09 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.45 -43.45 98.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 1.9 p -61.73 -47.19 86.37 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 120.949 0.404 . . . . 0.0 110.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.72 -29.34 70.04 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.089 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -50.72 58.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.84 -0.538 . . . . 0.0 110.461 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -44.15 90.42 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.582 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -47.5 85.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.181 -0.325 . . . . 0.0 111.156 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.12 -46.03 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -64.7 -34.93 79.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.3 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -63.51 -35.42 80.41 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.066 -0.397 . . . . 0.0 110.087 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -91.13 0.69 57.48 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 122.018 -0.426 . . . . 0.0 111.057 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.29 25.07 3.08 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.741 -0.599 . . . . 0.0 109.765 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 CA-C-O 117.953 -1.47 . . . . 0.0 109.625 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 167' ' ' THR . 3.5 t -131.74 89.45 39.35 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.93 161.11 45.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.242 1.962 . . . . 0.0 112.179 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 t -53.52 154.11 3.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.449 ' O ' HG22 ' A' ' 174' ' ' THR . 0.0 OUTLIER -84.52 -6.0 59.34 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 122.092 -0.38 . . . . 0.0 111.057 -178.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.92 -35.08 79.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.631 -0.668 . . . . 0.0 110.128 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 m -69.14 -48.07 63.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.206 -0.309 . . . . 0.0 110.34 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.84 -41.6 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.08 -0.388 . . . . 0.0 111.088 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 170' ' ' TRP . 7.5 t -62.86 -41.45 99.38 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.967 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ILE . . . . . 0.461 ' CG2' HG21 ' B' ' 175' ' ' ILE . 3.7 tp -66.25 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.29 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.07 -47.45 85.81 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.822 -0.549 . . . . 0.0 109.853 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.14 -39.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.912 -0.493 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.93 93.39 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.9 -42.37 94.94 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 183' ' ' ALA . 42.9 t -69.79 -44.99 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.98 -42.95 97.06 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.3 m -63.96 -44.34 93.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.08 -41.31 96.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.066 -0.397 . . . . 0.0 110.453 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -36.37 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.56 -41.79 96.08 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -36.1 65.64 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.871 0.759 . . . . 0.0 110.059 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.33 -47.93 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -62.66 -36.09 81.76 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -61.88 -39.08 90.7 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -83.01 -27.23 30.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.046 -0.408 . . . . 0.0 110.009 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 65.4 mtt -103.48 25.98 8.99 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 CA-C-O 118.076 -1.402 . . . . 0.0 109.616 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 3.5 m -122.16 78.9 43.39 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.24 155.69 69.48 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.464 2.11 . . . . 0.0 111.901 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 6.7 t -120.5 160.71 22.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -64.01 -11.77 32.08 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 122.107 -0.371 . . . . 0.0 111.146 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -67.13 -47.27 71.61 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.587 0.631 . . . . 0.0 110.232 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 9.9 t -70.3 -33.68 71.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 173' ' ' VAL . . . . . 0.438 ' O ' HG23 ' B' ' 177' ' ' VAL . 7.9 t -63.76 -43.66 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.4 p -64.76 -43.34 93.6 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.915 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.461 HG21 ' CG2' ' A' ' 175' ' ' ILE . 50.0 mt -66.25 -48.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 176' ' ' PHE . . . . . 0.451 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.28 -47.1 85.8 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 177' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.4 t -67.23 -39.84 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.29 73.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.922 -0.486 . . . . 0.0 110.449 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.77 -43.64 58.72 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 180' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 176' ' ' PHE . 62.0 t -70.06 -43.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 117.735 0.767 . . . . 0.0 108.957 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 181' ' ' LEU . . . . . 0.436 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.2 tt -64.18 -43.31 95.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 64.4 m -64.7 -43.0 94.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 183' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.045 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 30.3 t -68.96 -45.74 69.91 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.41 -44.04 92.5 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.588 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.8 m -65.26 -47.05 78.1 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 118.637 0.653 . . . . 0.0 109.954 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -66.94 -47.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -60.53 -38.34 84.12 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.02 -39.14 91.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -80.29 -27.23 38.55 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.232 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.7 mtm -105.51 22.61 15.18 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.664 0 CA-C-O 118.124 -1.376 . . . . 0.0 109.722 179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 . . . . . 0 N--CA 1.499 1.994 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 m -65.77 -45.74 81.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.1 -0.375 . . . . 0.0 110.397 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 174' ' ' THR . 35.4 m -68.33 -43.89 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.072 -0.392 . . . . 0.0 110.545 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 173' ' ' VAL . 15.4 p -65.2 -43.6 91.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.944 -0.472 . . . . 0.0 110.85 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 tp -66.45 -40.58 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.87 -46.94 88.62 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.23 -39.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.5 80.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.32 98.69 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -44.62 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -43.49 98.72 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 m -60.88 -42.21 97.52 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.66 73.05 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -60.11 -49.16 78.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 185' ' ' LEU . 4.3 mm? -64.42 -42.12 96.23 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.277 -0.265 . . . . 0.0 111.217 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 m -68.83 -47.33 66.29 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.844 -0.535 . . . . 0.0 110.589 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.07 -46.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.015 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 25.1 m . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 110.554 -0.165 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.09 -39.7 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.706 -0.621 . . . . 0.0 110.109 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.3 m -65.37 -43.97 89.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.831 -0.543 . . . . 0.0 110.231 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 5.8 tp -66.72 -37.89 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.853 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . 0.417 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.7 OUTLIER -59.37 -46.78 87.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.04 -39.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.22 93.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.872 -0.517 . . . . 0.0 109.881 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.5 55.06 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 176' ' ' PHE . 57.9 t -69.53 -42.0 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 117.801 0.8 . . . . 0.0 109.002 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.406 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.5 tt -61.92 -43.1 99.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.84 -47.01 79.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.31 74.99 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -46.57 86.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.2 -40.94 97.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.395 -0.19 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.6 m -63.96 -47.02 82.07 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 46.9 mt -65.93 -41.15 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -37.28 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.0 -27.05 54.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 49.5 mtt . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 . . . . . 0 N--CA 1.496 1.827 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.1 p -67.8 -43.5 79.55 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.039 -0.413 . . . . 0.0 110.588 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.4 m -68.21 -45.09 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.722 -0.611 . . . . 0.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 175' ' ' ILE . 7.6 t -65.34 -43.16 91.79 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.882 -0.511 . . . . 0.0 111.231 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' B' ' 175' ' ' ILE . 5.7 tp -66.39 -38.66 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.67 -0.644 . . . . 0.0 109.873 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -47.28 82.17 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.39 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.67 75.49 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.7 -39.38 93.68 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.38 -45.04 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.6 tt -64.16 -43.05 96.36 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.6 p -60.62 -47.0 88.14 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.4 72.74 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.746 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . 0.434 ' OG ' HD22 ' A' ' 185' ' ' LEU . 8.1 p -59.19 -46.64 87.88 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.434 HD22 ' OG ' ' A' ' 184' ' ' SER . 4.5 mm? -64.08 -42.79 96.84 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.1 p -68.37 -47.4 67.51 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.786 -0.571 . . . . 0.0 110.519 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.02 -45.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 9.6 m0 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.261 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 20.4 p . . . . . 0 N--CA 1.498 1.966 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.16 -43.91 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 30.5 p -65.39 -43.93 89.12 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.634 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 175' ' ' ILE . 6.1 tp -66.63 -37.77 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 175' ' ' ILE . 0.3 OUTLIER -58.77 -45.87 88.81 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.49 -39.92 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.17 87.32 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.15 -41.96 78.16 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.44 -38.44 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.43 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.0 tt -61.86 -43.24 99.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -47.12 75.77 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.3 71.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.295 -0.253 . . . . 0.0 110.382 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.9 m -66.02 -49.93 66.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.33 -41.93 96.55 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.515 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -70.05 -47.48 61.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.829 -0.544 . . . . 0.0 110.566 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.4 -45.03 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.3 -38.86 77.9 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -62.45 -39.1 92.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.07 -0.394 . . . . 0.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -83.37 -9.48 59.02 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.715 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.8 mtt . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 179.66 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 . . . . . 0 N--CA 1.499 1.997 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.5 p -64.74 -48.13 75.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.045 -0.41 . . . . 0.0 110.118 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 177' ' ' VAL . 28.8 m -68.4 -39.35 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.922 -0.486 . . . . 0.0 110.355 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 38.0 p -65.14 -43.68 91.09 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.923 -0.485 . . . . 0.0 110.574 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.5 tp -66.32 -37.93 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.9 -47.21 85.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 173' ' ' VAL . 51.3 t -67.23 -39.42 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.72 82.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.029 -0.419 . . . . 0.0 110.051 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.06 97.07 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -68.83 -43.71 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -43.48 90.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.186 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 p -66.87 -47.52 71.6 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.162 -0.337 . . . . 0.0 110.197 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.12 77.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.736 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.3 t -55.89 -41.01 73.84 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -40.92 96.4 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.4 p -73.82 -45.72 49.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.684 -0.635 . . . . 0.0 111.316 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.73 -46.02 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.887 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . 0.406 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.2 t . . . . . 0 N--CA 1.5 2.064 0 N-CA-C 110.607 -0.146 . . . . 0.0 110.607 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.406 ' N ' HG23 ' B' ' 172' ' ' THR . 16.6 m -68.26 -43.74 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.796 -0.565 . . . . 0.0 111.019 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 5.0 t -64.95 -43.05 94.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.811 -0.556 . . . . 0.0 111.397 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tp -66.04 -38.04 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.692 -0.63 . . . . 0.0 109.395 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.0 -43.46 91.52 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -39.66 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.69 -33.95 76.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.842 -0.536 . . . . 0.0 110.694 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.36 -46.32 34.14 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.22 -34.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.83 -42.95 99.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -40.34 96.8 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.32 85.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.27 -0.269 . . . . 0.0 110.647 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 6.3 p -66.88 -46.79 73.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.27 97.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.411 -0.181 . . . . 0.0 111.225 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 12.3 p -72.42 -47.34 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 0.0 110.334 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.18 -43.39 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -57.98 -44.29 87.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.16 -36.67 84.81 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -76.85 -26.97 54.89 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 53.6 mtt . . . . . 0 N--CA 1.496 1.844 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.792 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 24.5 p -66.19 -46.98 75.42 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.146 -0.346 . . . . 0.0 110.216 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.08 -42.84 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.975 -0.453 . . . . 0.0 110.747 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.1 m -62.85 -43.92 97.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.757 -0.59 . . . . 0.0 110.419 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.38 -38.35 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.56 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.1 t80 -66.15 -46.97 75.58 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.21 -39.81 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.9 88.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.862 -0.524 . . . . 0.0 109.812 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.98 -40.7 88.76 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' B' ' 183' ' ' ALA . 61.8 t -67.12 -40.98 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -62.48 -43.64 98.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.2 m -60.14 -46.27 90.21 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.88 66.14 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.2 p -61.4 -43.71 98.4 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 181' ' ' LEU . 4.6 mm? -64.11 -45.18 89.73 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.216 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.0 p -68.29 -47.24 68.19 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.848 -0.532 . . . . 0.0 110.93 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.13 -44.32 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 3.5 t90 . . . . . 0 N--CA 1.496 1.838 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.036 -178.71 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.0 t -68.26 -44.34 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 18.7 p -65.15 -43.43 91.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.199 -0.313 . . . . 0.0 111.56 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.35 -40.75 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.709 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.52 -46.51 82.58 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 173' ' ' VAL . 75.1 t -67.12 -39.95 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.18 88.97 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.16 -38.44 96.52 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.6 -41.45 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.409 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.9 tt -64.04 -43.16 96.38 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -44.26 89.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -57.78 -36.25 71.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 m -65.44 -49.34 69.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.36 -40.85 96.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 122.311 -0.243 . . . . 0.0 110.878 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -62.8 -47.2 84.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.854 -0.529 . . . . 0.0 110.028 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.06 -46.43 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -58.1 -41.99 84.73 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.69 -39.26 93.35 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -76.75 -27.08 55.24 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.068 -0.395 . . . . 0.0 110.216 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 4.8 mmt . . . . . 0 N--CA 1.499 1.992 0 O-C-N 121.918 -0.489 . . . . 0.0 110.359 -179.505 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.499 1.988 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.451 HG23 ' N ' ' A' ' 173' ' ' VAL . 6.4 t -67.88 -46.04 72.79 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.082 -0.386 . . . . 0.0 110.432 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 172' ' ' THR . 28.5 m -68.29 -45.79 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.893 -0.504 . . . . 0.0 110.912 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . 0.408 ' N ' HG23 ' A' ' 173' ' ' VAL . 7.4 t -65.18 -43.32 92.07 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.781 -0.574 . . . . 0.0 110.969 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.2 tp -66.1 -38.7 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.526 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -60.04 -47.0 87.66 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.96 -40.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.71 80.83 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.07 95.54 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.17 -45.04 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.5 -43.23 97.84 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.3 p -63.42 -45.98 88.47 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.89 68.06 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -59.63 -48.83 80.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.36 -41.55 96.67 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.345 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -70.14 -46.94 63.69 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.821 -0.549 . . . . 0.0 111.052 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.8 mt -66.92 -42.37 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 . . . . . 0 N--CA 1.495 1.821 0 O-C-N 122.236 -0.29 . . . . 0.0 111.01 -178.337 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.5 2.061 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 6.7 t -68.29 -42.75 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.938 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 18.2 tt -66.51 -38.4 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . 0.452 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.43 -47.16 85.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.97 -39.74 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.93 87.59 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.78 -39.62 76.4 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 176' ' ' PHE . 58.5 t -67.18 -42.78 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.488 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.0 tt -63.01 -43.18 99.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 29.9 m -62.18 -43.83 97.95 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -61.59 -49.44 76.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.002 -0.436 . . . . 0.0 109.897 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.21 -40.86 96.93 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.291 -0.256 . . . . 0.0 110.812 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 10.3 p -64.11 -47.23 80.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 55.2 mt -66.39 -36.21 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -44.6 86.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.26 -0.275 . . . . 0.0 110.674 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -72.0 -27.66 62.88 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.67 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -76.89 -26.93 54.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.847 -0.533 . . . . 0.0 110.375 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 24.2 mtt . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.485 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 . . . . . 0 N--CA 1.499 2.01 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.5 t -67.13 -39.39 86.6 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.84 -39.38 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -59.43 -41.4 89.5 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 51.1 mm -65.8 -46.88 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -59.28 -47.49 85.19 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.552 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 178' ' ' ALA . 34.4 m -67.6 -46.19 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.996 -0.44 . . . . 0.0 109.946 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . 0.442 ' N ' HG23 ' A' ' 177' ' ' VAL . . . -61.56 -40.16 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.98 99.22 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 176' ' ' PHE . 59.8 t -69.99 -43.89 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 117.846 0.823 . . . . 0.0 108.863 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.01 -43.11 99.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -63.85 -46.88 83.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.56 80.63 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m -55.68 -40.26 72.07 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -40.9 96.49 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.982 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.8 p -73.93 -47.17 39.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.653 -0.654 . . . . 0.0 110.782 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.9 mt -63.32 -49.06 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 19.5 t90 . . . . . 0 N--CA 1.495 1.824 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.792 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 45.4 p . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' B' ' 177' ' ' VAL . 6.2 t -68.4 -40.95 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 11.3 m -65.0 -43.86 91.16 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.221 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 tt -66.5 -42.48 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.185 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.88 -47.08 86.2 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 173' ' ' VAL . 57.3 t -65.89 -39.96 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.19 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.77 94.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.58 -44.15 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.2 tt -61.94 -43.35 99.03 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 19.3 m -64.62 -38.82 92.33 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.86 -36.3 72.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.347 -0.22 . . . . 0.0 110.905 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.3 p -69.31 -42.89 74.81 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.21 -43.34 95.34 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.423 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p -75.15 -47.38 28.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.713 -0.617 . . . . 0.0 110.795 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.42 -43.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -57.95 -39.82 79.04 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.797 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -78.04 -27.3 48.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.169 -0.332 . . . . 0.0 110.758 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.26 8.75 34.02 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.885 -0.509 . . . . 0.0 111.774 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.2 ptm . . . . . 0 N--CA 1.502 2.173 0 CA-C-N 119.022 0.828 . . . . 0.0 109.824 179.784 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 175' ' ' ILE . 63.2 p -67.93 -48.62 65.43 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.078 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -39.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.751 -0.593 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 47.8 p -65.34 -39.18 92.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.156 -0.34 . . . . 0.0 111.61 -178.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 172' ' ' THR . 5.9 tp -65.36 -40.85 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-N 118.705 0.684 . . . . 0.0 109.653 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -63.99 -44.62 92.12 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.18 -39.6 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.12 87.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.36 -42.24 97.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.99 -44.09 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.98 -43.2 99.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.9 m -59.0 -39.47 81.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.029 -0.42 . . . . 0.0 110.016 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.79 -37.44 73.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.019 -0.426 . . . . 0.0 110.763 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.3 t -58.98 -46.3 88.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.54 -42.49 95.7 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.57 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.8 p -68.96 -47.68 65.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.8 mt -67.14 -50.87 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 18.5 t90 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 10.0 m . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.427 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.1 t -68.29 -44.64 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 9.9 m -65.16 -43.39 91.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.387 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.11 -47.36 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.387 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.35 -46.8 72.32 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 173' ' ' VAL . 91.9 t -65.1 -39.4 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.57 82.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.843 -0.535 . . . . 0.0 109.69 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.28 -41.2 69.13 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -44.43 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 118.078 0.939 . . . . 0.0 109.077 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.8 tt -63.22 -43.2 98.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 186' ' ' THR . 59.5 m -63.93 -43.07 96.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.51 82.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.1 m -63.32 -43.12 98.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.37 -41.05 96.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.277 -0.264 . . . . 0.0 111.331 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 182' ' ' THR . 36.7 p -68.48 -47.28 67.47 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.64 -0.663 . . . . 0.0 110.464 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mt -65.55 -50.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -62.03 -45.09 95.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.66 -38.99 92.89 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -77.07 -27.22 54.18 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.189 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 42.5 mtt . . . . . 0 N--CA 1.499 1.98 0 O-C-N 121.963 -0.461 . . . . 0.0 109.804 -179.791 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 . . . . . 0 N--CA 1.498 1.946 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 25.0 m -70.06 -38.33 75.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 177' ' ' VAL . 4.9 t -68.29 -44.78 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.455 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.52 -42.91 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.037 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.432 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -60.69 -47.18 87.44 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 173' ' ' VAL . 87.4 t -61.38 -39.76 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.85 80.41 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.14 88.79 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 176' ' ' PHE . 16.1 t -69.53 -42.43 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.22 -43.09 99.61 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.614 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -66.51 -47.54 72.61 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.971 -0.456 . . . . 0.0 110.107 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.33 78.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -58.36 -36.03 72.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.15 -42.24 96.85 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 122.058 -0.401 . . . . 0.0 111.509 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.8 m -74.93 -47.25 30.65 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.846 0.748 . . . . 0.0 110.689 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 187' ' ' ILE . 44.7 mt -67.22 -45.84 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 46.4 t90 . . . . . 0 N--CA 1.5 2.039 0 O-C-N 122.004 -0.435 . . . . 0.0 110.389 -178.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.6 t . . . . . 0 N--CA 1.499 2.01 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 31.3 m -68.56 -38.78 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.1 -41.47 94.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.165 -0.334 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.42 -42.89 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.11 -45.91 75.76 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 173' ' ' VAL . 63.4 t -66.72 -39.92 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.69 88.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.85 -0.531 . . . . 0.0 109.667 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.33 -38.12 91.16 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.99 -45.04 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.82 -43.5 79.47 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -69.05 -38.83 79.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.403 ' O ' HG12 ' B' ' 187' ' ' ILE . . . -57.75 -50.27 73.79 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.6 m -51.49 -45.66 62.89 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 29.4 mt -64.32 -40.53 96.09 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.675 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 33.8 p -70.85 -47.46 59.24 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.849 -0.532 . . . . 0.0 112.424 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 187' ' ' ILE . 17.3 pt -67.11 -40.51 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.887 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -36.01 71.57 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.665 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.61 -38.96 90.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.048 -0.408 . . . . 0.0 110.277 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -91.56 -16.84 26.54 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 110.977 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 5.2 mmt . . . . . 0 N--CA 1.499 1.985 0 O-C-N 121.771 -0.581 . . . . 0.0 109.652 -179.627 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 t -70.12 -38.16 75.5 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.2 -43.97 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 74.8 m -65.25 -43.36 91.63 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 122.384 -0.197 . . . . 0.0 111.465 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.74 -41.0 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.483 -0.761 . . . . 0.0 110.59 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -61.91 -47.19 86.06 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 m -67.3 -38.96 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.07 84.93 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.61 92.42 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.87 -44.06 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 117.614 0.707 . . . . 0.0 109.15 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.73 -43.25 84.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.364 -0.21 . . . . 0.0 110.436 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 p -60.22 -47.63 85.16 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.06 -0.4 . . . . 0.0 110.374 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -69.85 -31.63 69.58 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.037 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 t -58.61 -40.76 84.17 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 185' ' ' LEU . 1.3 mt -64.44 -42.09 96.19 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.105 -0.372 . . . . 0.0 111.262 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 m -72.84 -47.42 46.4 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 118.812 0.733 . . . . 0.0 110.592 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.15 -49.67 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 122.113 -0.367 . . . . 0.0 110.255 -178.202 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 69.9 p . . . . . 0 N--CA 1.498 1.963 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.0 -40.69 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.7 m -64.51 -43.3 94.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.218 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -48.57 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.857 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.4 -47.39 70.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.859 -0.526 . . . . 0.0 110.137 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.19 -39.74 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.87 84.08 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 118.453 0.569 . . . . 0.0 109.94 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.74 -44.54 89.18 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.27 -39.56 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 117.683 0.741 . . . . 0.0 109.171 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -43.24 99.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.74 -47.13 84.91 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.39 -41.1 96.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 122.329 -0.232 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 19.1 m -69.07 -49.44 57.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.879 -0.513 . . . . 0.0 109.727 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.58 97.07 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.574 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 20.8 p -69.56 -47.51 63.4 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 118.606 0.639 . . . . 0.0 110.558 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.66 -45.43 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -57.91 -45.13 86.95 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.344 -0.223 . . . . 0.0 111.292 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -23.07 63.86 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.545 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -84.79 -13.65 50.49 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.873 -0.517 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.9 mtt . . . . . 0 N--CA 1.5 2.07 0 O-C-N 121.624 -0.672 . . . . 0.0 110.166 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 . . . . . 0 N--CA 1.498 1.928 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.4 m -61.86 -47.2 86.08 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 177' ' ' VAL . 32.0 m -68.16 -38.87 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.005 -0.435 . . . . 0.0 110.426 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 20.8 p -64.16 -43.91 93.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.784 -0.573 . . . . 0.0 111.561 -178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.69 -42.7 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 118.502 0.592 . . . . 0.0 109.902 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -63.15 -46.64 86.24 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 173' ' ' VAL . 62.6 t -64.64 -39.72 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.875 -0.516 . . . . 0.0 110.451 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.84 -43.91 48.91 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 176' ' ' PHE . 48.1 t -68.87 -43.75 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 118.015 0.908 . . . . 0.0 108.938 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.42 HD23 HD21 ' A' ' 185' ' ' LEU . 6.4 tt -63.01 -42.97 99.95 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.412 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 p -64.34 -47.27 79.98 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.61 78.21 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 m -58.95 -39.4 81.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.42 HD21 HD23 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -64.42 -41.27 96.7 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 122.12 -0.362 . . . . 0.0 111.382 -178.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -47.16 30.36 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -48.21 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 122.031 -0.418 . . . . 0.0 110.175 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.498 1.944 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.799 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 42.2 p . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 110.376 -0.231 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.422 ' O ' HG22 ' B' ' 177' ' ' VAL . 27.4 m -68.27 -39.45 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.906 -0.496 . . . . 0.0 109.922 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 27.5 m -62.31 -41.98 98.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.227 -0.296 . . . . 0.0 111.063 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.68 -41.77 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.932 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.08 -47.2 71.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.974 -0.454 . . . . 0.0 110.13 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 173' ' ' VAL . 31.6 m -67.05 -39.76 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.485 . . . . 0.0 109.799 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.85 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.6 -42.29 88.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.1 -40.92 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.415 ' O ' HD13 ' B' ' 185' ' ' LEU . 6.4 tt -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 22.5 m -68.55 -43.6 76.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.24 77.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.213 -0.304 . . . . 0.0 110.319 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.6 p -69.39 -41.44 76.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . 0.415 HD13 ' O ' ' B' ' 181' ' ' LEU . 6.7 mp -63.88 -44.24 93.62 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.46 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -47.29 74.33 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.32 -49.89 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -44.06 88.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -65.02 -37.86 89.02 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -78.84 -22.02 46.76 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.065 -0.397 . . . . 0.0 110.196 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 19.9 mmt . . . . . 0 N--CA 1.498 1.97 0 O-C-N 121.867 -0.52 . . . . 0.0 110.131 -179.719 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 m -57.52 -47.77 81.07 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.939 -0.475 . . . . 0.0 110.152 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.04 -38.91 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.339 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.4 p -65.4 -44.17 88.31 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.661 -0.649 . . . . 0.0 110.349 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.497 HG22 HG22 ' B' ' 175' ' ' ILE . 1.6 mp -66.69 -42.06 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.71 -46.88 86.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -39.93 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.59 80.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.02 -39.7 93.18 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.38 -44.56 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.023 0.912 . . . . 0.0 108.604 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.8 tt -64.46 -43.16 95.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.0 m -68.99 -45.67 70.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.51 80.76 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.8 p -57.97 -39.68 78.75 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -41.01 97.11 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.879 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 p -69.5 -47.35 64.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.656 -0.652 . . . . 0.0 110.88 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.43 -46.29 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 . . . . . 0 N--CA 1.496 1.837 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 177' ' ' VAL . 12.4 t -62.35 -40.36 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 16.7 m -58.99 -43.14 91.4 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 175' ' ' ILE . 3.3 mp -65.39 -45.41 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . 0.473 ' O ' HG23 ' B' ' 180' ' ' VAL . 1.0 OUTLIER -58.62 -44.14 89.87 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.7 t -59.02 -39.9 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -40.07 70.14 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.26 99.8 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 176' ' ' PHE . 96.4 t -64.32 -38.01 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.78 -43.18 99.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 11.4 m -58.98 -41.26 87.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.04 91.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -49.37 76.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -41.08 97.3 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.369 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.7 p -67.43 -47.54 69.9 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.683 -0.636 . . . . 0.0 111.339 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.23 -42.23 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.38 -44.25 97.48 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.869 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.78 -36.32 72.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -76.83 -27.08 55.0 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.371 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 9.6 mtt . . . . . 0 N--CA 1.497 1.909 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.93 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 . . . . . 0 N--CA 1.499 2.017 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 59.4 p -70.05 -34.69 73.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 177' ' ' VAL . 11.6 t -68.42 -42.42 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.1 m -65.24 -43.98 89.66 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.096 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.64 -44.56 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.092 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -65.87 -46.89 76.73 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 89.4 t -66.78 -39.62 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.07 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 118.564 0.62 . . . . 0.0 109.621 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.38 -44.26 85.17 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.8 t -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.66 -43.33 99.07 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -47.36 72.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.785 -0.572 . . . . 0.0 109.676 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.16 70.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.835 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.1 t -59.87 -46.86 87.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.51 -42.52 95.75 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -67.88 -47.37 69.04 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.234 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.46 -48.16 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.3 t-105 . . . . . 0 N--CA 1.496 1.851 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.809 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . 0.456 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.3 t . . . . . 0 N--CA 1.503 2.194 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.456 ' N ' HG23 ' B' ' 172' ' ' THR . 27.6 m -68.53 -42.46 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.803 -0.561 . . . . 0.0 110.437 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -64.97 -43.42 92.7 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 122.089 -0.382 . . . . 0.0 111.404 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.27 -41.79 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.718 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.03 -45.24 89.78 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 173' ' ' VAL . 73.8 t -67.09 -39.64 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.55 75.14 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.03 -42.13 94.8 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.99 -44.38 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.05 -43.14 99.48 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 57.1 m -62.42 -45.21 94.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -65.33 -36.91 85.49 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.091 -0.381 . . . . 0.0 110.749 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.7 p -69.82 -47.71 61.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.92 -40.61 96.87 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.499 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 4.0 m -75.0 -47.19 30.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.233 0.924 . . . . 0.0 110.23 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.21 -44.46 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -67.46 -43.11 81.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.092 -0.38 . . . . 0.0 110.974 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -66.89 -37.17 83.88 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.878 -0.514 . . . . 0.0 110.234 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -82.77 -27.31 31.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.042 -0.411 . . . . 0.0 110.169 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 32.2 mtt . . . . . 0 N--CA 1.498 1.969 0 O-C-N 121.91 -0.494 . . . . 0.0 109.716 179.9 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 . . . . . 0 N--CA 1.498 1.944 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 26.7 p -69.18 -31.82 70.7 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 177' ' ' VAL . 10.4 t -67.75 -43.91 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.5 m -65.02 -44.02 90.54 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.495 HG23 HD12 ' B' ' 175' ' ' ILE . 13.9 tt -66.73 -38.87 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' B' ' 175' ' ' ILE . 1.5 t80 -59.01 -45.98 89.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 173' ' ' VAL . 93.1 t -66.34 -39.29 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.03 85.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.995 -0.441 . . . . 0.0 109.932 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.06 72.61 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.4 t -68.89 -34.19 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 122.003 -0.704 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.7 OUTLIER -65.41 -43.2 91.34 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -62.86 -47.22 84.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.568 . . . . 0.0 109.944 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.29 -40.81 67.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -58.67 -42.85 89.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 181' ' ' LEU . 3.9 mm? -64.33 -43.06 95.81 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.186 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.03 -47.36 52.35 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.776 -0.577 . . . . 0.0 110.491 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.23 -49.2 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 62.8 t90 . . . . . 0 N--CA 1.495 1.798 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.218 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.9 t . . . . . 0 N--CA 1.501 2.111 0 CA-C-O 120.31 0.1 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 35.9 m -68.2 -40.37 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.517 . . . . 0.0 110.811 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.5 m -65.04 -43.61 91.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.684 -0.635 . . . . 0.0 110.96 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 175' ' ' ILE . 0.2 OUTLIER -66.41 -47.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.657 -0.652 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.36 -47.45 70.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.006 -0.434 . . . . 0.0 110.105 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 173' ' ' VAL . 85.1 t -67.22 -39.96 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.22 86.43 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.14 99.6 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.0 -39.98 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 mt -62.02 -43.64 98.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.22 -0.3 . . . . 0.0 110.368 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -46.95 65.79 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.999 -0.438 . . . . 0.0 109.839 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.43 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -61.61 -42.31 98.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.251 -0.28 . . . . 0.0 110.604 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 58.5 m -69.13 -50.04 51.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.887 -0.508 . . . . 0.0 110.317 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.47 -41.41 96.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.307 -0.246 . . . . 0.0 111.638 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 28.1 p -68.07 -47.34 68.58 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.408 0.549 . . . . 0.0 111.1 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.31 -44.83 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -62.15 -45.32 93.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.783 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -78.3 -31.09 48.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.771 -0.58 . . . . 0.0 110.985 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -79.1 -25.66 43.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.032 -0.418 . . . . 0.0 110.66 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 51.0 mtt . . . . . 0 N--CA 1.497 1.914 0 O-C-N 121.819 -0.551 . . . . 0.0 109.807 -179.808 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 . . . . . 0 N--CA 1.499 1.983 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.5 m -59.3 -47.02 86.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.138 -0.351 . . . . 0.0 110.171 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.5 m -63.74 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 109.912 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -58.65 -43.43 89.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.099 -0.375 . . . . 0.0 110.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 tp -65.51 -41.75 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.65 -45.75 91.37 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' VAL . 90.9 t -64.65 -39.63 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.692 -0.63 . . . . 0.0 109.807 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.52 -42.96 62.62 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.96 -44.36 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 117.977 0.889 . . . . 0.0 108.967 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.85 -43.3 99.16 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.5 m -58.94 -44.74 91.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.25 69.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.11 -0.369 . . . . 0.0 111.52 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -59.57 -44.42 93.31 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.43 -44.7 90.37 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 13.3 p -66.03 -47.76 73.33 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.429 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 59.0 mt -67.7 -50.76 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 . . . . . 0 N--CA 1.496 1.863 0 O-C-N 122.357 -0.214 . . . . 0.0 110.64 -178.373 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . 0.45 HG23 ' N ' ' B' ' 173' ' ' VAL . 7.5 t . . . . . 0 N--CA 1.501 2.106 0 CA-C-O 120.513 0.197 . . . . 0.0 110.479 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.547 ' O ' HG23 ' B' ' 177' ' ' VAL . 34.7 m -68.57 -39.24 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.765 -0.584 . . . . 0.0 110.264 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 21.2 p -64.16 -43.31 95.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.96 -0.463 . . . . 0.0 111.847 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.08 -42.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 118.798 0.727 . . . . 0.0 109.98 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.08 -45.7 76.53 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 173' ' ' VAL . 92.2 t -66.34 -40.3 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.79 79.0 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.847 -0.533 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.23 94.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.79 -43.09 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.45 -43.45 98.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 1.9 p -61.73 -47.19 86.37 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 120.949 0.404 . . . . 0.0 110.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.72 -29.34 70.04 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.089 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -50.72 58.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.84 -0.538 . . . . 0.0 110.461 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -44.15 90.42 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.582 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -47.5 85.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.181 -0.325 . . . . 0.0 111.156 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.12 -46.03 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -64.7 -34.93 79.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.3 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -63.51 -35.42 80.41 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.066 -0.397 . . . . 0.0 110.087 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -91.13 0.69 57.48 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 122.018 -0.426 . . . . 0.0 111.057 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 O-C-N 121.741 -0.599 . . . . 0.0 109.765 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 . . . . . 0 N--CA 1.5 2.058 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 m -69.14 -48.07 63.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.206 -0.309 . . . . 0.0 110.34 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.84 -41.6 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.08 -0.388 . . . . 0.0 111.088 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 7.5 t -62.86 -41.45 99.38 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.967 -178.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ILE . . . . . 0.461 ' CG2' HG21 ' B' ' 175' ' ' ILE . 3.7 tp -66.25 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.29 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.07 -47.45 85.81 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.822 -0.549 . . . . 0.0 109.853 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.14 -39.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.912 -0.493 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.93 93.39 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.9 -42.37 94.94 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 183' ' ' ALA . 42.9 t -69.79 -44.99 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.98 -42.95 97.06 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.3 m -63.96 -44.34 93.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.08 -41.31 96.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.066 -0.397 . . . . 0.0 110.453 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -36.37 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.56 -41.79 96.08 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -36.1 65.64 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.871 0.759 . . . . 0.0 110.059 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.33 -47.93 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 9.9 t . . . . . 0 N--CA 1.499 1.976 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 173' ' ' VAL . . . . . 0.438 ' O ' HG23 ' B' ' 177' ' ' VAL . 7.9 t -63.76 -43.66 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.4 p -64.76 -43.34 93.6 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.915 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 175' ' ' ILE . . . . . 0.461 HG21 ' CG2' ' A' ' 175' ' ' ILE . 50.0 mt -66.25 -48.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 176' ' ' PHE . . . . . 0.451 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.28 -47.1 85.8 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 177' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.4 t -67.23 -39.84 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.29 73.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.922 -0.486 . . . . 0.0 110.449 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.77 -43.64 58.72 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 180' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 176' ' ' PHE . 62.0 t -70.06 -43.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 117.735 0.767 . . . . 0.0 108.957 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 181' ' ' LEU . . . . . 0.436 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.2 tt -64.18 -43.31 95.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 64.4 m -64.7 -43.0 94.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 183' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.045 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 30.3 t -68.96 -45.74 69.91 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.41 -44.04 92.5 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.588 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.8 m -65.26 -47.05 78.1 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 118.637 0.653 . . . . 0.0 109.954 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -66.94 -47.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -60.53 -38.34 84.12 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.02 -39.14 91.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -80.29 -27.23 38.55 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.232 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.7 mtm . . . . . 0 N--CA 1.497 1.905 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.233 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 18.2 m -99.44 132.18 23.68 Favored Pre-proline 0 N--CA 1.495 1.82 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -66.86 149.62 83.24 Favored 'Trans proline' 0 N--CA 1.5 1.906 0 C-N-CA 121.842 1.695 . . . . 0.0 111.842 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 1.8 m -81.29 157.14 25.22 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.2 m-90 -102.07 -8.75 21.16 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.212 -179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -69.09 -40.3 78.51 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.592 -0.692 . . . . 0.0 110.093 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 15.7 m -65.77 -45.74 81.38 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 122.1 -0.375 . . . . 0.0 110.397 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 174' ' ' THR . 35.4 m -68.33 -43.89 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 122.072 -0.392 . . . . 0.0 110.545 -179.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.405 ' N ' HG23 ' A' ' 173' ' ' VAL . 15.4 p -65.2 -43.6 91.06 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.944 -0.472 . . . . 0.0 110.85 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.9 tp -66.45 -40.58 86.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -60.87 -46.94 88.62 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.7 t -66.23 -39.84 85.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.5 80.95 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.96 -41.32 98.69 Favored Glycine 0 N--CA 1.498 2.776 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.2 t -65.71 -44.62 93.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.99 -43.49 98.72 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 14.4 m -60.88 -42.21 97.52 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.03 -36.66 73.05 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 1.3 m -60.11 -49.16 78.74 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 185' ' ' LEU . 4.3 mm? -64.42 -42.12 96.23 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.277 -0.265 . . . . 0.0 111.217 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.8 m -68.83 -47.33 66.29 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.844 -0.535 . . . . 0.0 110.589 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.6 mt -67.07 -46.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 27.0 t-105 -58.17 -45.04 88.17 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 36.1 mttm -66.42 -36.07 81.89 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 14.0 tttt -78.88 -20.83 48.51 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 122.013 -0.43 . . . . 0.0 110.202 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 39.0 mtt -96.49 27.85 3.62 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.908 -0.495 . . . . 0.0 109.69 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.655 0 CA-C-O 118.006 -1.441 . . . . 0.0 109.625 179.903 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 40.7 p -124.03 83.9 55.33 Favored Pre-proline 0 N--CA 1.497 1.887 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -72.33 161.14 45.23 Favored 'Trans proline' 0 N--CA 1.497 1.732 0 C-N-CA 122.203 1.935 . . . . 0.0 112.253 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 1.7 m -51.63 160.77 0.59 Allowed 'General case' 0 N--CA 1.501 2.095 0 O-C-N 122.14 -0.35 . . . . 0.0 110.109 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -65.97 -31.46 72.38 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -68.3 -39.57 81.99 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 25.1 m -63.79 -43.0 97.64 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 122.26 -0.275 . . . . 0.0 110.554 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.09 -39.7 81.82 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 O-C-N 121.706 -0.621 . . . . 0.0 110.109 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 13.3 m -65.37 -43.97 89.07 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.831 -0.543 . . . . 0.0 110.231 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 5.8 tp -66.72 -37.89 80.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 C-N-CA 120.433 -0.507 . . . . 0.0 109.853 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . 0.417 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.7 OUTLIER -59.37 -46.78 87.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.299 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.04 -39.84 86.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.22 93.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.872 -0.517 . . . . 0.0 109.881 -179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.5 55.06 Favored Glycine 0 N--CA 1.499 2.848 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . 0.417 HG23 ' O ' ' B' ' 176' ' ' PHE . 57.9 t -69.53 -42.0 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 117.801 0.8 . . . . 0.0 109.002 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.406 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.5 tt -61.92 -43.1 99.55 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.84 -47.01 79.49 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -60.13 -35.31 74.99 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.6 -46.57 86.72 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 35.5 mt -64.2 -40.94 97.12 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 122.395 -0.19 . . . . 0.0 110.877 -178.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.6 m -63.96 -47.02 82.07 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -178.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 46.9 mt -65.93 -41.15 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -57.75 -37.28 73.35 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -61.91 -39.17 91.09 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 59.9 tttm -77.0 -27.05 54.54 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 109.848 -0.426 . . . . 0.0 109.848 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 49.5 mtt -99.98 38.24 1.5 Allowed 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.756 0 CA-C-O 117.939 -1.478 . . . . 0.0 109.596 179.868 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.4 m -111.79 89.84 11.93 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.0 159.35 34.11 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.131 1.888 . . . . 0.0 112.239 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 19.9 p -61.73 120.23 10.25 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.413 ' O ' HG22 ' A' ' 174' ' ' THR . 1.0 OUTLIER -96.91 -9.38 28.57 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 122.263 -0.273 . . . . 0.0 110.535 -179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 30.7 tt0 -68.7 -34.44 75.66 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.554 -0.716 . . . . 0.0 109.829 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 21.1 p -67.8 -43.5 79.55 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 122.039 -0.413 . . . . 0.0 110.588 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.4 m -68.21 -45.09 83.56 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.105 0 O-C-N 121.722 -0.611 . . . . 0.0 110.582 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.413 HG22 ' O ' ' A' ' 170' ' ' TRP . 7.6 t -65.34 -43.16 91.79 Favored 'General case' 0 N--CA 1.504 2.235 0 O-C-N 121.882 -0.511 . . . . 0.0 111.231 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' B' ' 175' ' ' ILE . 5.7 tp -66.39 -38.66 82.27 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 121.67 -0.644 . . . . 0.0 109.873 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -63.57 -47.28 82.17 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -64.39 -40.68 89.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.159 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -179.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.97 -35.67 75.49 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.7 -39.38 93.68 Favored Glycine 0 N--CA 1.497 2.733 0 N-CA-C 109.476 -1.449 . . . . 0.0 109.476 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 61.4 t -69.38 -45.04 79.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.405 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.6 tt -64.16 -43.05 96.36 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -179.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.6 p -60.62 -47.0 88.14 Favored 'General case' 0 N--CA 1.499 1.986 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.63 -34.4 72.74 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.746 -178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.434 ' OG ' HD22 ' A' ' 185' ' ' LEU . 8.1 p -59.19 -46.64 87.88 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.434 HD22 ' OG ' ' A' ' 184' ' ' SER . 4.5 mm? -64.08 -42.79 96.84 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 121.243 -0.183 . . . . 0.0 111.327 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.1 p -68.37 -47.4 67.51 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.786 -0.571 . . . . 0.0 110.519 -178.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 48.7 mt -67.02 -45.42 87.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -59.43 -38.48 80.79 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -63.0 -39.3 94.35 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -86.2 -16.78 36.7 Favored 'General case' 0 N--CA 1.504 2.232 0 O-C-N 122.071 -0.393 . . . . 0.0 110.556 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 23.7 mmt -98.53 22.38 9.92 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.802 -0.561 . . . . 0.0 109.962 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.739 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.406 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 41.3 p -131.71 85.94 50.21 Favored Pre-proline 0 N--CA 1.496 1.825 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.0 159.44 34.06 Favored 'Trans proline' 0 N--CA 1.497 1.681 0 C-N-CA 122.206 1.937 . . . . 0.0 112.281 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -119.2 130.96 55.76 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -35.61 20.59 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -60.23 -32.89 71.55 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 20.4 p -64.16 -31.68 72.96 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 5.0 t -68.16 -43.91 84.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 30.5 p -65.39 -43.93 89.12 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.634 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.664 HG21 HG21 ' A' ' 175' ' ' ILE . 6.1 tp -66.63 -37.77 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . 0.46 ' CE2' HD11 ' A' ' 175' ' ' ILE . 0.3 OUTLIER -58.77 -45.87 88.81 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 66.4 t -59.49 -39.92 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.907 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.65 -39.17 87.32 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.414 -0.588 . . . . 0.0 109.414 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.15 -41.96 78.16 Favored Glycine 0 N--CA 1.498 2.771 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 57.1 t -67.44 -38.44 80.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.43 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.0 tt -61.86 -43.24 99.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.93 -47.12 75.77 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.44 -30.3 71.34 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 122.295 -0.253 . . . . 0.0 110.382 -179.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.9 m -66.02 -49.93 66.01 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.33 -41.93 96.55 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.515 -179.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -70.05 -47.48 61.82 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.829 -0.544 . . . . 0.0 110.566 -178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.4 mt -67.4 -45.03 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.6 t90 -58.3 -38.86 77.9 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 65.7 tttt -62.45 -39.1 92.28 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 122.07 -0.394 . . . . 0.0 109.952 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -83.37 -9.48 59.02 Favored 'General case' 0 N--CA 1.505 2.305 0 C-N-CA 120.51 -0.476 . . . . 0.0 110.715 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.8 mtt -91.04 34.56 0.92 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.593 -0.692 . . . . 0.0 109.372 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.521 179.94 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 11.8 m -125.52 137.65 30.31 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.09 158.16 34.01 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 121.901 1.734 . . . . 0.0 112.344 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.1 m -82.94 129.46 35.03 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.415 ' O ' HG23 ' A' ' 174' ' ' THR . 5.6 m-90 -101.31 -2.91 29.91 Favored 'General case' 0 N--CA 1.501 2.077 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.976 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -59.59 -38.49 81.36 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.553 -0.717 . . . . 0.0 109.66 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.5 p -64.74 -48.13 75.7 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 122.045 -0.41 . . . . 0.0 110.118 -179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 177' ' ' VAL . 28.8 m -68.4 -39.35 80.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.922 -0.486 . . . . 0.0 110.355 -179.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.415 HG23 ' O ' ' A' ' 170' ' ' TRP . 38.0 p -65.14 -43.68 91.09 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.923 -0.485 . . . . 0.0 110.574 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.5 tp -66.32 -37.93 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.072 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -61.9 -47.21 85.97 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 173' ' ' VAL . 51.3 t -67.23 -39.42 82.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 -179.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.62 -38.72 82.06 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 122.029 -0.419 . . . . 0.0 110.051 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.76 -39.06 97.07 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.3 t -68.83 -43.71 82.43 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.983 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.43 -43.48 90.34 Favored 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.186 -178.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.3 p -66.87 -47.52 71.6 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 122.162 -0.337 . . . . 0.0 110.197 -178.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.95 -34.12 77.26 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.736 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 10.3 t -55.89 -41.01 73.84 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.59 -40.92 96.4 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.566 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 39.4 p -73.82 -45.72 49.58 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 121.684 -0.635 . . . . 0.0 111.316 -177.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 36.7 mt -60.73 -46.02 96.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 -178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.05 -35.2 70.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 29.1 ttmt -69.52 -39.05 77.78 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 122.161 -0.337 . . . . 0.0 110.39 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 48.9 pttt -91.65 -10.81 38.95 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.118 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 76.0 mmm -110.43 24.95 12.32 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.687 -0.633 . . . . 0.0 109.92 179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.69 0 CA-C-O 117.972 -1.46 . . . . 0.0 109.666 179.865 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 32.3 p -125.69 87.68 55.47 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.16 149.01 45.31 Favored 'Trans proline' 0 N--CA 1.497 1.711 0 C-N-CA 122.107 1.871 . . . . 0.0 112.39 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 2.9 m 62.87 151.63 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -101.7 -22.45 14.42 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 122.221 -0.299 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -64.26 -33.08 75.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.929 -0.482 . . . . 0.0 110.069 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . 0.406 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.2 t -66.76 -43.95 82.71 Favored 'General case' 0 N--CA 1.5 2.064 0 O-C-N 122.0 -0.437 . . . . 0.0 110.607 -179.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.406 ' N ' HG23 ' B' ' 172' ' ' THR . 16.6 m -68.26 -43.74 84.4 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.796 -0.565 . . . . 0.0 111.019 -178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 5.0 t -64.95 -43.05 94.0 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.811 -0.556 . . . . 0.0 111.397 -178.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 6.8 tp -66.04 -38.04 81.15 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 O-C-N 121.692 -0.63 . . . . 0.0 109.395 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -59.0 -43.46 91.52 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 94.7 t -63.37 -39.66 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.69 -33.95 76.79 Favored 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.842 -0.536 . . . . 0.0 110.694 -178.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -72.36 -46.32 34.14 Favored Glycine 0 N--CA 1.497 2.712 0 N-CA-C 109.409 -1.477 . . . . 0.0 109.409 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 10.5 p -70.22 -34.29 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 8.7 tt -61.83 -42.95 99.66 Favored 'General case' 0 N--CA 1.497 1.917 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -62.68 -40.34 96.8 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -58.04 -42.32 85.13 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 122.27 -0.269 . . . . 0.0 110.647 -179.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 6.3 p -66.88 -46.79 73.86 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.27 97.19 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 122.411 -0.181 . . . . 0.0 111.225 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 12.3 p -72.42 -47.34 49.92 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.763 -0.585 . . . . 0.0 110.334 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 69.1 mt -64.18 -43.39 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 32.4 t90 -57.98 -44.29 87.04 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 79.5 tttt -64.16 -36.67 84.81 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 20.1 tptt -76.85 -26.97 54.89 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 53.6 mtt -82.97 52.75 2.24 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.621 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.951 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 25.0 p -123.68 138.08 29.74 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.5 142.04 35.87 Favored 'Trans proline' 0 N--CA 1.499 1.806 0 C-N-CA 121.876 1.717 . . . . 0.0 112.117 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.1 p -133.03 116.36 16.27 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 17.0 m-90 -77.42 -16.28 58.9 Favored 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 121.044 -0.262 . . . . 0.0 110.495 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.11 -39.03 82.88 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.663 -0.648 . . . . 0.0 109.695 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 24.5 p -66.19 -46.98 75.42 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 122.146 -0.346 . . . . 0.0 110.216 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 31.3 m -68.08 -42.84 85.45 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.975 -0.453 . . . . 0.0 110.747 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 19.1 m -62.85 -43.92 97.52 Favored 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.757 -0.59 . . . . 0.0 110.419 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.38 -38.35 81.6 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.036 0 C-N-CA 120.323 -0.551 . . . . 0.0 109.56 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.411 ' O ' HG23 ' A' ' 180' ' ' VAL . 2.1 t80 -66.15 -46.97 75.58 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.21 -39.81 83.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.21 -39.9 88.24 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.862 -0.524 . . . . 0.0 109.812 -179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.98 -40.7 88.76 Favored Glycine 0 N--CA 1.499 2.87 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.456 HG13 ' HB2' ' B' ' 183' ' ' ALA . 61.8 t -67.12 -40.98 86.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.428 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -62.48 -43.64 98.34 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -179.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 21.2 m -60.14 -46.27 90.21 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.84 -29.88 66.14 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.622 -179.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.2 p -61.4 -43.71 98.4 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 181' ' ' LEU . 4.6 mm? -64.11 -45.18 89.73 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.216 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 7.0 p -68.29 -47.24 68.19 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.848 -0.532 . . . . 0.0 110.93 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.4 mt -65.13 -44.32 95.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 -178.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -59.98 -44.51 94.44 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.036 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 5.7 mtmm -64.39 -39.09 93.19 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -76.91 -27.27 54.87 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.403 -0.519 . . . . 0.0 110.372 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 94.7 mtp -97.35 28.07 3.88 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.856 -0.528 . . . . 0.0 109.721 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.692 0 CA-C-O 117.957 -1.469 . . . . 0.0 109.517 179.767 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.349 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 12.7 m -129.0 92.43 39.72 Favored Pre-proline 0 N--CA 1.494 1.772 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.99 160.48 49.47 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.988 1.792 . . . . 0.0 112.091 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 77.6 p -123.86 161.71 24.76 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 9.0 m-90 -95.03 -5.37 44.65 Favored 'General case' 0 N--CA 1.501 2.091 0 C-N-CA 120.879 -0.329 . . . . 0.0 110.834 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -62.74 -37.57 87.1 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.634 -0.666 . . . . 0.0 109.944 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 15.5 m -70.01 -39.11 76.04 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.464 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.0 t -68.26 -44.34 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 18.7 p -65.15 -43.43 91.84 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 122.199 -0.313 . . . . 0.0 111.56 -178.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 14.9 tt -66.35 -40.75 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.709 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -64.52 -46.51 82.58 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.464 HG23 ' O ' ' B' ' 173' ' ' VAL . 75.1 t -67.12 -39.95 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.037 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.18 88.97 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.16 -38.44 96.52 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 61.7 t -67.6 -41.45 85.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.409 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.9 tt -64.04 -43.16 96.38 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -44.26 89.45 Favored 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.456 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -57.78 -36.25 71.9 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.8 m -65.44 -49.34 69.54 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.4 mt -64.36 -40.85 96.66 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 122.311 -0.243 . . . . 0.0 110.878 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -62.8 -47.2 84.49 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.854 -0.529 . . . . 0.0 110.028 -178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.7 mt -67.06 -46.43 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -58.1 -41.99 84.73 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -64.69 -39.26 93.35 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 40.8 tptt -76.75 -27.08 55.24 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.068 -0.395 . . . . 0.0 110.216 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 4.8 mmt -89.21 23.75 2.38 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.918 -0.489 . . . . 0.0 110.359 -179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.733 0 CA-C-O 118.038 -1.423 . . . . 0.0 109.636 179.657 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 24.9 p -127.31 85.19 61.52 Favored Pre-proline 0 N--CA 1.495 1.8 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -66.98 152.48 80.25 Favored 'Trans proline' 0 N--CA 1.499 1.815 0 C-N-CA 122.249 1.966 . . . . 0.0 111.838 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.471 HG23 HG22 ' A' ' 172' ' ' THR . 5.0 t -59.26 133.8 56.42 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.667 ' O ' HG22 ' A' ' 174' ' ' THR . 8.4 m-90 -98.49 -8.85 25.96 Favored 'General case' 0 N--CA 1.501 2.103 0 C-N-CA 120.867 -0.333 . . . . 0.0 110.899 -179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -67.25 -36.87 82.52 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 121.792 -0.567 . . . . 0.0 110.012 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.471 HG22 HG23 ' A' ' 169' ' ' THR . 6.4 t -67.88 -46.04 72.79 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 122.082 -0.386 . . . . 0.0 110.432 -179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.451 ' N ' HG23 ' A' ' 172' ' ' THR . 28.5 m -68.29 -45.79 82.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.893 -0.504 . . . . 0.0 110.912 -178.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 170' ' ' TRP . 7.4 t -65.18 -43.32 92.07 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.781 -0.574 . . . . 0.0 110.969 -178.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.2 tp -66.1 -38.7 82.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 C-N-CA 120.328 -0.549 . . . . 0.0 109.526 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -60.04 -47.0 87.66 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 57.0 t -66.96 -40.15 85.01 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.3 -36.71 80.83 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.75 -40.07 95.54 Favored Glycine 0 N--CA 1.497 2.718 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 57.9 t -69.17 -45.04 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.8 tt -63.5 -43.23 97.84 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 3.3 p -63.42 -45.98 88.47 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.83 -32.89 68.06 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.3 t -59.63 -48.83 80.14 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -64.36 -41.55 96.67 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.345 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.6 m -70.14 -46.94 63.69 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.821 -0.549 . . . . 0.0 111.052 -177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.8 mt -66.92 -42.37 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 56.1 t-105 -57.84 -38.89 76.46 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 122.236 -0.29 . . . . 0.0 111.01 -178.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -78.07 -23.1 48.16 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.703 -0.623 . . . . 0.0 111.497 -178.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -83.42 -27.58 29.47 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 118.666 0.666 . . . . 0.0 110.989 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.16 33.13 2.59 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.763 0 CA-C-O 117.877 -1.513 . . . . 0.0 109.848 179.294 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 14.4 m -123.8 100.63 37.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -66.96 156.04 68.1 Favored 'Trans proline' 0 N--CA 1.499 1.816 0 C-N-CA 121.967 1.778 . . . . 0.0 111.883 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 5.1 t -55.68 171.6 0.2 Allowed 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.402 ' CD1' HG21 ' B' ' 173' ' ' VAL . 11.4 t90 -94.42 -13.1 26.6 Favored 'General case' 0 N--CA 1.499 2.025 0 O-C-N 122.281 -0.262 . . . . 0.0 110.646 -179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -59.0 -32.88 70.1 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.83 -0.544 . . . . 0.0 109.897 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 5.1 t -67.74 -32.13 72.52 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' B' ' 170' ' ' TRP . 6.7 t -68.29 -42.75 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 37.9 p -65.26 -43.78 90.22 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.938 -178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 18.2 tt -66.51 -38.4 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . 0.452 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.43 -47.16 85.28 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.97 -39.74 85.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.04 -39.93 87.59 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.78 -39.62 76.4 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 176' ' ' PHE . 58.5 t -67.18 -42.78 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.488 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.0 tt -63.01 -43.18 99.47 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 29.9 m -62.18 -43.83 97.95 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.59 -35.24 80.26 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 4.4 t -61.59 -49.44 76.62 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 122.002 -0.436 . . . . 0.0 109.897 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 31.6 mt -64.21 -40.86 96.93 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 122.291 -0.256 . . . . 0.0 110.812 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 10.3 p -64.11 -47.23 80.81 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.935 -0.478 . . . . 0.0 110.185 -178.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 55.2 mt -66.39 -36.21 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.8 -44.6 86.42 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 122.26 -0.275 . . . . 0.0 110.674 -178.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 4.9 pttm -72.0 -27.66 62.88 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 120.358 -0.537 . . . . 0.0 110.67 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 22.8 ttmt -76.89 -26.93 54.75 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 121.847 -0.533 . . . . 0.0 110.375 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 24.2 mtt -98.95 31.06 3.12 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.698 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.944 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.8 p -122.87 115.88 29.16 Favored Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.68 142.34 63.61 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 C-N-CA 121.818 1.679 . . . . 0.0 112.167 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.8 m -162.58 41.4 0.12 Allowed 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 3.9 m0 -85.54 -2.75 58.47 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.895 -0.503 . . . . 0.0 110.776 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -58.96 -46.26 88.5 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.596 -0.69 . . . . 0.0 109.782 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 5.5 t -67.13 -39.39 86.6 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.84 -39.38 85.22 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -59.43 -41.4 89.5 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 51.1 mm -65.8 -46.88 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.447 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.7 OUTLIER -59.28 -47.49 85.19 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 120.299 -0.561 . . . . 0.0 109.552 -178.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 178' ' ' ALA . 34.4 m -67.6 -46.19 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 O-C-N 121.996 -0.44 . . . . 0.0 109.946 -179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . 0.442 ' N ' HG23 ' A' ' 177' ' ' VAL . . . -61.56 -40.16 93.72 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 -179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.4 -41.98 99.22 Favored Glycine 0 N--CA 1.497 2.747 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 176' ' ' PHE . 59.8 t -69.99 -43.89 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 CA-C-N 117.846 0.823 . . . . 0.0 108.863 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.01 -43.11 99.52 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.7 m -63.85 -46.88 83.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.01 -35.56 80.63 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.808 -0.442 . . . . 0.0 109.808 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 58.6 m -55.68 -40.26 72.07 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.52 -40.9 96.49 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.982 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 5.8 p -73.93 -47.17 39.58 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.653 -0.654 . . . . 0.0 110.782 -178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 45.9 mt -63.32 -49.06 84.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 19.5 t90 -62.35 -45.12 94.63 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 22.9 mmtp -69.36 -35.39 75.8 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 122.126 -0.359 . . . . 0.0 110.164 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -80.58 -24.0 39.48 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 122.074 -0.391 . . . . 0.0 110.431 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 68.2 mtt -105.29 27.48 8.24 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.944 -0.472 . . . . 0.0 110.075 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.718 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.843 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 24.8 p -118.28 92.79 43.81 Favored Pre-proline 0 N--CA 1.496 1.829 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.96 161.03 44.61 Favored 'Trans proline' 0 N--CA 1.5 1.854 0 C-N-CA 122.071 1.848 . . . . 0.0 112.065 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 5.8 t -58.02 135.8 57.03 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -101.89 -9.35 20.79 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.918 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -63.35 -45.89 89.09 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.672 -0.643 . . . . 0.0 109.546 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 45.4 p -70.11 -33.79 72.29 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' B' ' 177' ' ' VAL . 6.2 t -68.4 -40.95 83.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 11.3 m -65.0 -43.86 91.16 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.221 -178.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.6 tt -66.5 -42.48 90.24 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 C-N-CA 119.89 -0.724 . . . . 0.0 109.185 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.88 -47.08 86.2 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' B' ' 173' ' ' VAL . 57.3 t -65.89 -39.96 86.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.03 81.19 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.27 -38.77 94.04 Favored Glycine 0 N--CA 1.496 2.656 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 59.9 t -68.58 -44.15 83.0 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.476 ' C ' HD23 ' B' ' 181' ' ' LEU . 10.2 tt -61.94 -43.35 99.03 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 19.3 m -64.62 -38.82 92.33 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -57.86 -36.3 72.14 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 122.347 -0.22 . . . . 0.0 110.905 -178.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 1.3 p -69.31 -42.89 74.81 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.21 -43.34 95.34 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.423 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 1.3 p -75.15 -47.38 28.73 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 121.713 -0.617 . . . . 0.0 110.795 -178.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 50.0 mt -66.42 -43.88 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.975 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 67.9 t90 -57.95 -39.82 79.04 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 120.513 -0.475 . . . . 0.0 109.797 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -78.04 -27.3 48.75 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 122.169 -0.332 . . . . 0.0 110.758 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -105.26 8.75 34.02 Favored 'General case' 0 N--CA 1.503 2.19 0 O-C-N 121.885 -0.509 . . . . 0.0 111.774 -178.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.2 ptm -101.53 30.61 4.18 Favored 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 119.022 0.828 . . . . 0.0 109.824 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 2.826 0 CA-C-O 118.034 -1.426 . . . . 0.0 109.694 179.834 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.508 ' O ' HG23 ' A' ' 167' ' ' THR . 3.7 t -125.25 91.62 48.73 Favored Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 122.132 -0.628 . . . . 0.0 109.506 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.98 148.52 82.03 Favored 'Trans proline' 0 N--CA 1.499 1.844 0 C-N-CA 122.142 1.894 . . . . 0.0 111.665 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 4.9 t -124.22 134.91 53.14 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.421 ' O ' HG23 ' A' ' 174' ' ' THR . 1.7 m-90 -99.14 -2.35 37.13 Favored 'General case' 0 N--CA 1.509 2.523 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -58.44 -33.75 70.05 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.475 -0.766 . . . . 0.0 110.481 -178.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.421 ' O ' HG22 ' A' ' 175' ' ' ILE . 63.2 p -67.93 -48.62 65.43 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 120.641 -0.424 . . . . 0.0 110.078 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 33.9 m -68.83 -39.2 79.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.751 -0.593 . . . . 0.0 110.384 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 170' ' ' TRP . 47.8 p -65.34 -39.18 92.05 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 122.156 -0.34 . . . . 0.0 111.61 -178.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 172' ' ' THR . 5.9 tp -65.36 -40.85 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 CA-C-N 118.705 0.684 . . . . 0.0 109.653 -178.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -63.99 -44.62 92.12 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.6 t -67.18 -39.6 83.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -40.12 87.33 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -64.36 -42.24 97.8 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.676 -1.369 . . . . 0.0 109.676 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.99 -44.09 88.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.0 tt -62.98 -43.2 99.45 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 -179.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 19.9 m -59.0 -39.47 81.94 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 122.029 -0.42 . . . . 0.0 110.016 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -70.79 -37.44 73.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 122.019 -0.426 . . . . 0.0 110.763 -178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 8.3 t -58.98 -46.3 88.46 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -64.54 -42.49 95.7 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.57 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 16.8 p -68.96 -47.68 65.02 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 121.754 -0.591 . . . . 0.0 110.747 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.8 mt -67.14 -50.87 59.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 18.5 t90 -60.31 -40.05 89.15 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -78.21 -23.35 47.54 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 122.08 -0.387 . . . . 0.0 111.363 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.5 -27.3 16.05 Favored 'General case' 0 N--CA 1.503 2.206 0 CA-C-N 118.655 0.661 . . . . 0.0 111.178 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 7.9 ptm -135.29 33.81 3.06 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.836 -0.54 . . . . 0.0 109.548 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.894 0 CA-C-O 117.861 -1.522 . . . . 0.0 110.261 179.497 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 65.1 p -99.08 138.15 20.55 Favored Pre-proline 0 N--CA 1.496 1.873 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.03 146.65 77.9 Favored 'Trans proline' 0 N--CA 1.499 1.84 0 C-N-CA 121.879 1.719 . . . . 0.0 111.983 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 22.9 p -120.62 161.82 20.7 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 23.2 t90 -60.28 -35.07 74.7 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 109.743 -0.465 . . . . 0.0 109.743 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.01 -33.32 70.59 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 122.028 -0.42 . . . . 0.0 110.207 -179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 10.0 m -69.96 -40.8 75.19 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.427 ' O ' HG23 ' B' ' 177' ' ' VAL . 4.1 t -68.29 -44.64 83.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 9.9 m -65.16 -43.39 91.93 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.387 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 7.0 tp -66.11 -47.36 85.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.387 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -67.35 -46.8 72.32 Favored 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' B' ' 173' ' ' VAL . 91.9 t -65.1 -39.4 85.46 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.81 -38.57 82.35 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.843 -0.535 . . . . 0.0 109.69 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.28 -41.2 69.13 Favored Glycine 0 N--CA 1.498 2.81 0 N-CA-C 110.46 -1.056 . . . . 0.0 110.46 -179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.1 -44.43 78.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 118.078 0.939 . . . . 0.0 109.077 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.459 ' C ' HD23 ' B' ' 181' ' ' LEU . 8.8 tt -63.22 -43.2 98.77 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . 0.438 ' O ' HG23 ' B' ' 186' ' ' THR . 59.5 m -63.93 -43.07 96.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -59.21 -39.51 82.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 39.1 m -63.32 -43.12 98.71 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 76.5 mt -64.37 -41.05 96.91 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 122.277 -0.264 . . . . 0.0 111.331 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . 0.438 HG23 ' O ' ' B' ' 182' ' ' THR . 36.7 p -68.48 -47.28 67.47 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 121.64 -0.663 . . . . 0.0 110.464 -177.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.9 mt -65.55 -50.72 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.4 t90 -62.03 -45.09 95.11 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -64.66 -38.99 92.89 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 25.7 tptt -77.07 -27.22 54.18 Favored 'General case' 0 N--CA 1.498 1.952 0 C-N-CA 120.813 -0.355 . . . . 0.0 110.189 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 42.5 mtt -96.14 31.57 2.14 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.963 -0.461 . . . . 0.0 109.804 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.72 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.512 179.79 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.5 m -115.23 83.3 10.01 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.06 157.19 34.19 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 122.208 1.939 . . . . 0.0 112.242 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.2 m -90.5 135.72 33.52 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 5.5 m-90 -59.78 -36.58 76.99 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 70.0 tp60 -59.06 -36.15 74.56 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 25.0 m -70.06 -38.33 75.75 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.477 ' O ' HG23 ' A' ' 177' ' ' VAL . 4.9 t -68.29 -44.78 83.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.11 -43.76 90.97 Favored 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.455 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.1 tp -66.52 -42.91 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 C-N-CA 120.213 -0.595 . . . . 0.0 110.037 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.432 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -60.69 -47.18 87.44 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 -179.386 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 173' ' ' VAL . 87.4 t -61.38 -39.76 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.85 -37.85 80.41 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -68.09 -39.14 88.79 Favored Glycine 0 N--CA 1.496 2.655 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 176' ' ' PHE . 16.1 t -69.53 -42.43 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.6 tt -62.22 -43.09 99.61 Favored 'General case' 0 N--CA 1.493 1.677 0 CA-C-N 116.72 -0.218 . . . . 0.0 110.614 -178.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -66.51 -47.54 72.61 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 121.971 -0.456 . . . . 0.0 110.107 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -65.2 -34.33 78.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 109.622 -0.511 . . . . 0.0 109.622 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 5.1 t -58.36 -36.03 72.85 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 2.0 mt -64.15 -42.24 96.85 Favored 'General case' 0 N--CA 1.505 2.311 0 O-C-N 122.058 -0.401 . . . . 0.0 111.509 -178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.8 m -74.93 -47.25 30.65 Favored 'General case' 0 N--CA 1.504 2.225 0 CA-C-N 118.846 0.748 . . . . 0.0 110.689 -178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.591 HD13 HD11 ' B' ' 187' ' ' ILE . 44.7 mt -67.22 -45.84 85.43 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 46.4 t90 -60.15 -28.78 68.19 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 122.004 -0.435 . . . . 0.0 110.389 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -61.59 -39.13 90.1 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tptt -89.85 0.9 56.76 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 122.099 -0.376 . . . . 0.0 110.745 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 42.0 mtt -108.8 64.82 0.61 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.732 0 CA-C-O 117.992 -1.449 . . . . 0.0 109.668 -179.888 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.3 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 19.8 p -127.32 92.75 42.82 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.47 158.21 44.36 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 121.982 1.788 . . . . 0.0 112.02 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . 0.421 HG21 ' OE1' ' B' ' 171' ' ' GLN . 1.5 m -78.2 155.03 30.59 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -99.83 -2.83 33.98 Favored 'General case' 0 N--CA 1.507 2.381 0 O-C-N 122.186 -0.321 . . . . 0.0 110.485 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . 0.421 ' OE1' HG21 ' B' ' 169' ' ' THR . 8.5 pt20 -62.99 -33.11 74.7 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.656 -0.653 . . . . 0.0 110.306 -179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.6 t -64.31 -48.41 75.72 Favored 'General case' 0 N--CA 1.499 2.01 0 C-N-CA 120.429 -0.508 . . . . 0.0 109.771 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 31.3 m -68.56 -38.78 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 12.7 m -65.1 -41.47 94.94 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 122.165 -0.334 . . . . 0.0 110.716 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 2.9 tt -63.42 -42.89 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -178.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -67.11 -45.91 75.76 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.45 HG23 ' O ' ' B' ' 173' ' ' VAL . 63.4 t -66.72 -39.92 84.87 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.92 -37.69 88.01 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.85 -0.531 . . . . 0.0 109.667 -179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.33 -38.12 91.16 Favored Glycine 0 N--CA 1.497 2.706 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.7 t -69.99 -45.04 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 5.0 tt -67.82 -43.5 79.47 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 30.1 m -69.05 -38.83 79.34 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.403 ' O ' HG12 ' B' ' 187' ' ' ILE . . . -57.75 -50.27 73.79 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 5.6 m -51.49 -45.66 62.89 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 29.4 mt -64.32 -40.53 96.09 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 116.689 -0.232 . . . . 0.0 110.675 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 33.8 p -70.85 -47.46 59.24 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.849 -0.532 . . . . 0.0 112.424 -177.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . 0.591 HD11 HD13 ' A' ' 187' ' ' ILE . 17.3 pt -67.11 -40.51 85.49 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.887 -178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -57.78 -36.01 71.57 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.665 -178.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.61 -38.96 90.92 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 122.048 -0.408 . . . . 0.0 110.277 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -91.56 -16.84 26.54 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.941 -0.474 . . . . 0.0 110.977 -179.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 5.2 mmt -92.85 31.77 1.35 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.771 -0.581 . . . . 0.0 109.652 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.744 0 CA-C-O 117.926 -1.486 . . . . 0.0 109.596 179.882 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.9 m -125.09 93.68 45.14 Favored Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.7 151.01 83.46 Favored 'Trans proline' 0 N--CA 1.5 1.881 0 C-N-CA 122.122 1.881 . . . . 0.0 111.963 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 31.6 p -79.62 164.75 23.56 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 6.2 m-90 -98.74 -2.94 36.89 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 122.139 -0.351 . . . . 0.0 111.063 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -65.33 -47.02 77.97 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.605 -0.685 . . . . 0.0 109.928 -179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 t -70.12 -38.16 75.5 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 3.6 t -68.2 -43.97 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 74.8 m -65.25 -43.36 91.63 Favored 'General case' 0 N--CA 1.501 2.094 0 O-C-N 122.384 -0.197 . . . . 0.0 111.465 -178.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 5.7 tt -66.74 -41.0 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.483 -0.761 . . . . 0.0 110.59 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -61.91 -47.19 86.06 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.1 m -67.3 -38.96 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.28 -40.07 84.93 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.61 92.42 Favored Glycine 0 N--CA 1.498 2.793 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 59.1 t -67.87 -44.06 85.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 CA-C-N 117.614 0.707 . . . . 0.0 109.15 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 8.3 tt -66.73 -43.25 84.7 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 122.364 -0.21 . . . . 0.0 110.436 -178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 2.1 p -60.22 -47.63 85.16 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 122.06 -0.4 . . . . 0.0 110.374 -178.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -69.85 -31.63 69.58 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 120.667 -0.413 . . . . 0.0 110.037 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 43.3 t -58.61 -40.76 84.17 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.466 ' N ' HD23 ' A' ' 185' ' ' LEU . 1.3 mt -64.44 -42.09 96.19 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 122.105 -0.372 . . . . 0.0 111.262 -178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 2.5 m -72.84 -47.42 46.4 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 118.812 0.733 . . . . 0.0 110.592 -177.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -67.15 -49.67 70.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 -179.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 58.1 t-105 -57.9 -37.07 73.34 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 122.113 -0.367 . . . . 0.0 110.255 -178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 41.9 tttp -61.91 -35.16 77.57 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 122.127 -0.358 . . . . 0.0 110.035 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -87.8 -0.56 57.11 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.921 -0.487 . . . . 0.0 111.303 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 48.5 mtp -89.35 23.12 2.63 Favored 'General case' 0 N--CA 1.501 2.111 0 CA-C-N 118.755 0.707 . . . . 0.0 110.016 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.604 0 CA-C-O 117.968 -1.462 . . . . 0.0 109.532 179.824 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 2.9 m -108.09 91.42 7.9 Favored Pre-proline 0 N--CA 1.496 1.826 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.46 161.01 47.59 Favored 'Trans proline' 0 N--CA 1.5 1.897 0 C-N-CA 121.998 1.799 . . . . 0.0 111.999 -179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 7.3 t -96.37 151.22 19.74 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -100.96 -16.69 17.08 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.133 -0.354 . . . . 0.0 110.413 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -58.95 -46.21 88.59 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.766 -0.584 . . . . 0.0 110.02 -178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 69.9 p -70.09 -33.75 72.29 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . . . . . . . . . 10.5 t -68.0 -40.69 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 28.7 m -64.51 -43.3 94.52 Favored 'General case' 0 N--CA 1.498 1.947 0 C-N-CA 120.544 -0.462 . . . . 0.0 110.218 -178.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -66.24 -48.57 80.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 C-N-CA 120.567 -0.453 . . . . 0.0 109.857 -178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -67.4 -47.39 70.45 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 121.859 -0.526 . . . . 0.0 110.137 -178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 85.3 t -67.19 -39.74 83.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.05 -38.87 84.08 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 118.453 0.569 . . . . 0.0 109.94 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.74 -44.54 89.18 Favored Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.899 -1.28 . . . . 0.0 109.899 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.3 t -69.27 -39.56 79.23 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 117.683 0.741 . . . . 0.0 109.171 -179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.99 -43.24 99.26 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -62.74 -47.13 84.91 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.39 -41.1 96.86 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 122.329 -0.232 . . . . 0.0 110.681 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 19.1 m -69.07 -49.44 57.33 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.879 -0.513 . . . . 0.0 109.727 -179.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.17 -41.58 97.07 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 116.692 -0.231 . . . . 0.0 111.574 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 20.8 p -69.56 -47.51 63.4 Favored 'General case' 0 N--CA 1.505 2.302 0 CA-C-N 118.606 0.639 . . . . 0.0 110.558 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.1 mt -67.66 -45.43 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 22.0 t90 -57.91 -45.13 86.95 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 122.344 -0.223 . . . . 0.0 111.292 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -69.2 -23.07 63.86 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.545 -178.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -84.79 -13.65 50.49 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.873 -0.517 . . . . 0.0 110.319 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 40.9 mtt -67.94 -27.27 66.47 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.624 -0.672 . . . . 0.0 110.166 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.653 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.982 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 p -97.35 138.02 21.16 Favored Pre-proline 0 N--CA 1.496 1.839 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -66.85 161.07 43.79 Favored 'Trans proline' 0 N--CA 1.498 1.787 0 C-N-CA 121.845 1.697 . . . . 0.0 111.672 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.5 p -50.3 115.82 1.61 Allowed 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.505 ' O ' HG23 ' A' ' 174' ' ' THR . 3.6 t90 -87.38 -19.52 28.01 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.261 -0.275 . . . . 0.0 110.363 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -67.03 -41.6 86.29 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.927 -0.483 . . . . 0.0 110.399 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.4 m -61.86 -47.2 86.08 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -178.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.625 ' O ' HG23 ' A' ' 177' ' ' VAL . 32.0 m -68.16 -38.87 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 122.005 -0.435 . . . . 0.0 110.426 -179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 170' ' ' TRP . 20.8 p -64.16 -43.91 93.72 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.784 -0.573 . . . . 0.0 111.561 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 6.0 tp -66.69 -42.7 89.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 118.502 0.592 . . . . 0.0 109.902 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.429 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -63.15 -46.64 86.24 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 173' ' ' VAL . 62.6 t -64.64 -39.72 86.59 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.07 -40.09 94.18 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.875 -0.516 . . . . 0.0 110.451 -178.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -71.84 -43.91 48.91 Favored Glycine 0 N--CA 1.5 2.914 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 176' ' ' PHE . 48.1 t -68.87 -43.75 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 118.015 0.908 . . . . 0.0 108.938 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.42 HD23 HD21 ' A' ' 185' ' ' LEU . 6.4 tt -63.01 -42.97 99.95 Favored 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 121.064 -0.254 . . . . 0.0 110.412 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.8 p -64.34 -47.27 79.98 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.309 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.6 -34.61 78.21 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 30.4 m -58.95 -39.4 81.55 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.42 HD21 HD23 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -64.42 -41.27 96.7 Favored 'General case' 0 N--CA 1.503 2.208 0 O-C-N 122.12 -0.362 . . . . 0.0 111.382 -178.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.03 -47.16 30.36 Favored 'General case' 0 N--CA 1.505 2.312 0 O-C-N 121.474 -0.766 . . . . 0.0 110.591 -177.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 52.7 mt -64.74 -48.21 85.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 122.031 -0.418 . . . . 0.0 110.175 -178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -66.11 -44.22 84.96 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.799 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 50.7 tttp -64.21 -39.02 93.11 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 122.061 -0.4 . . . . 0.0 110.013 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 5.2 tmtm? -80.95 -27.12 36.18 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 59.9 mtt -100.9 51.55 0.86 Allowed 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.663 0 CA-C-O 118.142 -1.366 . . . . 0.0 109.875 179.771 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 4.3 t -132.12 137.3 29.79 Favored Pre-proline 0 N--CA 1.499 2.01 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -66.82 158.6 55.53 Favored 'Trans proline' 0 N--CA 1.499 1.853 0 C-N-CA 121.898 1.732 . . . . 0.0 111.729 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 1.7 p -60.08 149.25 33.01 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -71.42 -23.03 61.78 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 121.06 -0.256 . . . . 0.0 110.325 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -58.96 -37.62 77.19 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.875 -0.516 . . . . 0.0 110.513 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 42.2 p -67.36 -48.36 67.67 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.982 -0.449 . . . . 0.0 110.376 -178.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.422 ' O ' HG22 ' B' ' 177' ' ' VAL . 27.4 m -68.27 -39.45 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.906 -0.496 . . . . 0.0 109.922 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 27.5 m -62.31 -41.98 98.99 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 122.227 -0.296 . . . . 0.0 111.063 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 3.4 tp -65.68 -41.77 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.932 -178.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -67.08 -47.2 71.98 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.974 -0.454 . . . . 0.0 110.13 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.422 HG22 ' O ' ' B' ' 173' ' ' VAL . 31.6 m -67.05 -39.76 84.0 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.153 0 O-C-N 121.923 -0.485 . . . . 0.0 109.799 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.84 -36.92 77.85 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.6 -42.29 88.34 Favored Glycine 0 N--CA 1.497 2.707 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 48.6 t -70.1 -40.92 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.415 ' O ' HD13 ' B' ' 185' ' ' LEU . 6.4 tt -63.7 -43.25 97.16 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 22.5 m -68.55 -43.6 76.31 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.46 -35.24 77.06 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 122.213 -0.304 . . . . 0.0 110.319 -179.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 66.6 p -69.39 -41.44 76.46 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . 0.415 HD13 ' O ' ' B' ' 181' ' ' LEU . 6.7 mp -63.88 -44.24 93.62 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.46 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -66.21 -47.29 74.33 Favored 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.813 -0.554 . . . . 0.0 109.865 -178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 43.9 mt -66.32 -49.89 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -58.32 -44.06 88.47 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 -178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -65.02 -37.86 89.02 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 67.1 tttt -78.84 -22.02 46.76 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 122.065 -0.397 . . . . 0.0 110.196 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 19.9 mmt -91.86 27.63 2.04 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.867 -0.52 . . . . 0.0 110.131 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.757 0 CA-C-O 117.99 -1.45 . . . . 0.0 109.727 179.839 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 19.0 p -128.56 96.02 31.25 Favored Pre-proline 0 N--CA 1.496 1.864 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.64 157.78 60.42 Favored 'Trans proline' 0 N--CA 1.498 1.792 0 C-N-CA 121.837 1.691 . . . . 0.0 111.952 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 21.4 p -99.39 122.25 42.26 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -87.96 -14.64 38.68 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.208 -0.308 . . . . 0.0 110.366 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -66.64 -32.76 74.28 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.727 -0.608 . . . . 0.0 109.682 179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 37.9 m -57.52 -47.77 81.07 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.939 -0.475 . . . . 0.0 110.152 -178.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.0 m -68.04 -38.91 80.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 C-N-CA 120.345 -0.542 . . . . 0.0 110.339 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 40.4 p -65.4 -44.17 88.31 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.661 -0.649 . . . . 0.0 110.349 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.497 HG22 HG22 ' B' ' 175' ' ' ILE . 1.6 mp -66.69 -42.06 89.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -58.71 -46.88 86.33 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 -178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 58.7 t -66.71 -39.93 84.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 109.057 -0.719 . . . . 0.0 109.057 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.59 80.41 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.02 -39.7 93.18 Favored Glycine 0 N--CA 1.496 2.689 0 N-CA-C 110.145 -1.182 . . . . 0.0 110.145 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.6 t -69.38 -44.56 80.1 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-N 118.023 0.912 . . . . 0.0 108.604 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.402 ' C ' HD23 ' A' ' 181' ' ' LEU . 8.8 tt -64.46 -43.16 95.12 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -179.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 23.0 m -68.99 -45.67 70.01 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.51 80.76 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.345 -178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 90.8 p -57.97 -39.68 78.75 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.28 -41.01 97.11 Favored 'General case' 0 N--CA 1.505 2.287 0 CA-C-N 116.768 -0.196 . . . . 0.0 110.879 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.6 p -69.5 -47.35 64.13 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.656 -0.652 . . . . 0.0 110.88 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 40.2 mt -66.43 -46.29 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 8.1 m95 -57.98 -45.09 87.31 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 62.0 tttp -76.69 -29.28 56.23 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 122.09 -0.381 . . . . 0.0 110.254 -179.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -89.09 7.39 35.27 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.953 -0.467 . . . . 0.0 111.008 -179.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 3.7 mtt -65.31 -26.89 68.25 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.562 -0.711 . . . . 0.0 109.968 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.642 0 CA-C-O 117.966 -1.463 . . . . 0.0 109.54 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 27.1 p -131.78 72.85 79.52 Favored Pre-proline 0 N--CA 1.495 1.789 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.52 157.87 36.32 Favored 'Trans proline' 0 N--CA 1.496 1.666 0 C-N-CA 122.156 1.904 . . . . 0.0 112.271 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 66.1 p 49.14 91.4 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.263 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -80.36 -36.49 33.99 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.37 -35.08 76.47 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 19.3 m -59.36 -33.74 71.54 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.434 ' O ' HG23 ' B' ' 177' ' ' VAL . 12.4 t -62.35 -40.36 87.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 16.7 m -58.99 -43.14 91.4 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.526 ' N ' HD12 ' B' ' 175' ' ' ILE . 3.3 mp -65.39 -45.41 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . 0.473 ' O ' HG23 ' B' ' 180' ' ' VAL . 1.0 OUTLIER -58.62 -44.14 89.87 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.059 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.434 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.7 t -59.02 -39.9 79.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.58 -40.07 70.14 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -62.51 -41.26 99.8 Favored Glycine 0 N--CA 1.498 2.789 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . 0.473 HG23 ' O ' ' B' ' 176' ' ' PHE . 96.4 t -64.32 -38.01 81.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 tp -61.78 -43.18 99.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 11.4 m -58.98 -41.26 87.14 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.28 -39.04 91.65 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 52.4 p -61.71 -49.37 76.73 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.15 -41.08 97.3 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.369 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.7 p -67.43 -47.54 69.9 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.683 -0.636 . . . . 0.0 111.339 -177.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 1.9 mp -67.23 -42.23 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 -179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 4.7 t90 -61.38 -44.25 97.48 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.869 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -70.78 -36.32 72.98 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 -179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -76.83 -27.08 55.0 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.371 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 9.6 mtt -122.3 38.49 4.13 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.724 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 179.851 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 46.6 p -102.77 138.04 19.49 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.27 153.07 35.6 Favored 'Trans proline' 0 N--CA 1.499 1.817 0 C-N-CA 121.988 1.792 . . . . 0.0 112.553 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 173' ' ' VAL . 14.7 m -117.82 131.98 56.5 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -102.21 -18.37 15.53 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 122.228 -0.295 . . . . 0.0 110.755 -179.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -63.21 -46.98 84.47 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.81 -0.556 . . . . 0.0 110.093 -179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 59.4 p -70.05 -34.69 73.53 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 177' ' ' VAL . 11.6 t -68.42 -42.42 83.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.1 m -65.24 -43.98 89.66 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.096 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 7.3 tp -66.64 -44.56 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 C-N-CA 120.3 -0.56 . . . . 0.0 110.092 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.4 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -65.87 -46.89 76.73 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 173' ' ' VAL . 89.4 t -66.78 -39.62 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.857 0 N-CA-C 109.97 -0.381 . . . . 0.0 109.97 -179.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.06 86.07 Favored 'General case' 0 N--CA 1.5 2.052 0 CA-C-N 118.564 0.62 . . . . 0.0 109.621 -179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -67.38 -44.26 85.17 Favored Glycine 0 N--CA 1.5 2.945 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.506 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.8 t -67.54 -35.37 72.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.2 tt -62.66 -43.33 99.07 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 110.21 -0.292 . . . . 0.0 110.21 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -66.81 -47.36 72.31 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.785 -0.572 . . . . 0.0 109.676 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -67.22 -30.16 70.01 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.835 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.1 t -59.87 -46.86 87.97 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -64.51 -42.52 95.75 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 111.676 0.251 . . . . 0.0 111.676 -179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.0 m -67.88 -47.37 69.04 Favored 'General case' 0 N--CA 1.502 2.129 0 C-N-CA 120.212 -0.595 . . . . 0.0 110.234 -178.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 50.6 mt -67.46 -48.16 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 34.3 t-105 -57.94 -38.06 75.25 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 -178.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -61.82 -38.77 89.42 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 -179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 44.2 mmtm -86.8 -20.84 26.97 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 122.11 -0.369 . . . . 0.0 110.577 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 8.8 mmt -77.85 0.33 24.33 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.841 -0.537 . . . . 0.0 110.888 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.639 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.368 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -132.01 89.1 39.22 Favored Pre-proline 0 N--CA 1.497 1.902 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.22 159.58 51.55 Favored 'Trans proline' 0 N--CA 1.499 1.805 0 C-N-CA 122.055 1.837 . . . . 0.0 112.052 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 24.7 p -76.64 154.73 34.06 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 7.1 m-90 -101.92 -2.6 29.47 Favored 'General case' 0 N--CA 1.5 2.057 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.044 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.75 -39.57 85.21 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.618 -0.676 . . . . 0.0 110.207 -179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . 0.456 HG23 ' N ' ' B' ' 173' ' ' VAL . 5.3 t -66.03 -48.0 72.57 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 122.067 -0.396 . . . . 0.0 110.32 -179.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.456 ' N ' HG23 ' B' ' 172' ' ' THR . 27.6 m -68.53 -42.46 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.803 -0.561 . . . . 0.0 110.437 -179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 15.5 m -64.97 -43.42 92.7 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 122.089 -0.382 . . . . 0.0 111.404 -178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.27 -41.79 89.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 C-N-CA 120.315 -0.554 . . . . 0.0 109.718 -178.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -64.03 -45.24 89.78 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 173' ' ' VAL . 73.8 t -67.09 -39.64 83.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.93 -35.55 75.14 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -66.03 -42.13 94.8 Favored Glycine 0 N--CA 1.496 2.688 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 47.0 t -67.99 -44.38 84.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.05 -43.14 99.48 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 57.1 m -62.42 -45.21 94.13 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.506 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -65.33 -36.91 85.49 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 122.091 -0.381 . . . . 0.0 110.749 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 48.7 p -69.82 -47.71 61.73 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 20.1 tp -63.92 -40.61 96.87 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.499 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 4.0 m -75.0 -47.19 30.38 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-N 119.233 0.924 . . . . 0.0 110.23 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 54.5 mt -67.21 -44.46 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.13 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 15.7 t90 -67.46 -43.11 81.86 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 122.092 -0.38 . . . . 0.0 110.974 -178.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 46.0 tttt -66.89 -37.17 83.88 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.878 -0.514 . . . . 0.0 110.234 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 2.7 tttm -82.77 -27.31 31.12 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 122.042 -0.411 . . . . 0.0 110.169 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 32.2 mtt -103.05 27.84 6.79 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.91 -0.494 . . . . 0.0 109.716 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.696 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.711 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.256 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.0 m -103.74 92.37 4.21 Favored Pre-proline 0 N--CA 1.495 1.788 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.32 154.78 71.32 Favored 'Trans proline' 0 N--CA 1.5 1.89 0 C-N-CA 122.059 1.839 . . . . 0.0 112.357 -179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 7.6 t -103.68 158.6 16.27 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -93.96 -23.89 17.88 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -179.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -58.97 -39.43 81.72 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 26.7 p -69.18 -31.82 70.7 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 177' ' ' VAL . 10.4 t -67.75 -43.91 86.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 10.5 m -65.02 -44.02 90.54 Favored 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.931 -178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.495 HG23 HD12 ' B' ' 175' ' ' ILE . 13.9 tt -66.73 -38.87 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 C-N-CA 119.929 -0.709 . . . . 0.0 109.52 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.615 ' CD2' HD11 ' B' ' 175' ' ' ILE . 1.5 t80 -59.01 -45.98 89.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 173' ' ' VAL . 93.1 t -66.34 -39.29 83.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.44 -40.03 85.51 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.995 -0.441 . . . . 0.0 109.932 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -69.69 -42.06 72.61 Favored Glycine 0 N--CA 1.501 2.969 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' B' ' 183' ' ' ALA . 44.4 t -68.89 -34.19 63.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 O-C-N 122.003 -0.704 . . . . 0.0 109.25 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.523 ' O ' HD23 ' A' ' 185' ' ' LEU . 0.7 OUTLIER -65.41 -43.2 91.34 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.209 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 1.2 p -62.86 -47.22 84.31 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.792 -0.568 . . . . 0.0 109.944 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.29 -40.81 67.29 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -178.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 54.5 p -58.67 -42.85 89.42 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -179.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.523 HD23 ' O ' ' A' ' 181' ' ' LEU . 3.9 mm? -64.33 -43.06 95.81 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.186 -179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.5 p -72.03 -47.36 52.35 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.776 -0.577 . . . . 0.0 110.491 -178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 51.3 mt -66.23 -49.2 77.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 62.8 t90 -60.27 -39.84 88.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -179.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 76.4 mttt -62.29 -24.94 67.58 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 122.096 -0.378 . . . . 0.0 110.537 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 34.5 tptt -76.75 -27.14 55.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.855 -0.528 . . . . 0.0 110.16 -179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 5.5 ptt? -126.38 36.07 4.55 Favored 'General case' 0 N--CA 1.502 2.137 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.711 0 CA-C-O 118.05 -1.417 . . . . 0.0 109.829 -179.805 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 16.7 p -121.87 94.31 48.29 Favored Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.1 159.32 54.39 Favored 'Trans proline' 0 N--CA 1.499 1.835 0 C-N-CA 122.085 1.857 . . . . 0.0 112.051 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 17.7 p -76.01 163.99 26.6 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 15.3 m-90 -94.4 -10.2 33.29 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 122.258 -0.276 . . . . 0.0 110.741 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 14.8 mt-30 -60.75 -40.54 92.84 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.589 -0.695 . . . . 0.0 110.182 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . 0.472 HG23 ' N ' ' B' ' 173' ' ' VAL . 6.9 t -67.84 -48.16 66.95 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.832 -0.347 . . . . 0.0 110.835 -178.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.472 ' N ' HG23 ' B' ' 172' ' ' THR . 35.9 m -68.2 -40.37 82.68 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.872 -0.517 . . . . 0.0 110.811 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.5 m -65.04 -43.61 91.78 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.684 -0.635 . . . . 0.0 110.96 -178.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.625 HD13 ' O ' ' B' ' 175' ' ' ILE . 0.2 OUTLIER -66.41 -47.11 84.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 121.657 -0.652 . . . . 0.0 110.15 -179.203 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -67.36 -47.45 70.38 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 122.006 -0.434 . . . . 0.0 110.105 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.425 HG23 ' O ' ' B' ' 173' ' ' VAL . 85.1 t -67.22 -39.96 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 -179.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.37 -37.22 86.43 Favored 'General case' 0 N--CA 1.502 2.127 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -61.93 -43.14 99.6 Favored Glycine 0 N--CA 1.497 2.708 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 55.6 t -70.0 -39.98 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 3.2 mt -62.02 -43.64 98.42 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 122.22 -0.3 . . . . 0.0 110.368 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -69.34 -46.95 65.79 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.999 -0.438 . . . . 0.0 109.839 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.43 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -61.61 -42.31 98.7 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 122.251 -0.28 . . . . 0.0 110.604 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 58.5 m -69.13 -50.04 51.55 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.887 -0.508 . . . . 0.0 110.317 -179.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 64.9 mt -64.47 -41.41 96.53 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.307 -0.246 . . . . 0.0 111.638 -178.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 28.1 p -68.07 -47.34 68.58 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 118.408 0.549 . . . . 0.0 111.1 -178.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 47.7 mt -63.31 -44.83 99.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 3.7 m95 -62.15 -45.32 93.96 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.783 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 45.0 pttt -78.3 -31.09 48.72 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.771 -0.58 . . . . 0.0 110.985 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -79.1 -25.66 43.01 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 122.032 -0.418 . . . . 0.0 110.66 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 51.0 mtt -100.68 35.31 2.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.819 -0.551 . . . . 0.0 109.807 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.749 0 CA-C-O 117.981 -1.455 . . . . 0.0 109.798 179.46 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 2.8 m -111.58 85.21 5.74 Favored Pre-proline 0 N--CA 1.496 1.855 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -75.88 161.3 36.36 Favored 'Trans proline' 0 N--CA 1.497 1.721 0 C-N-CA 122.375 2.05 . . . . 0.0 112.184 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 2.8 m 63.08 26.34 15.35 Favored 'General case' 0 N--CA 1.505 2.288 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.43 ' O ' HG22 ' A' ' 173' ' ' VAL . 3.3 t90 -89.01 -52.62 4.99 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -69.12 -33.06 72.88 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 2.5 m -59.3 -47.02 86.95 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 122.138 -0.351 . . . . 0.0 110.171 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.5 m -63.74 -38.15 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.715 -0.616 . . . . 0.0 109.912 -179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 32.4 m -58.65 -43.43 89.79 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 122.099 -0.375 . . . . 0.0 110.897 -178.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . . . . . . . . . 4.4 tp -65.51 -41.75 91.59 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.167 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -62.65 -45.75 91.37 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 173' ' ' VAL . 90.9 t -64.65 -39.63 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.68 -40.09 86.68 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.692 -0.63 . . . . 0.0 109.807 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.52 -42.96 62.62 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 51.0 t -67.96 -44.36 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 CA-C-N 117.977 0.889 . . . . 0.0 108.967 -179.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 7.2 tt -62.85 -43.3 99.16 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 -179.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 56.5 m -58.94 -44.74 91.46 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.62 -0.675 . . . . 0.0 109.499 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -72.17 -37.25 69.39 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 122.11 -0.369 . . . . 0.0 111.52 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 6.1 m -59.57 -44.42 93.31 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.43 -44.7 90.37 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -178.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 13.3 p -66.03 -47.76 73.33 Favored 'General case' 0 N--CA 1.502 2.125 0 C-N-CA 119.829 -0.748 . . . . 0.0 110.429 -178.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 59.0 mt -67.7 -50.76 57.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 61.8 t-105 -60.3 -42.74 96.14 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 122.357 -0.214 . . . . 0.0 110.64 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -61.86 -32.99 73.37 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.652 -0.419 . . . . 0.0 109.918 -179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 55.4 mmtt -77.76 -14.45 59.59 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 122.013 -0.43 . . . . 0.0 110.582 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 45.4 mtt -69.06 -26.6 65.04 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.751 -0.593 . . . . 0.0 110.031 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.649 0 CA-C-O 118.204 -1.331 . . . . 0.0 109.945 -179.77 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 2.4 t -130.03 74.43 80.53 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 122.189 -0.595 . . . . 0.0 109.424 -179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.37 156.61 50.36 Favored 'Trans proline' 0 N--CA 1.498 1.784 0 C-N-CA 122.295 1.997 . . . . 0.0 111.949 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 3.4 p -76.54 170.44 16.4 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . 0.444 ' O ' HG23 ' B' ' 174' ' ' THR . 19.8 m0 -95.35 -34.21 12.23 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 120.602 -0.439 . . . . 0.0 110.096 -179.433 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -60.34 -40.98 92.62 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 122.115 -0.366 . . . . 0.0 110.635 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . 0.45 HG23 ' N ' ' B' ' 173' ' ' VAL . 7.5 t -67.86 -48.06 67.17 Favored 'General case' 0 N--CA 1.501 2.106 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.479 -178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.547 ' O ' HG23 ' B' ' 177' ' ' VAL . 34.7 m -68.57 -39.24 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 121.765 -0.584 . . . . 0.0 110.264 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . 0.444 HG23 ' O ' ' B' ' 170' ' ' TRP . 21.2 p -64.16 -43.31 95.54 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.96 -0.463 . . . . 0.0 111.847 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 17.7 tt -66.08 -42.53 91.6 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 118.798 0.727 . . . . 0.0 109.98 -178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -67.08 -45.7 76.53 Favored 'General case' 0 N--CA 1.499 1.989 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 173' ' ' VAL . 92.2 t -66.34 -40.3 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.43 -34.79 79.0 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.847 -0.533 . . . . 0.0 109.572 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -63.91 -45.23 94.64 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . . . . . . . . . 60.2 t -69.79 -43.09 80.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . . . . . . . . . 1.2 tt -62.45 -43.45 98.8 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 1.9 p -61.73 -47.19 86.37 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 120.949 0.404 . . . . 0.0 110.016 -179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.72 -29.34 70.04 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.089 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -50.72 58.67 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.84 -0.538 . . . . 0.0 110.461 -178.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.94 -44.15 90.42 Favored 'General case' 0 N--CA 1.505 2.316 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.582 -178.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -47.5 85.67 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 122.181 -0.325 . . . . 0.0 111.156 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 51.1 mt -67.12 -46.03 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 14.7 t90 -64.7 -34.93 79.46 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 120.932 -0.307 . . . . 0.0 110.3 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -63.51 -35.42 80.41 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 122.066 -0.397 . . . . 0.0 110.087 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 8.5 mtmt -91.13 0.69 57.48 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 122.018 -0.426 . . . . 0.0 111.057 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -92.29 25.07 3.08 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.741 -0.599 . . . . 0.0 109.765 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 2.579 0 CA-C-O 117.953 -1.47 . . . . 0.0 109.625 179.911 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 167' ' ' THR . 3.5 t -131.74 89.45 39.35 Favored Pre-proline 0 N--CA 1.499 2.009 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.93 161.11 45.88 Favored 'Trans proline' 0 N--CA 1.5 1.865 0 C-N-CA 122.242 1.962 . . . . 0.0 112.179 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 9.4 t -53.52 154.11 3.77 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.449 ' O ' HG22 ' A' ' 174' ' ' THR . 0.0 OUTLIER -84.52 -6.0 59.34 Favored 'General case' 0 N--CA 1.505 2.289 0 O-C-N 122.092 -0.38 . . . . 0.0 111.057 -178.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -65.92 -35.08 79.63 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.631 -0.668 . . . . 0.0 110.128 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 m -69.14 -48.07 63.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 122.206 -0.309 . . . . 0.0 110.34 -178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 30.5 m -67.84 -41.6 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 122.08 -0.388 . . . . 0.0 111.088 -178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . 0.449 HG22 ' O ' ' A' ' 170' ' ' TRP . 7.5 t -62.86 -41.45 99.38 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.967 -178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ILE . . . . . 0.461 ' CG2' HG21 ' B' ' 175' ' ' ILE . 3.7 tp -66.25 -42.26 90.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.29 -179.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -60.07 -47.45 85.81 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 121.822 -0.549 . . . . 0.0 109.853 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 35.0 m -67.14 -39.76 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.235 0 O-C-N 121.912 -0.493 . . . . 0.0 109.815 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.93 93.39 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . -65.9 -42.37 94.94 Favored Glycine 0 N--CA 1.499 2.853 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' B' ' 183' ' ' ALA . 42.9 t -69.79 -44.99 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 6.9 tt -63.98 -42.95 97.06 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -179.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' THR . . . . . . . . . . . . . 74.3 m -63.96 -44.34 93.05 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -61.08 -41.31 96.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 122.066 -0.397 . . . . 0.0 110.453 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.71 -36.37 71.91 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 1.9 mt -64.56 -41.79 96.08 Favored 'General case' 0 N--CA 1.505 2.28 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -178.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -73.53 -36.1 65.64 Favored 'General case' 0 N--CA 1.51 2.546 0 CA-C-N 118.871 0.759 . . . . 0.0 110.059 -177.334 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 41.3 mt -67.33 -47.93 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 2.1 t-105 -62.66 -36.09 81.76 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 -179.166 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -61.88 -39.08 90.7 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.5 mttm -83.01 -27.23 30.52 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 122.046 -0.408 . . . . 0.0 110.009 179.61 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' MET . . . . . . . . . . . . . 65.4 mtt -103.48 25.98 8.99 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.675 0 CA-C-O 118.076 -1.402 . . . . 0.0 109.616 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.311 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 167' ' ' THR . . . . . . . . . . . . . 3.5 m -122.16 78.9 43.39 Favored Pre-proline 0 N--CA 1.497 1.915 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 168' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -67.24 155.69 69.48 Favored 'Trans proline' 0 N--CA 1.499 1.796 0 C-N-CA 122.464 2.11 . . . . 0.0 111.901 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 169' ' ' THR . . . . . . . . . . . . . 6.7 t -120.5 160.71 22.61 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 170' ' ' TRP . . . . . . . . . . . . . 19.1 m-90 -64.01 -11.77 32.08 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 122.107 -0.371 . . . . 0.0 111.146 -179.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 171' ' ' GLN . . . . . . . . . . . . . 51.7 tp60 -67.13 -47.27 71.61 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 118.587 0.631 . . . . 0.0 110.232 -178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 172' ' ' THR . . . . . . . . . . . . . 9.9 t -70.3 -33.68 71.84 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 -179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 173' ' ' VAL . . . . . 0.438 ' O ' HG23 ' B' ' 177' ' ' VAL . 7.9 t -63.76 -43.66 98.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 174' ' ' THR . . . . . . . . . . . . . 17.4 p -64.76 -43.34 93.6 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 120.646 -0.422 . . . . 0.0 109.915 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.461 HG21 ' CG2' ' A' ' 175' ' ' ILE . 50.0 mt -66.25 -48.25 81.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . 0.451 ' O ' HG23 ' B' ' 180' ' ' VAL . 0.2 OUTLIER -62.28 -47.1 85.8 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 -178.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . 0.438 HG23 ' O ' ' B' ' 173' ' ' VAL . 86.4 t -67.23 -39.84 83.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 -179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.63 -40.29 73.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.922 -0.486 . . . . 0.0 110.449 -178.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 179' ' ' GLY . . . . . . . . . . . . . . . -70.77 -43.64 58.72 Favored Glycine 0 N--CA 1.5 2.909 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 180' ' ' VAL . . . . . 0.451 HG23 ' O ' ' B' ' 176' ' ' PHE . 62.0 t -70.06 -43.0 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-N 117.735 0.767 . . . . 0.0 108.957 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 181' ' ' LEU . . . . . 0.436 ' C ' HD23 ' B' ' 181' ' ' LEU . 9.2 tt -64.18 -43.31 95.51 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 182' ' ' THR . . . . . . . . . . . . . 64.4 m -64.7 -43.0 94.88 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 183' ' ' ALA . . . . . 0.418 ' HB2' HG13 ' A' ' 180' ' ' VAL . . . -66.65 -39.04 88.05 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 120.795 -0.362 . . . . 0.0 110.045 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 184' ' ' SER . . . . . . . . . . . . . 30.3 t -68.96 -45.74 69.91 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 185' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -64.41 -44.04 92.5 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.588 -178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 186' ' ' THR . . . . . . . . . . . . . 3.8 m -65.26 -47.05 78.1 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 118.637 0.653 . . . . 0.0 109.954 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 187' ' ' ILE . . . . . . . . . . . . . 49.4 mt -66.94 -47.63 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 188' ' ' TRP . . . . . . . . . . . . . 36.0 t-105 -60.53 -38.34 84.12 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 189' ' ' LYS . . . . . . . . . . . . . 8.3 tmtm? -62.02 -39.14 91.25 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 37.6 mtpt -80.29 -27.23 38.55 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.232 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 191' ' ' MET . . . . . . . . . . . . . 28.7 mtm -105.51 22.61 15.18 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 192' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 2.664 0 CA-C-O 118.124 -1.376 . . . . 0.0 109.722 179.996 . . . . . . . . 0 0 . 1 stop_ save_